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THYROID HORMONE SYNTHESIS AND RELEASE. 
REGULATION BY DIETARY IODINE 
Iodine is an essential trace element and part of the thyroid hormones. It is thus 
obvious that the metabolism of iodine, the thyroid function and the thyroid hormone 
production are highly interconnected. 
The thyroid hormones, chemically known as the iodothyronines, are synthesized 
in the follicular cells of the thyroid gland1 •2 The main secretory product of the 
thyroid gland is thyroxine. (T 4 ), which has little intrinsic bioactivity and is generally 
regarded as a prohormone3•4 . Less than 20% of the bioactive hormone 
triiodothyronine (T 3) is produced by the thyroid gland, while the majority of T 3 is 
generated outside the thyroid (in the brain, liver and kidney) by monodeiodination of 
the phenolic ring of T4 5•6•7•8•9 •10 (see also later). The hormonal effects of the 
inactive pro hormone T 4 are therefore in vivo largely due to its conversion to T 3. 
The synthesis and release of the thyroid hormones by thyrocytes is regulated by 
Thyrotropin or Thyroid Stimulating Hormone (TSH), which is secreted by the 
thyrotrophic cells of the anterior pituitary gland. The synthesis of TSH by these pituitary 
cells is regulated by Thyrotropin Releasing Hormone (TRH), synthesized in the 
hypothalamus. A negative feedback loop exists, by which the T 3 and T 4 
concentrations regulate the synthesis and secretion of both TSH and TRH (see 
figure 1). 
The sequence of events that lead to the synthesis and finally the secretion of the 
iodothyronines T 3 and T 4 into the circulation are: 1) an active concentration of iodine 
as iodide by the thyrocytes in the thyroid gland, 2) the synthesis of thyroglobulin (Tg) 
by the thyrocytes, 3) iodination of tyrosyl residues of Tg mainly at the apical cell 
membrane of the thyrocytes, 4) coupling of mono- and diiodotyrosine residues with 
formation of iodothyronines also mainly at the apical cell membrane, and 5) resorption 
and subsequent proteolytic digestion of the iodothyronine-rich Tg by the thyrocytes 
and the release and secretion of the iodothyronines1•2 (see figure 1). 
1. 1. 1 Concentration of iodide by the thyroid gland; iodide transport 
The dietary iodine is quickly resorbed and spread through the body. Two third is 
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Figure 1. The sequence of events leading to thyroid hormone synthesis and release. Regulation 
via TRH and TSH 
The thyrocytes internalize the iodine as iodide via an active transport process 
using an iodide pump12, which is located in the besolateral membrane of the 
thyrocytes13. This iodide transport is dependent on a Na+ /K+·ATPese, which 
exchanges 3 Na + ions for 2 K+ ions 14. The iodide is cotransported with Na + via 
a specific carrier protein 15. In TSH stimulated thyrocytes the activity of the iodide 
pump can reach such activation that the iodide concentration in the cell is 500 times 
higher than the plasma iodide concentration. The active iodide transport can be 
blocked by the anion perchlorate (CL04 ) through a competitive binding process. 
CL04- is concentrated in the thyrocytes and decreases the iodide influx, while 
increasing the iodide efflux. 
Once internalized, the iodide is transported, or it diffuses to the apica pole of the 
thyrocyte. Mainly in the extracellular follicular lumen iodide is coupled to tyrosine 
12 
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residues in the storage protein Tg, but intracellular locations of the iodination system 
have also been proposed16. The coupling process is catalyzed by the enzyme 
thyroid peroxidase (TPO) in the presence of H20 2, which is generated by a NADPH-
dependent transmembrane enzyme complex (see later). 
1.1.2 Thyroglobulin 
After translation of the mRNA for the Tg molecule in the rough endoplasmic 
reticulum (rER) several post-transnational modifications like glycosylation 17, 
sulfatation 18 and phosphorylation 19•20 occur before the large protein Tg, 
transported in vesicles, encounters the apical membrane of the thyrocyte. The 
complete Tg molecule is a glycoprotein of 660 kD, consisting of two identical subunits 
of approximately 2800 aminoacids each21 . At the apical thyrocyte membrane the 
tyrosine residues of Tg are iodinated, which process is catalyzed by TPO. Before the 
tyrosyl residues of the Tg molecule can be iodinated, Tg, iodide, TPO and H2o2 must 
be present at the same time and at the same location (the apical thyrocyte 
membrane). 
1. 1.3 Thyroid peroxidase and the related myeloperoxidase 
TPO is a glycosylated transmembrane-bound enzyme with its COOH-terminal end 
projecting into the cytoplasm of the thyrocyte and the active site projecting into the 
follicular lumen22 Human TPO and human myeloperoxidase (MPO), the latter 
enzyme present in mononuclear phagocytes, have diverged from a common ancestral 
gene, since their DNAs and their amino acid sequences show a 46% and 44% 
homology, respectively23. MPO plays a major role in the H20 2 dependent anti-
microbial system during the respiratory burst of activated mononuclear phagocytes. 
It has been demonstrated that the enzyme TPO is oxidized by H20 2. However, the 
precise nature of the transmembranous H20 2-generating system in the thyroid is still 
unknown. It has been shown that the production of H20 2 is NADPH-
dependent24·25 and that it transfers electrons across the membrane in order to 
generate H20 2 from 2H + and 0 2. 
A similar NADPH oxidase is present in mononuclear phagocytes which is activated 
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by certain stimuli such as binding of bacteria to the cytoplasm membrane26. During 
the respiratory burst the NADPH oxidase produces superoxide and subsequently 
H2 0 2 and OH
0
. H2 0 2 and the radical products are capable of destroying the bacteria. 
Granules of the mononuclear phagocytes release MPO, which in the presence of H20 2 
and halide ions (such as cr and I") produce further active radicals such as 
hypochlorous acid, CIOH, or hypoiodous acid, IOH (in which the iodonium ion is I+). 
1. 1.4 Iodination of tyrosyl residues of thyroglobulin and coupling of 
monoiodotyrosine and diiodotyrosine residues 
The enzyme TPO is oxidized by H20 2, resulting in the formation of Compound I, 
which subsequently oxidizes iodide. This leads to the formation of the iodonium ion 
(1+)27 that reacts with H20 to form hypoiod~e (10") probably via the formation of 
hypoiodous acid (IOH)28. These reaction products, that are still bound to the 
enzyme TPO, react with the tyrosyl residues of Tg to form monoiodotyrosine (MIT) and 
diiodotyrosine (DIT) residues. Compound I is reduced to the native form concomitantly 
with the iodination of Tg. The coupling of one MIT and one DIT or two DIT residues 
is catalyzed by the enzyme TPO, which leads to the formation of T 3 and T 4 , 
respectively, bound to Tg2. In vivo coupling of MIT and DIT residues can lead to 1-2 
molecules T3 or T4 bound to the Tg dimer
29
. The iodinated Tg molecule is stored 
in the follicular lumen (colloid). 
The anti-thyroid drug methimazole (MMI), which is used to treat hyperthyroidism, 
inhibits TPO by competing with its active thioureylene group with iodide lor the enzyme 
TP030. It has been shown that the action of MMI is not restricted to the thyroid 
enzyme TPO, but that it also inhibits peroxidase systems of other cell types31 . 
1. 7.5 Resorption and lysosomal degradation of iodinated thyroglobulin 
Upon TSH stimulation, the endocytosis of Tg is stimulated via a) macropinocytosis 
and the formation of pseudopods into the colloid, b) via fluid-phase 
micropinocytosis32 and c) receptor mediated micropinicytosis33. The endocytosed 
iodinated Tg is transferred to the lysosomes of the thyrocytes lor proteolytic cleavage 
and thyroid hormone release. Selective cleavage of Tg by the endopeptidases 
14 
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cathepsin D, 8, and Lis followed by a further degradation of the iodinated Tg molecule 
by exopeptidases34. The early degradation process leads to the release of T3 and 
T 4 and further proteolysis results in the total degradation of Tg. The non-secreted 
iodotyrosines are deiodinated intracellularly by the enzyme iodotyrosine deiodase and 
the free iodide can be reused. T 3 and T 4 are secreted at the basolateral surface of the 
thyrocyte via an unknown mechanism, probably involving thyroid hormone carrier 
proteins35. 
1.1.6 Regulation by the dietary iodine of thyroid hormone synthesis and release 
Excessive iodine diet 
Besides the regulation by TSH, an autoregulation of the thyroid exists particularly 
in respect to the dietary iodine intake. A prominent and acute increase of the dietary 
iodine intake results in an acute but transient decrease of the iodide transport 
mechanism36 and hence in a decrease in the iodination of Tg, leading to a 
decreased iodothyronine formation and thyroid hormone secretion. This phenomenon 
is known as the Wolff-Chaikoff effect37. When a high level of plasma iodide is 
maintained, the inhibitory effects of iodide disappears and iodothyronine formation is 
restored (escape from the Wolff-Chaikoff effect). The precise mechanisms causing this 
escape are still unknown. When the level of plasma iodide falls below a critical level 
(20-30pgjml), iodothyronine formation is also restored38. 
The effects of a chronic excessive dietary iodine intake are largely unknown. 
Under most circumstances, overt abnormalities of thyroid function have not been 
observed in normal individuals receiving chronic iodide therapy but subtle changes do 
occur. A small, significant decrease in the serum concentrations ofT 4 and T 3 with a 
small rise in serum TSH have been observed39•40. Changes are usually within the 
normal range lor the various parameters evaluated. 
Deficient iodine diet 
During iodine deficiency the iodide extraction from the blood by the thyrocytes is 
more efficient due to an increased activity of the iodide pump. This increased activity 
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is partly due to a stimulatory effect of TSH41 and partly to an autonomous control 
mechanism by the thyroid itself2. The iodide extraction from the blood is negatively 
correlated with the anorganic iodide plasma concentration, resulting in a constant 
iodide uptake by the thyrocytes per time period. However, complete compensation via 
the above described mechanisms is not reached when the dietary iodine intake is too 
low. 
Besides an increased iodide clearance from the plasma, the iodide metabolism is 
changed during iodine deficiency. The intracellular iodide taken up by the thyrocytes 
or intracellular released during the degradation of MIT and DIT residues (see above) 
is very efficiently reused, resulting in a minimal iodide leakage. Furthermore, the iodide 
ions recently bound to tyrosyl residues in the Tg molecule are also the first ones to be 
used for the secretion of thyroid hormones ("last come - first served"). This aspect of 
the iodide metabolism is increased during iodine deficiency and a faster release of 
thyroid hormones occurs43. 
Additionally, the degree of iodination of the Tg molecule is lower during iodine 
deficiency, which leads to more MIT than DIT residues and thus to more T3 than T4 . 
In this way an enhanced synthesis of the biologically active T 3 at the expense of the 
production of the prohormone T 4 occurs, thereby allowing an efficient usage of the 
small amounts of iodide available with an optimal biological potency per Tg 
molecule44 
The above described compensatory mechanisms of the thyroid are able to 
maintain euthyroidism during relatively mild iodine deficiency. Only during more severe 




THE ACTION OF THYROID HORMONES AND 
THYROID HORMONE METABOLISM 
1.2.1 The action of thyroid hormones 
Thyroid hormones play a key role in the regulation of metabolic processes 
involved in temperature adaptation and calorigenesis45. Furthermore, a lack of 
thyroid hormones in fetuses causes growth retardation and a hampered neurological 
and mental development. In humans, over 99% of the circulating T 4 and T 3 is bound 
to plasma proteins: 75% to thyroxine-binding globulin (TBG), 15% to thyroxine-binding 
prealbumin (TBPA) and 10% to albumin46•47•48. Although thyroid hormones are 
hydrophobic molecules, they do not enter cells by simple diffusion. Cellular uptake of 
thyroid hormones is an active process, mediated by specific, sodium and energy 
dependent carrier systems located in the cell membrane49•50•51 . Since only 
nonprotein-bound thyroid hormone is taken up by the cells, the free iodothyronine 
concentration in serum determines hormone transfer to the cells. Furthermore, transfer 
ofT 3 from the cytoplasm to the nucleus may also be a specific and energy-dependent 
process, determining the hormone levels at the nuclear T 3 receptor site 52. 
By binding to nuclear receptors, T 3 exerts its effect at the transcriptional 
level52•53•54•55•56. It functions as a signalling substance by regulating the 
transcription of certain T 3-responsive genes 57 (most notably the c-erbA proto-
oncogenes58). Cellular responses toT 3 hence depend - amongst other factors - on 
the bioavailability and concentration of T 3 within the nucleus and cytoplasm, which is 
regulated by different mechanisms. 
Apart from the exchange of T 4 and T 3 between tissues and plasma, the 
bioavailability ofT 3 also depends on the intracellular thyroid hormone metabolism. The 
major pathways in this intracellular thyroid hormone metabolism are: 1) removal of 
iodine substituents by deiodination (conversion of T4 into T3 or rT3), 2) conjugation 
of the phenolic hydroxyl group of the iodothyronines with glucuronic acid or sulfate, 
3) oxidative deamination and decarboxylation of the alanine side chain and 4) ether 
link cleavage59•60. Except for the conversion ofT 4 into T 3 all other pathways lead 
to inactivation of thyroid hormone. 
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1. 2. 2 Deiodination 
The bioinactive prohormone T 4 can be transformed into the bioactive thyroid 
hormone T 3 through elimination of an iodide from the phenolic outer ring. In contrast 
to this activation step, an inactivation through deiodination can also occur, through 
deiodination of the inner phenolic ring. This leads to the formation of reverse T 3 (rT :0, 
a compound without hormonal activity. Like T 4 , T 3 is inactivated by inner ring 
deiodination, which yields 3,3'-T2 (see figure 2, 3,5-T2 and 3',5'-T2 are minor 
metabolites). Further stepwise deiodination results via T 1 intermediates in the formation 
of thyronine (T0), the noniodinated backbone molecule of thyroid hormones. 
The deiodination reactions are cataiY2ed by at least 3 different iodothyronine-
deiodinating enzymes. 
The type I iodothyronine deiodinase is most abundant in the endoplasmic 
reticulum of liver, the plasma membrane of kidney and membrane fractions of the 
thyroid. It is capable of deiodinating the inner ring as well as the outer ring of 
iodothyronines and is largely responsible lor the production of plasma T 3 as well as 
clearance of plasma rT3 (see figure 2). 
type I deiodinase 
type II deiodinase 
T, 
type I deiodinase 
type Ill deiodinase 
outer ring inner ring 
1 s· s· 1 s s 
HOO· ) 00• ~ CH,- 2:'_ COOH . 






type Ill deiodinase 
rT, 
type l deiodinase 
type II deiodinase 
Figure 2. Deiodination of thyroxine (f J. 
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The type II iodothyronine deiodinase acts only on the outer ring and is present in 
pituitary, brown adipose tissue and the central nervous system. This type II enzyme 
is important for the local supply ofT 3 (see figure 2). 
The type Ill enzyme is an inner ring deiodinase and catalyzes conversion ofT 4 to 
rT 3 and of T 3 to 3,3' -T 2 and is mainly found in brain and skin (see figure 2). 
1.2.3 Conjugation, oxidative deamination and decarboxylation, and ether-link 
cleavage 
The second important pathway in the metabolism of thyroid hormones is 
conjugailon of the phenolic hydroxyl group with glucuronic acid or sulfate (see 
figure 3). This reaction increases the water-solubility of lipophilic substances and 
facilitates their excretion in bile and urine. Furthermore, type I deiodination of T 3 is 
enhanced after sulfatation61 . 
deiodination 
,/ ,, 
"0 \ o~cH,-d:'-cooH triiodothyronine (T:J 
---------- '- t ).J- • 
conjugation ether bond cleavage oxidative deamlnation 
and decarboxylation 
' t ' <00000<,-=· 
1 triiodothyroacetic acid 
-o,,-obob'"·-d:·:,oo-




' ' ' _ HNH, OH 
diodotyrosine (Oil) 
' 
Figure 3. Metabolic pathways of triiodothyronine (T 3). 
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Transformation of the alanine side chain of an iodothyronine and subsequent 
conversion by oxidative deamination and decarboxylation leading to the corresponding 
iodothyroacetic acid derivative is a relatively minor pathway in the normal iodothyronine 
pathway and occurs in the liver, kidney and brain (see figure 3). lodothyroacetic acids 
are metabolized via the same deiodination and conjugation pathways as the normal 
iodothyronines. Although the iodothyroacetic acid derivatives can be found in tissues 
and in the circulation, the reason for oxidative deamination and decarboxylation of 
iodothyronines still remains unclear. 
Cleavage of the diphenyl ether link between the two phenolic ring structures of the 
thyronine molecules requires H20 2 and occurs in the granular fraction (which contains 
MPO) of activated phagocytes during the respiratory burst. Activated leukocytes use 
T 4 as substrate and DIT and iodide are released (see figure 3). This is a minor 
pathway by which iodothyronines are metabolized. 
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THE REGUlATION OF THYROID GROWTH. EFFECTS OF DIETARY IODINE 
The last few decades many studies have been focussed on the mechanisms of 
the regulation of thyroid growth under physiological as well as pathological conditions. 
However, many controversies and discrepancies with regard to the nature and action 
of growth factors have arisen due to the use of different investigative in vitro and in 
vivo models and different end-point measurements. These models and end-point 
measurements include a whole variety ranging from biochemical techniques (for 
instance the preparation and use of cell fractions for binding studies and growth factor 
receptor assays) and cellular biological techniques (for instance the measurement of 
3H-thymide incorporation into DNA of primary cell cultures and long-term established 
cell lines of human or animal origin) to in vivo approaches (for instance the histological 
effects seen in thyroid tissue transplants in nude mice). 
The regulation of thyroid cell growth was once a classical example of the concept 
one hormone - one cell type- one intracellular secondary messenger with its pleiotypic 
effects. Nowadays it is considered to be the result of a complex network of cross-
inked regulatory steps in which extracellular and intracellular signal molecules act on 
:heir receptors to turn other pathways on or off. Such regulatory networks differ from 
Jne cell type to another and, for a given cell type, from species to species. Taken this 
nto account, many apparent discrepancies in the literature can be explained. 
1.3. 7 The growth effects of thyrotropin or TSH 
The main and best known regulatory network involves thyrotropin (TSH) 
rrimulation of plasma membrane adenylate cyclase (see later). By activating cyclic 
IMP-dependent protein kinases, the main functions of the thyroid gland, namely the 
Jdination of Tg and iodothyronine formation, i.e. the synthesis of thyroid hormones, 
•nd the uptake of Tg and its hydrolysis, i.e. the secretion of thyroid hormones are 
•nhanced. Also the prolfferation of thyrocytes is stimulated by TSH, although 
lepending on the in vivo or in vitro system used. 
Extracellular signals such as hormones and growth factors bind selectively to 
pecific receptors and are transformed through intracellular systems into second 
1essengers. When these transducing systems are activated by the binding of 
ormone to receptor, there is an increased production of intracellular second 
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messengers that act largely by stimulating protein phosphorylation. Most normal cells 
have at least two classes of transducing systems via membrane receptors. The 
transducing systems activated by TSH in the normal thyroid gland are the adenylate 
cyclase - protein kinase A system and the phOsphoinositide (PI) turnover protein 
kinase C calcium system (phospholipase C system)62•63•64-65,6S. TSH 
stimulates the adenylate cyclase and the phospholipase C system by first binding to 
the TSH receptor on the cell surface. In both transducing systems the TSH signal is 
transmitted through guanyl nucleotide regulatory proteins (G proteins) that link the TSH 
receptor to the catalytic unit of the enzymes adenylate cyclase and phospholipase C. 
The binding of TSH to its receptor alters the conformation of the G proteins in such 
a way that GTP is able to bind to the G proteins. In the GTP-bound state the G 
proteins are able to stimulate the activity of adenylate cyclase or phospholipase C. 
Once the G proteins have activated their effector molecules, the intrinsic GTPase 
activity converts GTP to GOP resulting in an inactive G protein that is then able to be 
reactivated by interaction with the hormone-receptor complex. 
Adenylate cyclase converts adenosine triphosphate (ATP) to cyclic adenosine 
monophosphate (cAMP) that activates protein kinase A by binding to the regulatory 
subunit, releasing the active subunit. Protein kinase A subsequently phophorylates 
cellular proteins. 
The activated enzyme phospholipase C hydrolyses phosphatidylinositol 4,5-
biphosphate (PIP 2) and generates two intracellular signalling molecules: inositol 1 ,4,5-
triphosphate (IP3) and diacylglycerol (DAG). IP3 causes the release by endoplasmic 
reticulum of stored Ca2 + which results in a rise of the intracellular Ca2 + 
concentration. An increased intracellular Ca2 + concentration leads to cell proliferation 
in some cell types by yet unknown mechanisms. DAG activates the protein k'1nase C, 
which (like protein kinase A) phosphorylates cellular proteins. 
Both receptor-transducer systems rapidly converge on several events such as the 
phosphorylation of tyrosine residues of proteins and both systems are capable to give 
rises in c-fos and c-myc protooncogene mRNA. These early events are assumed to 
be necessary for growth stimulation, but a causative relationship with late commitment 
to DNA replication remains unclear67 
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1.3.2 The effects of other growth factors such as Epidermal Growth Factor and 
Insulin-like Growth Factors 
Epidermal growth factor (EGF) is a well known growth factor and plays a role in 
the regulation of thyroid growth and fuction68•69•70•71 •72•73. EGF exerts 
its effects via protein tyrosine kinase activity. The EGF receptor is like the TSH receptor 
located on the basolateral cell surface of the thyrocyte74•75 and TSH synergizes 
with EGF in growth stimulation by mechanisms involving upregulation of the EGF 
receptor by TSH 76. 
Insulin-like growth fators (IGF-1, IGF-11) and insulin have been shown to be involved 
in thyroid growth77•78. lnsuline has a mitogenic action on the thyroid, besides the 
stimulation of metabolism 79. A simultaneous stimulation of human thyrocytes with 
TSH and IGFs resulted in a more than additive effect on thyrocyte proliferation. 
However, the effect of these growth factors depend on the model system used. 
TSH, EGF and IGFs are thus important thyrocyte growth stimulators. The precise 
second messenger systems triggered by these growth factors and their 
interrelationships are not completely unraveled. Further investigations are necessary 
to elucidate the complex interactions of growth regulation in human thyrocytes. 
1.3.3 The effects of iodine on thyroid growth 
Iodine deficiency leads in the majority of individuals to thyroid growth (endemic 
goitre). Iodine depletion has been considered by some to be directly responsible for 
thyrocyte growth by a direct antimitotic effect of iodine on thyrocytes80. The 
proliferative effect of EGF on thyroid follicles in suspension culture inversely depends 
on the iodine supplementation of these follicles, indicating that thyroid growth is mainly 
inversely correlated with the iodine content of the thyroid gland. In other words mainly 
during iodine deficiency thyroid growth is observed. However, goitre formation during 
excessive dietary iodine intake has also been described81 . 
Endemic goitre, of sometimes enormous size, due to iodine deficiency is 
according to most investigators not solely due to the rises in TSH observed in these 
patients. One should keep in mind that TSH and EGF act synergistically on thyroid 
growth. Other paracrine growth factors like IGF and cytokines may also be involved 
in this growth regulation. 
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An intimate role of the immune system in regulating iodine-deficienf2-83-B4 
(and iodine excess81) goitre formation has been suggested by us and others before. 
This thesis is particularly meant to study the relationship between dietary iodine intake, 
thyroid metabolism, and thyroid autoimmunity. 
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THYROID AUTOIMMUNE RESPONSES 
In healthy individuals some autoreactivity towards thyroid cells and other body 
components is nowadays considered to be a normal process controlled by several 
suppressor mechanisms. Ma~unction of these suppressor mechanisms may result in 
autoimmune disease. A considerable proportion of the thyroid diseases in 
industrialized countries are due to aberrant immune reactions towards self-antigens of 
the thyroid. 
1.4.1 Tolerance to thyroid autoantigens. Defects in thyroid autoimmune 
disease85 
As in normal immune reactions, T lymphocytes and B lymphocytes play an 
important role in thyroid autoimmunity. 
CDB + T lymphocytes, which recognize the self-antigens only when presented on 
MHC class-1 molecules, are primarily cytotoxic (fc) for thyrocytes. 
CD4 + T lymphocytes recognize the self-antigens only in the context of MHC class-
11 molecules and these lymphocytes can be divided into two subsets: The T helper 1 
(fh1) subset produces cytokines such as interferon-gamma (IFN-y), which is capable 
of activating macrophages to become auto-aggressive, and lnterleukin-2 (IL-2) which 
stimulates the proliferation of COB+ cytotoxic T cells. The T helper 2 (Th2) subset 
secretes cytokines such as IL-4 and ll-5; these cytokines assist the B lymphocytes in 
the production of autoreactive antibodies of lgG isotype. 
Normally autoreactivity towards thyroid antigens is controlled and self-tolerance 
is acquired by mechanisms that delete or inactivate auto-reactive T and B cell clones. 
Deletion of large numbers of autoreactive T cytotoxic, Th1 and Th2 cells occurs 
within the thymus during the differentiation of prothymocytes to mature T cells86. 
T cells with high affinity towards self-determinants presented on MHC class-1 and MHC 
class-II positive cells of the thymic micro-environment are effectively eliminated via a 
process of programmed cell death (apoptosis)87. Self-reactive B cells can also be 
deleted as was first proposed by Burnett88. Premature contact of self antigens by 
an immature B cell may prevent it from developing into a clone of antibody-forming 
cells. However, not all self reactive clones may be deleted which is indicated by the 
presence of Tg-reactive T cells in the peripheral blood of normal rats89 . 
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A second mechanism to maintain self-tolerance is the generation of active 
immunosuppressor systems90. These suppressor circuits are not only formed by 
CDS+ T suppressor (Ts) cells, but also by CD4 + T lymphocytes and by B lymphocy-
tes. These may operate in (amongst others) an idiotype-anti-idiotypic network. In every 
healthy individual a balance exists between autoreactive effector and suppressor 
mechanisms in favor of the suppressor systems. It has been suggested that such a 
controlled network of autoreactive T lymphocytes is actually an advantage and 
facilitates the recognition of foreign invaders: foreign invaders are thought to share 
antigenic structures with evolutionary well conserved structures on our own cells91 . 
With regard to thyroid self-antigens antigenic structures homologous to the TSH-
receptor are present on Yersinia and Klebsiella bacteria. 
In the animal models for spontaneous thyroid autoimmune disease (the as-
chicken, the BB-rat and the NOD-mouse) intrathymic clonal deletion andjor the 
induction of active suppressor systems is disturbed or even absent. This is due to 
maturation defects in the thymic micro-environment and defects at the post-thymic 
level92,93,94,95,96_ 
When autoreactive T and B cells have escaped clonal deletion and when 
suppressor systems are insufficient a third control mechanism should come into 
operation, namely the process of T cell anergr7 •98 . When an autoantigen is 
presented to autoreactive effector T cells on not-professional antigen presenting cells, 
the T cells will become anergic. The induction of the anergic state is supposed to be 
due to the lack of provision of sufficient second signals, such as the induction of 
various adhesion molecules and the production of various cytokines, for T cell 
stimulation to occur. The recently discovered principle ofT cell anergy suggests that 
the earlier found MHC class-If positivity of the thyrocytes in classical thyroid 
autoimmune disease may earlier be "suppressive" than being a stimulus for the thyroid 
autoimmune reaction99. The relatively late appearance of MHC class-If molecules 
on thyroid cells in the disease process after the appearance of thyroid autoantibodies 
in the circulation supports such a view 100. 
The existing control over non-reactivity to thyroidal antigens can be broken when 
thyroid autoantigens are presented to the immune system on professional antigen-
presenting cells capable of providing activating signals for T and B cells. Knight et 
aJ. 101 have shown that as few as 105 dendritic cells (the professional antigen 
presenting cells par excellence) pulsed w~h Tg were effective in inducing a thyroiditis 
after cell transfer to normal non-autoimmune BALB/c mice. 
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1.4.2 The thyroid autoimmune diseases: Hashimoto's goitre, primary 
hypothyroidism (atrophic myxedema) and Graves' disease 
The major criteria of 'autoimmune disease' are defined as follows: 
1. the presence of lgG autoantibodies andjor autoreactive T effector lymphocytes 
towards antigens of the affected organ or organ systems, this presence correlating 
to functional and/or morphological abnormalities of the affected organ or organ 
systems, 
2. the possibility to induce these functional and/or morphological abnormalities in 
organs or organ systems by the transfer of the lgG autoantibodies andjor the 
autoreactive T lymphocytes. 
According to these criteria only three thyroid diseases can presently be considered 
as autoimmune thyroid diseases; namely Hashimoto's goitre, primary hypothyroidism 
(atrophic myxedema) and Graves' disease. 
Thyroid autoimmune reactions, however, do occur in several other thyroid 
abnormalities, such as sporadic and endemic goitre (see later), hyperthyroid nodular 
goitre {Plummer's disease), congenital hypothyroidism and endocrine ophthalmopathy. 
Further investigation is necessary to reveal whether these disorders can be included 
in the spectrum of autoimmune thyroid diseases. 
The involvement ofT lymphocytes in thyroid autoimmune responses is easily visualized 
in the histopathology of the various thyroid autoimmune reactions. Two _types of 
lymphoid cell infiltrations can be discerned in thyroid glands affected by a thyroid 
autoimmune disease: 
1. Destructive lymphoid cell infiltrations102. These infiltrations do not show a 
recognizable organization, and consist of a mixture of predominantly T cells and 
macrophages in destroyed and disrupted thyroid follicles. The function of the T 
cells in this type of infiltration is on the one hand cytotoxicity (CD8 +, T cytotoxic 
cells) and on the other hand the activation of the macrophages to become 
cytolytic (by CD4 +, Th1 cells through the production of IFN-y). The destructive 
lymphoid cell infiltrations are predominantly found in Hashimoto's goitre. 
2. Highly organized accumulations of lymphoid ce//s103. These infiltrations are not 
destructive and are primarily found in Graves' disease and sporadic goitre 
adjacent to stimulated thyroid tissue, but can also be found in Hashimoto's goitre. 
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These lymphoid cell infiltrations represent an intrathyroidally developed lymphoid 
tissue with a similar architecture to that of mucosa-associated lymphoid tissue. 
Thyroid associated lymphoid tissue (TAL T) is composed ofT cell zones, B cell 
follicles and plasma cells in the periphery of the tissue. The plasma cells can also 
be observed in cord-like structures radiating from the lymphOid tissue in between 
the thyroid follicles. TALT is involved in thyroid autoantibody production 100. The 
T cell zones of TALT consist of CD4 + and CDS+ lymphocytes in a ratio of 2-3:1. 
The function of these T lymphocytes is probably to regulate immune 
responsiveness and probably mainly involve Th2 cells and other regulatory T and 
B lymphocytes. 
Hashimoto's goitre 
Upon histological examination Hashimoto's goitre forms a spectrum of 
inflammatory abnormalities ranging from mild lymphoid cell infiltration Quvenile form, 
difficult to distinguish from euthyroid sporadic goitre) via the most prevalent classical 
oxyphil variant (females of 30-40 years of age, dense lymphoid cell accumulations, 
areas of destructive thyroiditis, regrowth of follicles) to the fibrous form (older age, 
predominantly fibrosis, mainly infiltration with plasma cells). 
Over 90% of patients with Hashimoto's disease show high levels of serum 
antibodies to thyroidal antigens. The mechanisms of destruction mediated by these 
antibodies are a) antibody-mediated direct cytotoxicity, b) antibody-dependent cell-
mediated cytotoxicity (ADCC), and c) immune complex mediated reactions. 
Although autoreactive T lymphocytes are more important in thyrocyte destruction, 
thyroid autoantibodies can nevertheless be considered as good markers of the 
destructive autoimmune process and are therefore diagnostically used. 
The goitre of Hashimoto's disease is not only caused by lymphoid cell infiltrations 
but also by the regrowth of destroyed thyroid follicles. This regrowth is induced by a 
raised plasma TSH (compensation for the fall in thyroid hormones, subclinical 
hypothyroidism), or by thyroid growth stimulating antibodies (see later) that may 
further contribute to the regrowth and restimulation of the remaining thyrocytes. In a 
proportion of the Hashimoto's goitres the regeneration processes ultimately fail. The 
immune reaction finally leads to a total destruction of the gland with signs and 
symptoms of overt clinical hypothyroidism. 
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The first thyroid autoantigen discovered in relation to Hashimoto's goitre was Tg. 
Raitt and Doniach (1956) used a precipitation reaction in agar for the detection of 
these autoantibodies. In this assay only very high titres of Tg-autoantibodies could be 
detected. Thereafter, other detection methods have been developed such as the 
indirect immunofluorescence (IIF) assay, in which sections of thyroid tissue are 
exposed to the serum of patients. If autoantibodies towards thyroidal antigens are 
present in the serum, these antibodies bind to the thyroid antigens in the section. This 
can be visualized in fluorescence microscopy using a fluorescent-labeled animal 
antibody to the human antibodies (figure 4). 
Figure 4. Anti-colloid antibodies visualized by indirect immunofluorescence using porcine thyroid 
sections (see text for more detail). 
Thyroid autoantibodies discovered using IIF were directed towards colloidal 
components (mainly Tg) and towards the cytoplasmic microsomal fraction 
('cytoplasmic' or 'microsomal' antibodies). Biochemical characterization revealed that 
the microsomal antigen was also expressed on the cell surfece of living thyrocytes. 
This antigen later proved to be the enzyme TPO 104, which plays a key role in 
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oxidative reactions during the iodination of Tg (see before). 
Although Tg and TPO are the most well-known thyroid self-antigens, other 
thyroidal antigens which can be the target of a thyroid autoimmune reaction (and to 
which autoantibodies have been found) are: the thyroid hormones 105 , an 
undefined second colloid antigen (detected in IIF106), and a lew poorly defined cell 
membrane proteins detected in Western blot analysis such a 64 kD cell membrane 
protein, occurring in thyrocytes and eye muscle cells 107. 
Primary hypothyroidism or atrophic myxedema 
A large number of patients with serum antibodies to TPO and Tg develop 
hypothyroidism and thyroid atrophy without a history of Hashimoto's goitre. This 
disorder is called primary hypothyroidism or atrophic myxedema. In general, patients 
suffering from this disorder have lower serum antibody titres to TPO and/or Tg in 
comparison to Hashimoto's goitre patients. The rapid development of the thyroid 
atrophy despite the excessively high plasma levels of TSH is presently explained by 
the additional existence of antibodies directed to the TSH receptor 108 that block 
the growth and hormone synthesis potential of the raised plasma TSH 109 (see 
below). 
The disease "primary thyroid atrophy" mainly strikes at older age, but it can also 
affect younger women. If these younger women become pregnant, it is possible that 
they transfer the thyroid blocking antibodies to the neonates via the transplacental 
passage 110. This may result in a transient or even permanent form of congenital 
hypothyroidism, the so-called familial congenital hypothyroidism (CHT). This neonatal 
disease constitutes approximately 1-5% of the CHT cases detected in infant screening 
programs in the USA and Western Europe 111 . 
Graves' disease 
Besides antibodies directed to the TSH-receptor that block the action of TSH, 
there are TSH-receptor antibodies capable of stimulating thyroid cells and mimicking 
the action of TSH: upon binding of such antibodies to the TSH-receptor they often 
induce cAMP responses which result in the metabolic stimulation of the thyrocyte and 
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the production of thyroid hormones. The hyperthyroidism of Graves' disease is caused 
by these bioactive TSH-receptor antibodies which is indicated by the transplacental 
passage of such autoantibodies from Graves' mothers, resulting in a transient state 
of thyrotoxicosis in the newborn. 
The Graves' autoantibodies capable of stimulating the hormone synthesis of 
thyrocytes are collectively called Thyroid stimulating Antibodies (TsAbs). The evidence 
that these TsAbs are directed to the TSH-receptor was presented in studies in which 
TsAbs positive lg-fractions of Graves' patients exerted a dose-dependent inhibition of 
binding of radioactively labeled TSH to guinea pig and human thyroid cell membrane 
fractions 112 The term Thyrotropin-Binding Inhibitory lgG (TBII) has been 
introduced for the lgGs exerting an effect in such TSH-binding assays. Presently, a kit 
is available to test for TBII on a routine clinical basis (Henning, Berlin). A new 
approach is the use of CHO-cells transfected with the TSH-receptor to perform a TBII-
assay as well as a cAMP stimulation assay 113. 
Although many thyroid-directed antibodies (Abs) can bind to the TSH-receptor 
(and are thus called TBII), only a few are also capable of actually stimulating the 
thyrocytes (TsAbs). In large groups of Graves' patients a limited correlation between 
the TBII assay, cAMP stimulation and thyroid hormone production was found. Some 
patient lgGs were positive in the TBII assay while having little or no activity in the cAMP 
assay. Since the TBII assay measures only the binding of the antibody to the TSH-
receptor, it may give misleading results when a receptor antibody exhibits mainly 
blocking (antagonist) rather than stimulating (agonist) activity (figure 5, see also before 
with primary hypothyroidism). The discrepancy in the various assays could thus mean 
that the TSH-receptor antibody population of Graves' patients is heterogeneous and 
composed of a variable mixture of agonists, antagonists and perhaps non-agonist 
receptor antibodies. Conclusive evidence for the occurrence of functionally hetero-
geneous receptor antibodies within one individual patient has indeed been 
provided114 
The basically polyclonal autoanf1body response in Graves' disease is consonant 
with studies of individual patients revealing a changing relationship over time between 
the TBII, the TsAbs activity and the degree of thyrotoxicosis. In addition, the 
occasional emergence of hyperthyroidism in a patient who previously had well-
documented primary hypothyroidism can also be explained115. 
Since the TSH-receptor antibodies of Graves' patients differ in respect to their 
functional effects, these antibodies will presumably also bind to different epitopes 
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within the TSH-receptor (see figure 5). Ongoing research in delineating the TSH-
receptor epitopes may reveal to which epitopes the stimulating and the blocking 











~ TSH receptor 
Figure 5. TSH-receptor antibodies (the so called TSH binding inhibiting immunoglobulins, TBII) 
can either have stimulating effects or blocking effects. The blocking antibodies probably bind to 
a different part of the TSH-receptor than the stimulating antibodies. 
1.4.3 Thyroid growth stimulating antibodies and goitrous growth 
Since 1980 it has also become clear that not only hormone production of 
thyrocytes can be stimulated or blocked by receptor antibodies, but also the 
proliferation of thyrocytes (goitre-induction). Deborah Doniach was the first to 
hypothesize that patients with euthyroid "colloid" goitres may possess circulating 
immunoglobulins (lgs) stimulating the growth of their thyrocytes. Such a pathogenic 
process would be analogous to that of Graves' disease where lgs stimulate thyroid 
hormone synthesis 117. 
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It lasted till 1980 before it proved possible to detect growth stimulating antibodies 
in euthyroid colloid goitre using a Cytochemical BioAssay (CBA) based on Feulgen 
densitometry; in this CBA system patient lgs stimulated the cells of guinea pig thyroid 
explants kept in organ culture to enter the S-phase. These in vitro findings suggested 
that the disease process of at least some of the patients with sporadic nontoxic goitre 
was autoimmune in nature and related to that of Graves' disease and Hashimoto 
goitre. 
Since 1980 several investigators have provided additional evidence on the 
existence of Abs capable of stimulating the growth of thyrocytes in vitro. These Abs 
were found in large Graves' goitres, in Hashimoto's goitre and sporadic nontoxic 
goitre, but also in iodine deficient endemic goitre. 
Description of the methods to detect thyroid growth stimulating antibodies 
A CBA for detecting thyroid stimulating Abs was developed by Bitensky et 
al1 18 and it is still the most sensitive method available. To measure growth 
stimulating Abs two other quantitative cytochemical techniques have been developed, 
one is based on nucleic acid cytophotometry (Feulgen-CBA) and the other on the 
measurement of glucose-6-phosphate dehydrogenase (G6PD) activity (G6PD-CBA). 
The Feulgen-CBA involves the measurement of the amount of DNA in individual 
follicle-cell nuclei of a guinea-pig thyroid segment kept in organ culture and exposed 
to the putative growth stimulating lgs. The DNA measurement is performed by means 
of a microdensitometer or cytophotometer and the results are expressed by a 
computer as population histograms in which the nuclear DNA content is plotted 
against the cell number. The cell cycle forms the basis of the assessment and from 
the population histograms the percentage of cells in S-phase can easily be computed. 
The percentage of cells in S-phase reflects the proliferative state of the cultured thyroid 
segment and is thus a measure of proliferation induction. A detailed description of the 
methodology has been given elsewhere 119. 
The other CBA for measuring DNA synthesis is the G6PD-CBA. G6PD is the first 
and rate controlling enzymatic step of the pentose-shunt pathway, which is the major 
source of ribose sugars needed for DNA synthesis 120. It also provides much of the 
NADPH in the cytosol which is essential for many biosynthetic steps required for 
cellular growth. The total generation of NADPH from G6P and NADP by action of the 
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enzyme can be measured in the thyroid cells from the cultured guinea pig thyroid 
segments when the enzyme reaction is carried out in the presence of PMS. PMS 
transfers reducing equivalents directly from the generated NAPDH to the final acceptor 
neotetrazolium chloride which on reduction precipitates as a blue formazan. The 
amount of formazan is measured by microdensitometry. A detailed description of this 
methodology has been given elsewhere 121 • 122. 
A good correlation exists between the outcomes of the Feu:gen-CBA and those 
of the G6PD-CBA. Both CBA's detect TGAbs in about 90% of large Graves' goitres (> 
40 gr) and in about 60-70% of euthyroid colloid goitres. 
Because the CBA's are labour intensive more simplified methods for measuring 
TGAbs have been developed. Chiovato et al123., Schatz et al124 and Wadeleux 
et al125 have described methods in which 3 H-thymidine incorporation into 
reconstituted thyroid follicles in suspension culture was used as the growth parameter. 
These culture methods require less technical skill but are still labour intensive. A further 
drawback is that they are less sensitive in comparison to the CBA and only detect 
TGAbs in 70% of Graves' goitres and 10-35% of euthyroid colloid goitres. 
The Fisher rat thyroid cell line-5 (FRTL-5) 126 is a continuous cell line in culture 
which can be used to measure cAMP stimulation induced by the classical TSAbs of 
Graves' disease patients. The assay system is nearly as effective as human thyroid-
slice and cell systems. The most simple and direct method for detecting thyroid cell 
growth in FRTL-5 cells has been developed by Ealey et ai 127•128 and is based 
on the enumeration of mitotic figures in the FRTL-5 cells. A mitotic arrest is induced 
during the endstages of a given culture by adding colchicine. The metaphase figures 
are visualized by staining and subsequently counted using an inverted light 
microscope. 
Until shortly, FRTL-5 cell assays could only detect growth promoting antibodies 
in active Graves' disease, whereas Abs of sporadic euthyroid colloid goitre were 
negative. Wilders et al83 have modified the mitosis arrest assay of Ealey et ai127•128 
by cocultering lg preparations of patients with a suboptimal dose of TSH to synergize 
the effects of the growth stimulating Abs. In this way they found 80% of sporadic 
nontoxic goitre patients positive for TGAbs. A similar assay approach has been used 
by Boyages et ai81 . 
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Validation of the Feulgen cytochemical bioassay to detect thyroid growth stimulating 
antibodies in vitro 
Criticism has been raised on the methods to detect TGAbs, their interpretations 
and the lg-preparations used129, 130• It has been argued that 3H-thymidine 
incorporation into DNA may not reflect cell proliferation whereas the intensity of the 
Feulgen reaction product more likely measures the degree of unfolding of DNA than 
an increase in the quantity of DNA129. The modified FRTL-5 mitotic arrest assay 
developed by Wilders et a183 avoids these technical pitfalls and directly measures cell 
proliferation by determining the percentage of cells in mitosis. To validate the Feulgen-
CBA methodology a double blind study was carried out in which results obtained with 
a series of lgGs in the Feulgen-CBA were compared with those obtained in the 
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Figure 6. A comparison between the outcomes of the Feu!gen-CBA and the FRTL-5 mitosis arrest 
assay (modification Wilders) stimulated with either 10 lg-preparations of healthy individuals (open 
circles 0) or 13 lg-preparations of sporadic goitre patients (closed circles •). Outcomes were 
scored "negative~. or scored "lowjintermediatejhigh positive~ depending on the lowest amount 
of lgG needed to obtain a positive growth response in the assay (either > 5% of thyrocytes in $-
phase or > 7% of FRTL-5 cells in mitosis). 
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Both assays gave almost identical results (see figure 6) thus showing the validity 
of the Feulgen-CBA to detect Abs stimulating mitogenesis in vitro. In fact the CBA 
proved to be more sensitive and detected TGAbs activity in three more sporadic goitre 
cases, while the assay needed 10 times less lgG to give a positive growth response. 
The criticism that contaminations of the lg preparations with growth factors other 
than TGAbs can be hold responsible for the observed growth effects 131 has now 
also been excluded in a series of experiments. 
Firstly patients' TSH from the serum sample was removed before the preparation 
of lg-fractions by pretreating the serum samples with a solid phase anti-TSH; this did 
not abolish the growth stimulating potential. 
Secondly, protein-A sepharose column purification is used to prepare almost pure 
lgG fractions from patient serum; these fractions still contain TGAb activity. Further-
more, the growth promoting activity of the protein-A-sepharose purified lgG fractions 
cen be neutralized by anti human lgG antibodies, whereas anti human EGF or anti 
human TSH have no effects83. 
These experiments provide ample evidence that it is lgG that is responsible lor the 
observed in vitro growth effects. It has also been shown that a (Fab)z fragments 
prepared from a sporadic goitre lgG exerted the growth promoting activity in the 
Feulgen CBA in a fashion similar to that of the original lgG preparation 132 
Thyroid growth stimulating antibodies in sporadic nontoxic colloid goitre 
To establish a role for TGAbs in the pathogenesis of sporadic colloid goitre, 
several studies have now been performed. At first we showed133 a TGAb-positivity 
in 65% of patients using the Feulgen-CBA. Almost identical findings on the prevalence 
of TGAb in sporadic goitre were reported by McMullan and Smyth using the G6PD-
CBA 122. They found TGAb present in 68% of cases and they confirmed the earlier 
expressed view that the TGAb in sporadic goitre patients was less potent in 
comparison to the TGAb of goitrous Graves' disease patients. 
Evidence for the presence of TGAb in sporadic goitre patients has also been given 
by Chiovatto et al123 and Wadeleux et al125, who found 10 and 35%, respectively, of 
sporadic goitre patients positive for TGAb using 3H-thymidine incorporation assays on 
thyroid follicles in suspension culture. 
Using the FRTL-5 assays, however, lgs of sporadic euthyroid goitre patients were 
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initially invariably negative for growth stimulation. To investigate this problem Wilders 
et al83 modified the FRTL-5 mitosis arrest assay of Ealy et al127•128 and tested the 
colloid goitre lgG preparations in the presence of a suboptimal dose of TSH. Stimula-
tion of mitogenesis could now be detected in 9 out of 14 lgG preparations of patients 
with sporadic colloid goitre. Anti-human lgG abolished these growth promoting effects. 
Despite the TGAb activity, sporadic goitre patients do normally neither have TSH 
receptor Abs nor cAMP stimulating Abs in their serum. The discrepancy between the 
presence of growth stimulating effects and the absence of TSH receptor Abs and lgs 
stimulating cAMP strongly suggests that the TGAbs of sporadic goitre patients are not 
specific for the TSH binding site of the TSH receptor. 
It has recently been shown by Wulffraat et al (to be published) that Abs directed 
against the IGF-1 receptor were present in 13 out of 14 patients with Graves' disease 
and in 10 out of 11 patients suffering from sporadic nontoxic goitre. This implies that 
apart from the TSH-receptor, other structures present on the thyrocytes, such as the 





Figure 7. Thyroid stimulating antlbodies (fsAbs) from Graves' patients bind to the TSH receptor, 
stimulate second messenger systems (cAMP, inositol triphosphate, IP3 and diacylglycerol, DG) 
which results in thyroid growth andjor thyroid hormone synthesis. It is still not clear whether 
thyroid growth promoting antibodies (fGAbs) from Graves' patients or from sporadic goitre 
patients bind to special parts of the TSH receptor (separate from those involved in the stimulation 
of hormone synthesis) or to a growth receptor other than the TSH-receptor, for instance the 
lnsuline-like Growth Factor receptor (IGF-R). 
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Thyroid growth stimulating antibodies in endemic goitre 
Immunoglobulins capable of stimulating thyroid cell growth proved not only to be 
detectable in the serum of patients with sporadic goitre, but also in the serum of 
patients with iodine deficient endemic goitre. 
Schatz et al124 found 14% of endemic cases positive for TGAbs in the Giessen 
area in Germany, whereas Medeiros-Neto et al84 reported a 50-60% positivity in cases 
from Brazil. In a recent study, Wilders et al83 showed a growth promoting effect in 65 
of 71 endemic goitre lg preparations tested in their FRTL-5 mitotic arrest assay (91% 
positivity, Graz area). In her experiments the lgG preparations of 15 healthy controls 
living in an area of iodine sufficiency (Amsterdam) and of 18 Austrian subjects without 
an endemic goitre and without iodine deficiency did not stimulate FRTL-5 cell growth. 
The lgG samples from endemic goitre patients who reported a recent thyroid 
enlargement or who showed a postoperative recurrence of their goitre reached a 
maximal in vitro growth stimulation at relatively low concentrations of lgG. This 
indicates that such endemic goitre patients may have TGAbs with a higher growth 
promoting potency. 
The mechanism by which the combination of a suboptimal concentration of TSH 
and endemic goitre TGAb synergize to promote the in vitro mitogenesis in FRTL-5 cells 
is still not understood, but it clearly shows that the TSH receptor needs to be 
stimulated before TGAb is able to fully induce FRTL-5 cell growth. It is tempting to 
speculate that such a combined action of TSH and TGAb will also play a role in 
endemic goitre formation in vivo. Already in 1968134 it was reported that TSH has 
a stronger growth promoting action in in vivo conditions of iodine deficiency. 
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THYROID AUTOIMMUNE RESPONSES AND DENDRITiC CELLS 
Tolerance towards thyroid self antigens can be broken (see before). For the 
production of auto-antibodies and the expansion of autoreactive helper and cytotoxic 
T cells, an antigenic stimulation by so-called antigen-presenting accessory cells is 
required. Only a few antigen-presenting accessory cells are capable of inducing 
effective immune responses. These cells include MHC class-11 positive B lymphocytes 
and macro phages, but the dendritic cell or veiled cell is amongst the accessory cells 
the professional antigen-presenting cell par excellence 135• 136. Dendritic cells 
expose a high density of MHC class-1 and II molecules on their long cytoplasmic 
extensions or veils and actively seek contact with T lymphocytes. For the antigen-
presentation and T cell stimulation the dendritic cell forms cell clusters with the 
lymphocytes and in this cluster formation various adhesion molecules are 
operative 137. Apart from cluster formation in which a micro-environment is created 
suitable for antigen-presentation, the dendritic cell is capable of producing a series of 
cytokines which activate T and B lymphocytes 138. The adhesion molecule 
interactions and the cytokine production provide enough second signal to make the 
dendritic cell the only cell capable of stimulating naive T cells to clonally expand135• 
Dendritic cells do not only occur in the T cell areas of spleen and lymph nodes as 
so-called interdigitating dendritic cells, but also in the skin as Langerhans cells and in 
the gut mucosa. It is now generally accepted that the dendritic cells of the skin and 
the gut mucosa travel via the lymph as veiled cells to the draining lymph nodes, while 
transporting antigens from the periphery to these lymphoid organs. The dendritic cells 
present the antigens toT cells in the lymph node and initiate the immune response 135. 
Dendritic precursor cells originate from the bonemarrow. Such precursors 
probably circulate and reside within the blood monocyte pool. We and others have 
shown the maturation of purified blood monocytes into MHC class-11 + cells with a 
dendritic morphology and function 139•140 (see also Chapter 6). It has also been 
established that the cytokine granulocyte-macrophage-colony-stimulating-factor (GM-
CSF) induces the blood precursor cells to become fully active dendritic cells 141 . 
In autoimmune endocrine diseases such as Graves' disease and Hashimoto's 
goitre high numbers of class-11 positive cells with a dendritic morphology and a 
phenotype of interdigitating dendritic cells can be found in the affected 
tissues142•143. An increase in the number of these cells, and a local clustering 
of these cells are the very first signs of a developing thyroid autoimmune 
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reaction100•144 (figure 8). This local accumulation of the dendritic cells precedes 
the autoimmune reaction in the draining lymph nodes, the production of thyroid 
autoantibodies by these lymph nodes and the further signs and symptoms of thyroid 
autoimmune disease 100. These morphological events indicate that the process of 
autoantigen presentation preceding the development of the thyroid autoimmune 
disease is similar to that of normal presentation of antigens; in other words, the 
morphological events strongly suggest that the dendritic cells which accumulate early 
in the endocrine tissue process endocrine autoantigens and travel with these to the 
draining lymph nodes to initiate the autoimmune reaction (figure 9). Dendritic or veiled 
cells have indeed been observed in lymph draining the thyroid and, additionally, Tg 
containing monocyte-like cells with a dendritic morphology have been observed in the 
marginal sinuses of draining lymph nodes 100. 
Figure 8. lntrathyroidal dendritic cells forming clusters with each other during iodine deficiency. 
Rat thyroid sections were incubated with acid phosphatase and the monoclonal antibody OX-6 
directed against MHC class-11 antigens. Dendritic cells were identified as strong class-11 positive 
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Figure 9. A schematic representation of the initiation of thyroid autoimmune reactivity. 
lntrathyroidal dendritic cells pick up thyroid antigens, travel to the draining lymph nodes (a) to 
initiate an immune response. Thyroid autoreactive T cells and B cells can be activated (b, c) and 
autoantibodies can be produced by plasma cells. The thyroid autoreactive T cells and antibodies 
exert their effects on the thyroid (d). The immune response can be continued in the thyroid-
associated lymphoid tissue (fALT) in the thyroid itself (e). 
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OUTLINE OF THE THESIS 
Iodine is an essential trace element being part of the thyroid hormones. Therefore 
an iodine deficiency or excess of iodine leads to disturbances in thyroid physiology, 
thyroid growth and thyroid hormone production. 
There are also strong indications that an iodine deficiency or an excess of iodine 
has effects on the thyroid autoimmune reactivity. 
Iodine deficiency has been described to lead to: 
a. a higher incidence of anti-Tg antibodies 145, 
b. the generation of antibodies that affect the growth of thyrocytes in vitro (fGAbs) in 
individuals with endemic goitre83•84 and endemic cretinism 146•147•148 , 
and 
c. intrathyroidal aggregates of epitheloid cells and dendritic cells in endemic 
goitres 149. 
An excessive dietary iodine intake has also been described to lead to thyroid 
autoimmune reactivity: 
a. in individuals with a preexisting thyroid abnormality, such as an iodine deficient 
goitre, an excessive dietary iodine intake results in a proportion of the individuals 
in the development of an attack of thyroiditis; those affected by the thyroiditis 
show anti-Tg and anti-microsomal antibodies in their serum150•151 •152, 
b. in animals that spontaneously develop thyroid autoimmune disease, such as the 
Cornell C Strain of chicken, the Obese Strain of chicken and the BB rat, a high 
dietary iodine intake results in an increase in the incidence and severity of the 
thyroiditis 153• 154. 
The mechanisms underlying the thyroid autoimmune phenomena induced by an 
excessive or iodine deficient dietary intake are only partly understood. 
In order to study these phenomena further and in more detail, we developed two 
animal models in which 3-weeks-old Wistar rats and 3-weeks-o/d BB rats (thyroid 
autoimmune prone) were kept on lour dietary iodine regimens lasting for a period of 
18 weeks, namely: 
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a. an enriched iodine diet {1 0 times the normal iodine intake; urinary iodine excretion 
100 pg per day), 
b. a normal iodine diet (urinary iodine excretion 7 pg per day) 
c. a low iodine diet (2 days of 1% KCI04 in the drinking water, followed by distilled 
drinking water and iodine deficient pellets; urinary iodine excretion undetectable), 
and 
d. an extremely low iodine diet (continuously 1% KCI04 in the drinkingwater and 
iodine deficient pellets, urinary iodine excretion undetectable). 
These animal models have allowed us to study the effects of a low or a high 
dietary iodine intake in normal and thyroid autoimmune prone rats on thyroid 
performance (Chapters 2 and 3), on anti-colloid antibody production (Chapters 2, 4 
and 5), the production of thyroid growth stimulating antibodies (fGAbs, Chapter 2.1.), 
and on the intrathyroidal infiuxes of dendritic cells, T lymphocytes, B lymphocytes and 
macrophages (Chapters 2 and 5). 
In addition to these in vivo experiments, in vitro studies were performed on the 
effects of thyroid hormones -and other iodinated compounds on the monocyte to 
veiled/dendritic cell transition (Chapter 6). 
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Iodine deficiency and thyroid autoimmunity in Wistar rats 
SUMMARY 
The last two decades it has become clear that iodine deficiency has a 
modulating effect on the thyroid autoimmune response in humans. Also in animals 
that spontaneously develop autoimmune thyroid disease evidence is accumulating 
that a low iodine intake can modulate thyroid autoimmune reactivity. However, it is 
still not clear what the effect of a low iodine intake on thyroid autoimmune reactivity 
is in normal non-autoimmune animals. To study the relationship of a dietary low 
iodine intake on the thyroid autoimmune reactivity in non-autoimmune animals, 
normal Wister rats (female) were kept on an enriched iodine diet (EID; daily iodine 
intake of 100,ug of iodine), a for our area normal (conventional) diet (COD; daily 
iodine intake of 7,ug of iodine), a low iodine diet (LID; 2 days of 1% KCL04 followed 
by iodine deficient drinking water/pellets), or an extreme low iodine diet (LID+; 
continuously 1% KCL04 in the drinking water, iodine deficient pellets). 
The EID rats were euthyroid (T 3: around 8 nM/1, T 4 : around 50 nM/1 and TSH: 
around 2 ngjml), had a normal thyroid weight (around 12.5 mg), and there were 
only minimal signs of a local thyroid immune reactivity: low numbers of 
intrathyroidal dendritic cells (DC, around 35 DC/mm2), CD4 + cells (around 2 
cellsjmm\ and cos+ cells (around 2.5 cellsjmm2) were found in combination 
with a low anti-colloid antibody production Qncidence of positive animals 12.5%). 
The COD resulted in a normal thyroid function. The rats were euthyroid (range 
T3: between 1.6 and 1.2 nM/1, T4 around 50 nM/1 and TSH around 2 ngjml) and 
had a normal thyroid weight (around 12.5 mg). However, some signs of thyroid 
autoimmune reactivity could be found: number of intrathyroidal DC around 
40/mm2 , around 3 CD4 + cellsjmm2 and around 3 CDS+ cells/mm2 together with 
a 30% incidence of anti-colloid antibodies. 
The LID and uo+ not only induced goitre formation (thyroid weight 27.3±4.2 
mg (mean±SD) after 12 weeks of LID and 38.4±5.3 mg (mean±SD) after 4 
weeks of LID+) and a low production of thyroxine from the thyroid (28±3 nM/1, 
mean ±SD) after 12 weeks of LID and 14±3 nM/1 (mean±SD) after 2 weeks of 
LID+), they also induced various signs of thyroid autoimmune reactivity. 
These constituted of: 
a. influxes of DC into the thyroid (63.4±3.8 DC/mm2 (mean±SD) after 12 weeks 
of LID and 64.4±9.0 DC/mm2 (mean±SD) after 3 weeks of uo+); 
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b. the formation of homotypic clusters of these DC; 
c. influxes of intrathyroidal CDS and CD4 positive T cells (10.3±3.5 CD4+ 
cellsjmm2 (mean±SD) after 3 weeks of LID, 1S.0±4.7 CD4 + cellsjmm2 
(mean±SD) after 4 weeks of uo+ and 7.6±4.1 cos+ cells/mm2 (mean±SD) 
after 6 weeks of LID, 25.7±6.3 cos+ cells/mm2 (mean±SD) after 6 weeks of 
LID+) and 
d. increases in the production of anti-colloid antibodies Qncidence of 60% positive 
animals after 1S weeks of LID and 73% after 10 weeks of LID+). 
These data collected in normal non-autoimmune female Wister rats show that 
- as in humans - iodine deficiency precipitates thyroid autoimmune reactivity. 
INTRODUCTION 
The last two decades it has become clear that a high dietary iodine intake may 
aggrevate thyroid autoimmune reactivity in both humans as well as experimental 
animals suffering from thyroid (autoimmune) disease. 
In experimental animals 1•2 •3 •4 and humans5•6•7 •8 with a preexisting 
thyroid abnormality, such as an iodine deficient goitre, a single administration of a 
high dose of iodine resulted in an attack of thyroiditis positive for anti-thyroglobulin 
and anti-microsomal antibodies. In the Cornell C Strain of chicken9 and in the BB 
rat 10 it was shown that a high dietary intake of iodine led to an increase in the 
incidence and severity of the thyro!ditis of these animals. 
Evidence is also accumulating that iodine deficiency is able to precipitate thyroid 
autoimmune reactivity in humans: 
a. a higher incidence of anti-thyroglobulin (Tg) antibodies has been described in 
areas of iodine deficiency 11 ; 
b. the majority of patients suffering from diseases linked to iodine deficiency, such 
as endemic goitre 12• 13 and endemic cretinism 14• 15• 16 show lgG's 
in their serum that affect the growth of thyrocytes in vitro (the so-called thyroid 
growth-stimulating immunoglobulins, TGis). It must be noted however, that the 
character and meaning of these TGis are still under debate17•12; some 
investigators have found these TGis in the absence of TSH receptor 
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antibodies 18, whereas others consider the TGI effect as a classical TSH 
receptor stimulator effect of thyroid stimulating immunoglobulins (TSis) 19; 
c. thyroids of iodine deficient goitre patients contain aggregates of epitheloid cells 
and dendritic cells20. Dendritic cells are the antigen presenting cells par 
excellence21 and play a major role in the initiation of immune responses. 
They have been described as the first cells arriving in thyroids before thyroid 
autoimmune reactivity develops22•23. Additionally, dendritic cells are 
capable of transferring autoimmune thyroiditis in an experimental animal 
model24 and are thus considered to be responsible for the initiation of the 
thyroid autoimmune response. Others consider an abberant MHC class-11 
expression on thyrocytes as the primary event in thyroid autoimmune 
disease25. 
In animals, the effect of a low dietary iodine intake on thyroid autoimmune 
reactivity has only been studied in the existing models of autoimmune thyroid 
disease. To our knowledge, it has not been studied whether iodine deficiency 
precipitates thyroid autoimmune reactivity in non-autoimmune, normal, euthyroid 
animals. Such a study might ·be a better reflection of the effect of the dietary iodine 
intake on thyroid autoimmune reactivity in average human populations. Therefore 
we developed an animal model in which normal female Wistar rats were kept on 
four iodine regimens, namely an iodine enriched diet (EID), a for our area normal 
(conventional) diet (COD), a low iodine diet (LID), and an extremely low iodine diet 
(LID+) for periods of up to 18 weeks starting from the third week of life. The extent 
of iodine deficiency /sufficiency was determined by the urinary iodine excretion. The 
severity of hypothyroidism was measured by the serum TSH and thyroid hormone 
levels. Goitre formation was determined by measuring the thyroid weight. Thyroid 
autoimmune reactivity was measured by counting the number of intrathyroidal 
infiltrated leucocytes (MHC class II positive dendritic cells, T cells and B cells) and 
measuring the incidence of anti-colloid and anti-cytoplasmic antibodies. The effects 
of the iodine diet on the serum levels of lgGs that stimulate the growth of 
thyrocytes in vitro (the socalled TGis) will be discussed in another report. 
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MATERIALS AND METHODS 
Animals and diets 
Female Wistar rats were purchased from TNO Rijswijk, The Netherlands and 
kept at the central experimental animal housing facilities of the Erasmus University 
Rotterdam under standard conditions. Directly after weaning (at the age of 3 
weeks) 5 consecutive cohorts of rats (n =30-60) were kept each on four dietary 
iodine regimens: 
1. An enriched iodine diet (EID); the rats received conventional pellets (Am-11, 
Hope Farms bv, Woerden, The Netherlands) ad libitum as well as an extra 
iodine supplementation of 6.5mg Kl/1 added to the drinking water. 
Consequently the iodine intake was about 100pg of iodine per day. 
2. A for our area normal (conventional) diet (COD); the rats received conventional 
pellets (Am-11, Hope Farms bv, ± 0.35 mgjkg iodine) and Rotterdam tap water 
ad libitum. The iodine intake in this group was about 7pg of iodine per day. 
3. A low iodine diet (LID); the rats received 1% KCL04 in the drinking water for a 
period of 2 days and thereafter distilled water and iodine deficient pellets 
(Modified Remmington diet, Hope Farms bv) ad libitum. 
4. An. extreme low iodine diet (LID+); the rats continuously received 1% KCL04 in 
their distilled drinking water and iodine deficient pellets (Modified Remmington 
diet, Hope Farms bv) ad libitum. 
Wistar rats of the 5 cohorts were sacrificed by aortic exsanguination under 
ether anaesthesia after 3, 6, 9, 12 or 18 weeks of diet, in such a way that 5-18 
animals per time group could be used for evaluation. Serum was prepared for T 3, 
T 4 , TSH evaluation and anti-colloid antibody determination. T 3 , T 4 , and TSH were 
measured by conventional RIA's (Dr. W.M. Wiersinga, Mrs. M. Broenink, 
Academical Medical Centre Amsterdam, The Netherlands). For the rat TSH-RIA, the 
rat TSH reference preparation NIADDK-rTSH-RP-2 was used (176 times more 
potent than the NIADDK-rTSH-RP-1, kindly provided by Or. Parlow from the UClA 
Medical Centre, Torrance, USA. Thyroid glands were removed, weighed and stored 
at -80 °C until immunohistological examination. 
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Iodine measurement in rat urine 
Rat urine was collected during 24 hours by keeping the rats in metabolic 
cages. Iodine excreted in the urine was measured using a modified method 
described by Benetti et al26. In brief, the urine samples were destructed by 
adding an equal volume of 30% chloric acid and incubating the samples at 200 °C 
for several hours. The iodine reacted as a cathalysing agent in the redox reaction 
between cerium ammonium sulphate and arsenic acid. During the reaction the 
yellow Ce4 + was converted into the colourless Ce3 + which was measured using 
an ELISA reader at 405 nm. 
Immunohistological examination of thyroids 
Immunohistological examination was performed according to Green et al. 27 
with minor modifications. Of each frozen thyroid, one lobe was semiserially cut into 
6 pm thin sections. The sections were airdried overnight and fixed in acetone at 
room temperature for 10 minutes. The sections were incubated with either a 
monoclonal antibody specific for MHC class II molecules, CD4 + cells, CDS+ cells 
or B cells (see table 1) for 60 minutes, washed with phosphate buffered saline 
(PBS) containing 0.2% bovine serum albumin (BSA, Sigma Chemical Co, USA) for 
10 minutes, and further incubated with a rabbit anti-mouse lg-HRP labeled 
conjugate (Dakopatts, Denmark) for 30 minutes, diluted 300 times in PBS containg 
1% normal rat serum and 0.2% BSA. After washing the slides in PBS containing 
0.2% BSA for 10 minutes and rinsing them with 0.1 M sodium acetate buffer, pH 
6.0, the sections were developed with a metal-enhanced 3,3' -diaminobenzidine 
(DAB) solution containing 0.05% DAB (Sigma), 1% nickel sulphate (Merck), 0.068% 
imidazole (Sigma), and 0.8% sodium chloride in 0.1 M acetate buffer pH 6.0 for 3-5 
minutes. Hydrogen peroxide was added to a final concentration of 0.01 %. After 
DAB development, the sections were washed briefly in 0.1 M Tris-HCI buffer, pH 7.6, 
and immersed in a 0.5% solution of cobalt chloride in 0.1 M Tris-HCI buffer, pH 7.2 
at room temperature for 4 minutes. The slides were either counterstained with 0.1% 
nuclear fast red in 5% aluminium sulphate for 2 minutes or incubated with acid 
phosphatase at 37°C for 30 minutes and subsequently counterstained with 
hematoxylin. The slides were dehydrated and embedded in DePeX mounting 
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medium (Gurr, BDH limited Poole, England). 
For the quantification of intrathyroidal infiltrated cells, 4 sections of each thyroid, 
with intervals of at least 1 OOpm, were reacted with the appropriate marker 
monoclonal antibody. Positive infiltrated cells were counted using light microscopy 
at a magnification of 400x. The surface area of the thyroid sections in which the 
infiltrated cells had been counted was measured using a camera attached to a Leitz 
Diaplan light microscope and a Videoplan image processing system (Kontron, Bild 
Analyse GmbH, Germany). The number of infiltrated DC Qdentifred as strong MHC 
class-11 + cells with cytoplasmic processes and weak or absent acid phosphatase 
activity), CD4 + T cells and CDS+ T cells were expressed per mm2 surface area of 
a thyroid section. It is of importance to note that similar results were obtained when 
the number of DC and T cells were not expressed per mm2 surface area of the 
section but were expressed per observed thyroid follicle in the plane of section or 
per surface area of thyrocyte parenchyma. 
Table 1. Monoclonal antibodies used for the detection of leucocytes. 
MoAb Specificity 
OX6 (Seralab, UK) MHC class-11 
W3(2!5 (Seralab, UK) C04 antigen 
8115-4 (Holland CD4 antigen 
Biotechnology, 
The Netherlands) 
oxa (Seralab. UK) CDS antigen 
HIS 14 (F.G.M. Kroese) 8 cells 







6 pm thin frozen porcine thyroid sections were cut, airdried overnight and fixed 
in cold acetone (-20 °C) for 10 minutes. Porcine thyroid tissue was used, since it 
gave optimal results as compared to rat or human tissue. The sections were 
preincubated with normal rabbit serum (DAKO-immunoglobulins, Denmark), diluted 
50 times in PBS with 1% BSA, for 10 minutes. Subsequently, the rat sera were 
applied Qn duplicate, diluted 10 times in 0.9% NaCI) and the slides were incubated 
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at room temperature for 60 minutes. After washing in PBS, the sections were 
incubated with rabbit anti-rat immunoglobulins, fluorescein-isothiocyanate-(FITC)-
Iabeled (DAKO immunoglobulins, Denmark) for 30 minutes (diluted 25 times in PBS 
with 1% BSA). After this second step and rewashing, the slides were embedded in 
aquamount (Gurr, BDH Limited Poole, England) and examined using a fiuorescense 
microscope. Three control slides were included; one without incubation of rat 
serum, another incubated with a rat serum previously scored as negative and a 
third incubated with a rat serum previously scored as positive. The staining intensity 
of each serum was arbitrarily and blindly scored (under code, by two independent 
investigators) as negative, positive or strongly positive. 
Statistical analysis 
Differences inthyroid weight, serum T3 , T4 , and TSH, and number of 
intrathyroidal MHC class-11 + DC, clusters of these cells and T cells were compared 
by Wilcoxon's rank sum test. The incidence of anti-colloid antibody production was 
tested by X2 analysis. 
RESUlTS 
Thyroid weight 
The thyroid weight of animals kept on an EID and a COD increased slightly 
from 6. 7 ± 1.1 mg to 13.3 ± 2.9 mg (mean± SD) after 6 weeks of diet as could be 
aspected from the normal growth development and the thyroid/body weight index 
remained constant namely 0.07. The absolute thyroid weight after 6 weeks of diet 
remained at 13 to 14 milligrams for the further experimental period (figure 1A). 
In animals kept on a LID however, a stronger increase in thyroid weight was 
found, that was statistically significantly different from the thyroid weights of animals 
kept on an EID or COD (p<0.05, Wilcoxon's rank sum test). After 6 weeks of diet 
the thyroid weight was 20.1 ± 2.8 mg (mean± SD) and the goitre reached maximal 
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Figure 1. Thyroid weight and endocrine status. Female Wistar rats were kept on 4 dietary 
iodine regimens; an enriched iodine diet (EID), an conventional diet (COD), a low iodine diet 
(LID) and an extreme low iodine diet (LID+) for a period of 18 weeks from 3 weeks of age 
onwards. Rats were sacrified and thyroids were removed and weighed to measure goitre 
development (A), serum was collected to measure serum TSH (B, please note the different 
scale for the upper and the lower part of the figure), serum T 3 (C), and serum T 4 (D) levels by 
RIA. The mean and standard deviation are given of 5-18 anlmals per group. 
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It is worthy to note that the increase in thyroid weight was neither in time, nor 
in extent related to increases in serum TSH levels in the LID group (figure 1A vs 1 B, 
see also later). 
Rats receiving a UD + showed a more pronounced goitre development. As 
soon as after 2 weeks of diet statistically significantly higher thyroid weights were 
found compared to rats kept on an EID, COD or LID (p<0.05, Wilcoxon's rank sum 
test). After 4 weeks of diet the thyroids reached a maximal weight of 38.4 ± 5.3 mg 
(mean±SD), remaining constant thereafter (figure 1A). 
Thyroid endocrine status and urinary iodine excretion 
In animals kept on an enriched iodine diet (EID) the T4 output from the thyroid 
was normal (figure 1 D). Serum T 3 levels however were low (figure 1 C). Similar low 
serum T 3 levels have been described by other investigators in rats treated with a 
high iodine dose (300-500 pg of iodine per day)34•35. Serum TSH levels in the 
EID rats were in the normal range (between 2.1 ±0.4 (mean±SD) and 2.5±0.3 
(mean±SD)) during the entire experimental period (figure 1B). The urinary iodine 
excretion of the Wistar rats receiving an EID was high: an excretion of 50 pg 1/day 
was measured after 1 week of diet and excretion reached a plateau after 3 weeks 
(6 weeks of life) of 100 pg 1/day. These latter values reflected the estimated daily 
intake. 
In animals receiving a for our area normal (conventional) diet (COD) serum T 4 
levels started to increase during the first 3 weeks of diet to reach a constant level of 
50 nM/1 for the remaining experimental period (figure 1D). Serum T3 levels were 
high (1.6±0.2 nM/1 (mean±SD)) at the start of the experimentent. They gradually 
decreased after 3 weeks of diet from 1.6±0.1 nM/1 (mean±SD) to 1.2±0.1 nM/1 
(mean± SD) at 12 weeks of diet and stayed at that level thereafter (figure 1 C). Such 
relatively high serum T 4 and T 3 levels in prepubertal rats compared to adult rats 
have been described by others before35 and these authors regarded the high 
thyroid hormone levels as necessary for optimal brain development in the 
prepubertal age. The need for the high serum thyroid hormone levels in the young 
rats was reflected by their urinary iodine excretion: the rats on a COD showed a 
relatively long period of low urinary iodine excretion; an output of 1.6±0.3 pg 1/day 
(mean± SD) at the age of 3 weeks while it lasted till the age of 6 weeks that urinary 
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iodine excretion had reached 7.6±1.5 pg 1/day (mean±SD), the latter value 
reflecting the daily iodine intake. This excretion level was maintained during the 
remaining experimental period. Serum TSH levels of the COD animals were in the 
normal range during the entire period of observation (figure 1 B). 
In animals kept on a low iodine diet (LID) the T4 output of the thyroid gland 
gradually failed and the animals became subclinically hypothyroid after 12 weeks of 
diet. Serum T4 levels were as low as 28.0±2.5 nM/1 (mean±SD) and remained 
lower than the levels in EID and COD animals (P < 0.05, see figure 10). A very slight 
but statistically significantly rise in serum TSH levels could be observed alter 6 
weeks of a LID compared to the TSH levels found in EID and COD rats, but a more 
clear rise in TSH levels was not found until 18 weeks of LID (6.4±1.8 vs 2.0±0.4 
and 2.3±0.3 ngjml (mean±SD) compared to EID and COD animals respectively, 
figure 18). The serum T3 levels remained in the normal range (figure 1C). The low 
iodine intake was well reflected by the urinary iodine excretion. After 1 week of diet 
the excreted urinary iodine was under the lower limit of detection of our assay. 
The animals kept on an extreme low iodine diet (LID+) became severely 
hypothyroid. After 2 weeks of a LID+ a decline in T4 levels from 37.4±7.5 to 
13.3±2.2 nM/1 (mean±SD) was seen and levels remained low during the 
remaining experimental period (figure 1 D). Also very low serum T 3 levels were 
found that were below the detection limit (:50.03 nMjl) after 2 weeks of diet (figure 
1 C). The serum TSH levels of animals on a LID+ were already high after 2 weeks 
of diet (24.3±2.1 ngjml (mean±SD)) and reached maximal values after 8 weeks of 
diet (88±9.9 ngjml (mean±SD)) slightly declining to 60.4±9.2 ngjml (mean ±SD) 
after 10 weeks (figure 18). The urinary iodine excretion was extremely low: as early 
as after 1 week of diet iodine could not be detected in the excreted urine. 
Observations were stopped after 10 weeks of LID+ diet since then animals 
became severely ill due to their hypothyroidism. 
Signs of immune reactivity in the thyroid 
At the start of the experiment only a few DC were found in the thyroids of the 
animals. The DC were scattered throughout the thyroid and were localized in the 
interstitial connective tissue and never in between the thyrocytes. The DC were not 
only found as single cells, they also made contact with other DC and with mast 
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cells present in the interstitial tissue to form small cellular clusters (homotypic 
clusters, figure 2A). A few CD4 + and cos+ T cells were also present and were, 
like the DC, found scattered throughout the thyroid in the interstitium. Sometimes 
however, the T cells could be observed between the thyrocytes being part of the 
thyroid follicle lining. The T cells were never grouped together or found clustered to 
other cells, but were present as single cells (figure 28). B cells could not be 




Figure 2. lntrathyroidal dendritic cells and T cells. 
A lntrathyroidal MHC class-11 positive dendritic cells with cytoplasmic protrusions forming 
homotypic clusters. The thyroid section from a rat kept on a UD for 6 weeks was 
incubated with the monoclonal antibody OX-6 (Magn. 1000x). 
B. lntrathyroidal single round CDS positive T cells (Magn. SOx). The thyroid section from a rat 
kept on a LID+ for 10 weeks was incubated with the monoclonal antibody OXS. Insert 
shows a higher magnification of a round T cell (Magn. 1500x). 
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In animals receiving an EID the intrathyroidal dendritic cells (DC) remained at a 
low constant level during the entire experimental period (range between 30 and 40 
DCjmm2, figure 3A). Also the number of intrathyroidal CD4 + and CDS+ T cells 
stayed low (range between 1.4 ± 0.9 and 2.0 ± 0.5 (mean± SD) for CD4 + cells and 
between 1. 7 ± 1.6 and 2.S ± 1.0 (mean± SD) for CDS+ cells, figure 3C, D). 
It must be stressed that similar results were obtained when the number of DC 
and T cells were not expressed per mm2 surface area of the section but were 
expressed per observed thyroid follicle in the plane of section or per surface area 
of thyrocyte parenchyma. 
In the thyroids of rats kept on a COD the number of DC increased to around 
45 DCjmm2 in the first weeks. This increase occured at the same time as the 
increase in the serum T 4 level. After 9 weeks and thereafter the number of 
intrathyroidal DC dropped to a lower level of 35 DCjmm2 and remained at this level 
(figure 3A). The number of intrathyroidal CD4 + and CDS+ T cells remained low 
during the entire experimental period in rats receiving a COD (range between 
0.6±0.5 and 4.4±2.9 CD4 + cellsjmm2 (mean±SD) and between 1.2±0.S and 
5.2 ± 1.S CDS+ cellsjmm2 (mean± SD), figure 3C, D). 
The LID caused a slightly stronger accumulation of DC and of T cells in the 
thyroid as compared to the EID and COD rats. There was a clear increase of DC 
numbers after 12 weeks of diet and values of 65 DCjmm2 were found. This 
increase occured at the same time as the goitre development in these animals. 
After 1S weeks DC numbers dropped to 45 DCjmm2 (figure 3A). Not only an 
increase in DC numbers could be found during LID, but the cells also became 
more active to form homotypic clusters. During the first weeks of the LID the 
number of intrathyroidal small cellular clusters of DC had increased from 0.6 ± O.S 
clustersjmm2 (mean± SD) at the start of the experiment to 3.9 ± 1.4 clustersjmm2 
(mean± SD, 3 weeks of diet). Thereafter a gradual decrease was seen (figure 38). 
The number of CD4 + and cos+ T cells increased to 10.3 ±3.5 CD4 + cellsjmm2 
(mean±SD) and 7.6±4.1 cos+ cellsjmm2 (mean±SD) after 3 and 6 weeks of 
LID respectively. After a drop in numbers, relatively high values were again reached 
at 1S weeks of diet (6.6±2.5 CD4 + cellsjmm2 (mean±SD) and 10.2±4.2 cos+ 
cellsjmm2 (mean±SD), figure 3C, D). 
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Figure 3.1mmune reactivity in the thyroid. Thyroid lobes of groups of rats (n=5~12) kept on an 
enriched iodine diet (ElD), a conventional diet (COD), a low iodine diet (LID) and an extreme 
low iodine diet (LID+) were removed, frozen and sections of 6pm were incubated with several 
monoclonal antibodies to identify intrathyroidal leucocytes. The mean number and SEM of 
intrathyroidal dendrttic cells (A), clusters of dendrttic cells (B), intrathyroidal CD4 + cells (C) 




The LID+ caused a pronounced increase in cell infiltration of DC, CD4 + and 
CD8 + T lymphocytes and of homotypic clustering of DC. Values of around 65 
DCjmm2 were already seen after 3 weeks of the LID+ After 6 weeks a decline 
could be observed and values of 40 DCjmm2 were reached after 10 weeks of 
LID+ (figure 3A). A pronounced peak of clusters of DC occured in the same 
period, reaching a maximal value of S.1 ±2.5 clustersjmm2 (mean±SD) after 4 
weeks of LID+ (figure 38). 
Not only an accumulation of DC was induced in the thyroid of LID+ animals 
but also a rapid and clear increase in both the number of intrathyroidal CD4 + and 
cos+ T cells (reaching maximal values of 1S.7±6.0 CD4+ cells (mean±SD) after 
S weeks of diet and 25.7±6.3 cos+ cells (mean±SD) after 6 weeks of diet, figure 
3C, D). These T cells were as in the animals kept on other diets single cells present 
in the interstitium and in between the thyrocytes. 
Anti-thyroid antibody production 
At the start of the experiments the incidence of anti-colloid antibodies in the 
Wistar rats colony was 4% (n=24). Anti-cytoplasmic antibodies were not detected. 
In rats receiving an EID the incidence of anti-colloid antibodies remained low 
and did not exceed an incidence of12.5% from 6 weeks of diet onwards (n=S-16, 
figure 4). Anti-cytoplasmic antibodies were not detected during the entire 
observation period in rats receiving an EID. 
Keeping the rats on a COO resulted in an incidence of anti-colloid antibodies of 
30% (n =25) after 5 weeks and onwards (figure 4). This incidence was however, not 
statistically significanctly different from the incidence of anti-colloid antibodies in EID 
rats (p>0.05, X2 analysis). Anti-cytoplasmic antibodies were sporadically found: in 
1 out of 17 rats after 3 weeks of diet and in 1 out of 9 rats after 6 weeks of diet. 
The other rats were negative. 
The LID resulted in a similar increase in anti-colloid antibody production as the 
COD, and incidences of 33% (n = 1S) were found after 5 weeks of diet. After 1S 
weeks however, the incidence was statistically significantly different from that of the 
EID rats and had reached 60% (n=10, p<0.05 compared to EID rats, X2 analysis, 
figure 4). At that time the rats had become subclinically hypothyroid and had 
developed a goitre (see above). In rats on a LID anti-cytoplasmic antibodies were 
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not detected. 
The LID+ stimulated the production of anti-colloid antibodies in our Wistar 
colony even stronger than the LID. After 10 weeks of diet all the rats (n=7) showed 
anti-colloid antibodies in their serum (figure 4). At that time the rats were severely 
hypothyroid, showing clearly enlarged thyroids. Only a few rats showed anti-
cytoplasmic antibodies in their serum: after 2 weeks of a LID+ 1 out of 18 and after 
6 weeks of diet 1 out of 7. The other rats were negative. 
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Figure 4. Incidence of anti-colloid antibody. The incidence of anti-colloid antibody production 
is given of various age groups of female Wistar rats (n=8-20 per age group) kept on an 
enriched iodine diet (EID), a conventional diet (COD), a !ow iodine diet (UD) and an extreme 
low iodine diet (UD+) from 3 weeks of age onwards for a period of 18 weeks.* p<O.OS, ** 
p<0.001 compared to EID, X2 analysis. 
DISCUSSION 
This study in normal Wistar rats shows that the dietary iodine intake not only 




An iodine-insufficient diet in our experimentel animals resulted in: 
a. an intrathyroidal accumulation of DC and T-cells; 
b. a clustering of the thyroid infiltrated DC, and 
c. an increased anti-colloid antibody production. 
The Wister rats suppleted with iodine showed a very low local thyroid immune 
response (few intrathyroidal dendritic cells and T-cells) and a very low production of 
anti-colloid antibodies. 
The higher incidence of anti-colloid antibodies in the iodine-deficient goitrous 
Wister rats is in accordance with the higher prevalences of anti-thyroglobulin 
antibodies reported in endemic goitre patients living in iodine-deficiency 11 . The 
direct pathogenic effects of anft-Tg antibodies are not clear. It must be noted that 
immunization with Tg can induce thyroiditis in experimental animals36; however, 
autoreactive T cells are considered more important in this phenomenon than 
thyroid autoantibodies. In a recent report not Tg, but TPO is thought to be of 
greater importance as an autoantigen in autoimmune thyroid disease37. In the 
thyroid autoimmune prone BB rat anti-cytoplasmic antibodies (anti-TPO antibodies) 
are indeed more frequent (10%) than in Wister rat strains (3%, unpublished data). 
The here reported experiments also show that this low frequency of anti-
cytoplasmic (anti-TPO) antibodies did not increase due to iodine deficiency or 
iodine excess. The anti-cytoplasmic antibodies are thus considered of minor 
importance in inducing thyroid autoimmune reactivity. 
The observed increases in the number of intrathyroidal dendritic cells and 
homotypic clusters of these cells in the rat goitres find their human parallel in the 
reported increases in dendritic cell infiltration and clusteri~g of these cells in 
thyroids of iodine-deficient endemic goitre patients20. 
Toxic effects of KCIO 4 on thyrocytes, inducing thyroid antigen release and 
explaining the thyroid autoimmune effects of the iodine-deficient diets in our rats 
can practically be excluded. Firstly because KCIO 4 was only given for the first two 
days of the diet in our LID group, while the increases in leucocyte infiltration and 
anti-colloid antibody production in this animal group were found only after 3-4 
weeks and 12-18 weeks of LID respectively, and secondly because thyroid cell 
death could not be observed in our histological specimen of LID and LID+ thyroids 
(on the contrary, an active high columnar epithelium was evident). 
The mechanisms of the infiuxes of DC and lymphocytes into the Wister thyroids 
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during iodine deficiency are speculative. DC are the antigen-presenting cells par 
excellence38, and are the most potent inducers of experimental autoimmune 
thyroiditis after transfer24. They are the first cells to appear in the thyroid during the 
development of the 88 rat thyroiditis23. It is likely that the macrophage-like dendritic 
cells accumulating early in the 88 rat thyroid pick up thyroid antigens, travel with 
these via the lymph to the draining lymphnode to initiate the autoimmune 
response38. 
We hypothesize that the high thyroid metabolic activity and the enhanced 
proliferation rate of the thyrocytes induced by the iodine deficiency played a role in 
the attraction of the dendritic cells by an enhanced expression and release of 
thyroid autoantigens. This might have triggered the dendritic cells to accumulate 
and to start a thyroid autoimmune response. It has indeed been suggested that a 
high thyrocyte metabolism might be involved in initiating a thyroid autoimmune 
response in the OS chicken. An intrinsically high thyroid metabolism has been 
described in the OS-chicken as a primary genetic abnormality of the target organ 
that forms one of the basic conditions for susceptibility to thyroid autoimmune 
disease39. In our experiments the stimulation of the iodine-deficient Wistar 
thyrocytes by the relatively high levels of serum TSH might also have played an 
additional role. Indeed, the serum TSH levels of the LID+ rats correlated well with 
the influxes of DC, the clustering of these cells and the incidence of anti-colloid 
antibodies. Chiovatto et af0 observed that TSH enhances the expression of the 
antigen thyroid peroxidase41 on the cell surface of the rat thyroid cell line FRTL-
5, whereas TSH also induces a higher production of the autoantigen Tg from 
thyrocytes. In addition when serum levels of TSH were suppressed in 88/Wor rats 
by T4 treatment lower levels of Tg-antibodies and a decreased incidence of 
thyroiditis were found42. 
The here reported data also indicate that there is a marked contrast between 
Wistar rats on the one hand and 88 rats and OS chickens on the other hand with 
regard to their response to deficient or sufficient iodine diets. In the OS-chicken and 
the 88/W rat, both well esthablished models of spontaneous autoimmune thyroid 
disease, a low iodine intake ameliorated the thyroid autoimmune reaction, whereas 
an increase in the incidence of thyroiditis was found during a high iodine 
intake43•44. 
The iodine intake in the studies on the 88 rat and OS-chicken (5.000-1 0.000 pg 
I per day) are considerably higher in comparison to the iodine suppletion used in 
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the here reported Wister study (100 pg I per day) which could explain the observed 
discrepancy. However, recent experiments performed by us (to be published) show 
that the relatively low excess of iodine of 100 pg I per day is sufficient to induce a 
marked and enhanced leucocytic infiltration in the thyroids of BB rats. This means 
that the discrepancy between Wister rats and BB rats/OS chickens in their 
response towards high and low iodine diets must be due to specific differences 
between the animals, which also relates to their different susceptibility for 
spontaneous thyroid autoimmunity. It must be noted however - although the Wister 
rat is not as severely genetically predisposed to thyroid autoimmune disease as the 
BB rat - the animal does show some susceptibility to thyroid autoimmune reactivity 
such as the presence of thyroid-specific T cells45 . 
In several studies the thyroid autoimmune promoting effects of the high iodine 
diets in BB rats and OS chickens are generally attributed to the direct effects of 
iodine on the thyroid autoimmune response itse~. Iodine increases the antigenicity 
of thyroglobulin46A7 (although this is also disputed48•49) or directly 
stimulates the function of macrophages50, T cells51 and B cells52. To 
explain our results (the virtual absence of thyroid autoimmune reactivity in Wister 
rats on a high iodine diet) one has to assume that either iodine has no such 
autoimune stimulating effects in the Wister rat or that the autoimmune promoting 
effects of iodine are overruled by autoimmune suppressor mechanisms specific for 
the Wister rat (tolerance induction). Since our histology showed that the thyrocytes 
of Wister rats kept on an El D had a very low level of metabolic activity (the cells 
showed a flattened appearance with prominent colloid spaces, to be published), it 
could also be envisaged that the iodine intake of 100 pg per day during the iodine 
suppletion is the most optimal intake for the Wistar rat and that this intake allows 
the Wister thyrocytes to function on a low metabolic level. 
If the metabolic activity of thyrocytes is indeed coupled to their autoantigenicity 
(see discussion above) one could imagine that a dietary intake of 100 pg of iodine 
per day in Wister rats is capable to keep the thyroid autoimmune reactivity at a very 
low level, despite the direct stimulating effects of the iodine on immune cells. Future 
studies need to unravel these possible mechanisms. 
In conclusion, the here reported data show that an insufficient dietary iodine 
intake is capable to precipitate a thyroid autoimmune response in normal non-
autoimmune Wistar rats, as in normal human populations. 
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Iodine deficiency and TGAbs in Wistar rats 
INTRODUCTION 
Patients suffering from diseases linked to iodine deficiency, such as endemic 
goitre 1 •2 and endemic cretinism3•4•5 often show lgG's in their serum that 
affect the growth of thyrocytes in vitro. The patients suffering from endemic goitre 
are often euthyroid and gottre development is not necessarily related to increases 
in TSH levels6 . 
In Chapter 2.1 of this thesis we described that Wistar rats kept on a moderately 
low dietary iodine regimen developed a goitre 6 weeks after starting the diet (at 9 
weeks of age) without any noteworthy increases in the serum TSH level. The 
observed thyroid growth in these rats could therefore not be due to TSH. Other 
growth factors must be involved in the iodine deficient goitre development. 
At earlier occasions we suggested that immune factors, such as thyroid growth 
stimulating antibodies (TGAbs) might play a role in iodine deficient goitre formation. 
We therefore tested in a preliminary set of experiments crude immunoglobulin 
preparations of rats kept on several dietary iodine regimens on growth stimulating 
capactty in a mitotic arrest assay using the rat thyrocyte cell line FRTL-5 as 
indicator cells. Since it proved to be difficult to purify lgGs from rat sera via protein-
A sepharose techniques, we first set out to study the effects of crude lg 
preparations (ammonium sulphate precipitates) of the serum of the Wistar rats to 
establish any positivtty in the mitotic arrest assay. 
MATERIALS AND METHODS 
Animals and diets 
Female Wistar rats were purchased from TNO Rijswijk, The Netherlands and 
kept at the central experimental animal housing facilities of the Erasmus Universtty 
Rotterdam under standard conditions. Directly after weaning (at the age of 3 
weeks) groups of rats (n=S-18) were kept on several dietary iodine regimens: 
1. An enriched iodine diet (EID); the rats received conventional pellets (Am-11, 
Hope Farms bv. Woerden, The Netherlands) ad libitum as well as an extra 
iodine supplementation of 6.5mg Kl/1 added to the drinking water (the urinary 
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iodine excretion was about 100pg of iodine per day, for methods see ref). 
A for our area normal iodine diet (NID); the rats received conventional pellets 
(Am-11, Hope Farms bv, ± 0.35 mg/kg iodine) and Rotterdam tap water ad 
libitum (the urinary iodine excretion in this group was about 7 pg of iodine per 
day). 
A low iodine diet (LID); the rats received 1% KCL04 in the drinking water for a 
period of 2 days and thereafter distilled water and iodine deficient pellets 
(Modified Remmington diet, Hope Farms bv) ad libitum (urinary iodine excretion 
undetectable). 
An extreme low iodine diet (LID+); the rats continuously received 1% KCL04 in 
their distilled drinking water and iodine deficient pellets (Modified Remmington 
diet, Hope Farms bv) ad libitum (urinary iodine excretion undetectable). 
Wistar rats were sacrificed by aortic exsanguination under ether anaesthesia at 
the start of the experiment and after 3, 4, 6, 8 and 9 weeks. Serum was collected 
and prepared lor TGAb measurement. Each group consisted of 4-8 rats. 
Preparation of the serum samples 
Serum samples were diluted with an equal volume of phosphate buffered saline 
(PBS). Immunoglobulin (lg) fractions were precipitated in 25% saturated 
ammoniumsulphate at 4°C and centrifuged at 1000x g. After several washing 
steps, the lgG fractions were dialyzed in PBS for 18 hours at 4°C. The protein 
concentration of each serum fraction was measured spectrofotometrically at 280 
nm. 
Measurement of thyroid growth stimulating activity 
The growth stimulating activity of the serum samples was measured using the 
mitotic arrest assay described by Ealy et al8 and modified by Wilders et al1 . The 
rat thyroid cell line FRTL-5 used in this assay was cultured under standard 
conditions9. For the mitotic arrest assay 0.5.105 cellsjml culture fluid were seeded 
in each well of 24-wells plates (Costar, Cambridge, MA), with round glass 
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coverslips on the bottom of each well. They were maintained in 6 hormone mixture 
(6H, see ref1) for 7 days and subsequently cultured in the same culture fluid 
without TSH (5 hormone mixture, 5H) for another 7 days. Every third or fourth day 
the culture fluid was replaced. 
To test the serum samples for their growth potential, purified preparations were 
added in (when possible) four concentrations (dilutions in 1 mljwell 5H, 0.2 mgjml 
often proved to be the optimal concentration), plus a suboptimal dose of TSH, 
namely 10pU TSHjwell. To serve as positive control, FRTL-5 cells were cultured in 
6H, and as baseline control FRTL-5 cells were cultured in 5H plus the suboptimal 
dose of TSH (10pUjml). After a culture period of 44 hours, Colcemid (Sigma), a 
mitotic spindle poison, was added to each well in a final concentration of 166pgjl 
to accumulate metaphases during the final 3 hours of culture. Cu~ure fluid was 
removed and the glass coverslips were airdried for at least two hours. Thereafter, a 
May-Grunwald Giemsa staining of the cells on the coverslips was performed. 
Coverslips were removed and mounted upside down on microscope slides. 
The mitosis index (Ml) was determined by counting the percentage of cells in 
metaphase using light microscopy. Of each coverslip 500 cells were counted, with 
a minimum of 5 microscopic fields at a magnification of x400. The relative 
stimulation of each seperate test was calculated as the ratio between the Ml of cells 
cultured in 5H with the purified serum samples plus 1 OpU jml TSH and the Ml of 
cells on 5H plus 10pUjml TSH alone: 
Ml of cells with lg preparation + 10pUjml TSH 
relative stimulation = 
Ml of cells with 10pUjml TSH 
RESULTS 
The growth stimulating activity of the ammonium sulphate-purified serum 
samples was considered to be positive - on the basis of the data in Wistar rats on 
a normal iodine diet - when one of the concentrations of serum samples tested 
resulted in a relative stimulation index (viz mitotic index in the presence of lg 
preparation j mitotic index in the absence of lg preparation) of > 3. 
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Serum samples of Wistar rats kept on a normal iodine diet (NID) did - by 
definition - not show any growth stimulating activity on the rat thyroid cell line FRTL-
5 and relative stimulations ranged from 1 to 3 (4-6 rat lg preparations tested in 
each group in 1-4 concentrations, figure 1). 
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Figure 1. The percentage of rats kept on an enriched iodine diet (EID), a normal iodine diet 
(NID), a low iodine diet (UD) or an extreme low iodine diet {liD+) with thyroid gro"Wth 
stimulating activity in their serum, measured in a mitotic arrest assay using the rat thyroid cell 
line FRTL~5 as indicator cells. The ammonium sulphate-purified serum samples were 
considered to be positive when relative stimulations of > 3 were found. 
Also in rats kept on an enriched iodine diet (EID) growth stimulating activity 
was limited. After 6 weeks of diet 2 out of 8 (25%), and after 9 weeks of diet 1 out 
of 8 (12%) rat lg preparations tested stimulated the growth rate of the FRTL-5 cells 
with a relative stimulation of 4. The other samples were negative (relative stimulation 
< 3, 6-8 rat lg preparations tested in 1-5 concentrations). 
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However, when Wistar rats were kept on a low iodine diet (LID) or an extreme 
low iodine diet (LID+), a considerable proportion of serum samples of the rats had 
growth stimulating activity. 50% of the rats kept on a LID were positive after 3 
weeks of diet (with a relative stimulation of 4, 4 rat lg preparations tested, in 1-4 
concentrations) which incidence declined to 20% after 4 weeks (with a relative 
stimulation of 6, 5 rat lg preparations tested, in 2-4 concentrations) to drop to 0 
after 6 weeks of diet (with relative stimulations of 1-3, 8 rat lg preparations tested, 
in 1-2 concentrations). 
The rats on a LID+ also showed thyroid growth stimulating activity a few weeks 
after introducing the diet (viz at 4 weeks, with relative stimulations of 3.5-4.5, 6 rat 
lg preparations tested, in 2-4 concentrations). These rats however remained 
positive till the end of the experiment: after 8 weeks of diet 66% of the rats tested 
still showed growth stimulating activity in their serum (relative stimulations of 4.5 
and 5, 3 rat lg preparations tested in 4 concentrations, figure 1). 
DISCUSSION 
This preliminary study shows that thyroid growth stimulating activity was indeed 
found in a considerable proportion of ammonium sulphate precipttates of the serum 
samples of Wistar rats kept on a moderately low (LID) or extreme low iodine diet 
(LID+). This activity was not detectable in the ammonium sulphate precipttates of 
the serum samples of Wistar rats kept on a normal iodine diet (NID) and only in a 
limited number of the precipitates of rats kept on an enriched iodine diet (EID). 
Rats kept on a LID showed thyroid growth stimulating activity in their serum 
fractions relatively early after introducing the diet. During this time serum TSH and 
thyroid growth were normal (see Chapter 2.1). Goitre development was only 
observed after 6 weeks of diet (when the incidence of thyroid growth stimulating 
activity of the serum samples already declined) and at which time serum TSH levels 
were still within the normal range. 
It is possible that the observed thyroid growth stimulating activity of the serum 
samples in the early phases of the experiment is responsible for or 
modifies/regulates the goitre development observed somewhat later in these LID 
rats. The thyroid growth stimulating activity cannot be ascribed to TSH since serum 
TSH levels were within the normal range. Whether the growth stimulating activity 
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represents an immunoglobulin effect {for instance an immunoglobulin directed 
against the TSH receptor or against the IGF-1 receptor) or whether an other growth 
factor present in the ammonium sulphate precipitates is responsible for the thyroid 
growth stimulating activity needs further investigation. 
Experiments are planned based on a further purification of lg fractions from the 
ammonium sulphate precipitates or a neutralization of the thyroid growth stimulating 
activity via a treatment with a-lg antibodies or with antibodies to IGF-1, EGF or 
other growth factors. 
In rats kept on a LID+, thyroid growth stimulating activity was observed in the 
serum fractions 4 and 8 weeks after introducing the diet. During this time the rats 
showed a pronounced goitre development {see Chapter 2.1). During this period the 
rats were hypothyroid and showed highly elevated serum TSH levels. It is however 
not possible that the observed thyroid growth stimulating activity is due to TSH in 
the ammonium sulphate-purified serum fractions, since the suboptimal dose ol TSH 
(10pU/ml) added to the FRTL-5 cells in the mitotic arrest assay is already much 
higher than the TSH present in the serum ol the hypothyroid rats. 
Our data nevertheless indicate that circulating thyroid growth factors are 
present in iodine deficient Wistar rats. The stimulation of thyroid autoimmune 
phenomena in iodine deficient Wistar rats {see Chapter 2.1) suggests that these 
circulating thyroid growth stimulating factors might likely be thyroid growth 
stimulating antibodies (TGAbs). 
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BB rats compensate low iodine regimens 
ABSTRACT 
Female Wistar rats and female autoimmune-prone BB rats were kept on a low 
iodine diet (LID) lor a period of 18 weeks from 3 weeks of age onwards. The LID 
consisted of 1% KCL04 in the drinkingwater lor 2 days, followed by distilled water and 
iodine deficient pellets for the remaining period. Rats kept on a for our area normal 
iodine diet (NID: normal pellets and Rotterdam tap water) served as controls. 
In the Wistar rats, the LID resulted in a relatively slow goitre formation (thyroid 
weights at 18 weeks of diet: 13.5±2.0 (mean ±SO, NID) vs 26.3 ±7.3 mg (mean±SD, 
LID) p<0.05), and a gradual development of a mild hypothyroidism (at 18 weeks of 
diet NID vs LID values: T3=1.21 ±0.1 (mean±SD) vs 1.07±0.1 nmoljl (mean±SD), 
p<0.05; T4 =44±10 (mean±SD) vs 21 ±4 nmoljl (mean±SD), p<0.05; 
TSH=2.3±0.3 (mean±SD) vs 6.4±2.1 ngjml (mean±SD), p<0.05). 
In the BB rats the LID resulted in a relatively rapid goitre formation, and maximal 
thyroidal weight (31.2 ± 8 mg, mean± SO) was already reached after 6 weeks of diet. 
Also and in contrast to the Wistar rats, the BB rats only developed a transient 
subclinical hypothyroidism from 3 till 6 weeks of LID (NID vs LID values after 6 weeks 
of diet: T3 =1.21 ±0.24 (mean±SD) vs 1.15±0.14 nmol/1 (mean ±SO); T4 =44.8±8.8 
(mean± SO) vs 18.1 ± 2.4 nmol/1 (mean± SO), p < 0.05; TSH = 1.59 ± 0.8 (mean± SO) 
vs 10.7±3.6 ngjml (mean±SD), p<0.05). Euthyroidism was fully restored after 9 
weeks of the l(lw iodine diet and NID vs LID value were: T 3 = 1.05 ± 0.18 (mean± SD) 
vs 1.28±0.1 nmol/1 (mean±SD); T4 =56.5±8.6 (mean±SD) vs 43.8±6.5 nmoljl 
(mean±SD) and TSH=1.35±0.4 (mean±SD) vs 3.0±1.1 ngjml (mean±SD). 
Our data show that the autoimmune-prone BB rats of our colony are capable to 
compensate for mild iodine deficiency by a rapid goitre formation, this in contrast to 
the Wistar rats that became gradually hypothyroid. Hypothetical explanations for the 
compensating mechanisms are: 1) an autonomous high intrinsic metabolism and 
growth rate of BB-thyrocytes such has been described in another thyroid autoimmune 
animal model, namely the OS chicken and 2) an enhanced production of thyroid 
growth stimulating antibodies as has been described to be present in our BB rat strain. 
INTRODUCTION 
Over the past few years we have used two experimental animal strains - viz. the 
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Wistar rat and the BB rat - to study the effects of the dietary iodine intake on thyroid 
autoimmune reactivity. The development of thyroid autoimmune reactivity was studied 
in relation to thyroid performance (serum thyroid hormone levels, TSH levels) and 
goitre development1•2•3 •4 . During our studies we observed that the thyroid 
autoimmune prone BB rats were capable to compensate for a moderately low dietary 
iodine intake in contrast to normal Wistar rats. After a short transient period of 
subclinical hypothyroidism the 88 rats were able to increase their thyroidal T 4 output, 
restoring full euthyroidism. This report describes the experimental details of this 
phenomenon and discusses possible explanations. 
MATERIALS AND METHODS 
Animals and diets 
Female Wistar rats were purchased from TNO Rijswijk, The Netherlands and kept 
at the central experimental animal .housing facilities of the Erasmus University 
Rotterdam under standard conditions. 
88 rats were initially provided by Dr. H.A.M. Verheul and Mr. E. Cremers from 
Organon 8V, The Netherlands; presently the strain is bred and kept at the central 
experimental animal:-housing facilities of the Erasmus University Rotterdam. 
8B rats which became diabetic (at the age of approximately 10 weeks; daily 
controlled by urinary glucose levels using Gluketur-Test sticks, Boehringer, Germany) 
were treated subcutaneously with 21U protamine zinc insulin (daily injections of isofarie 
protamine bovine insulin, lnsulinum N.P.H., Organon Oss bv,. The Netherlands). 
Directly after weaning (at the age of 3 weeks) groups of female Wistar and B8 rats 
(n=5-18) were kept on either a normal or a low iodine diet: 
1. The normal iodine diet (NID); the rats received normal pellets (Am-11, Hope Farms 
bv, Woerden, The Netherlands, ± 0.35 mgjkg iodine) and Rotterdam tap water 
ad libitum. The daily iodine intake in this group was about 7pg of iodine, verified 
by urinary iodine excretion (for details of assay see ref5). 
2. The low iodine diet (LID); rats received 1% KCL04 in the drinking water for a 
period of 2 days and thereafter distilled water and iodine deficient pellets (Modified 
Remmington diet, Hope Farms bv) ad libitum. After 1 week of diet the excreted 
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urinary iodine during 24 hours was under the detection limit of our assay (for 
details of assay see ref5). 
Various groups of these Wistar and BB rats were sacrificed by aortic 
exsanguination under ether anaesthesia after 3, 6, 9, 12 or 18 weeks of diet Serum 
was prepared for T3 , T4 and TSH evaluation (measured by RIA, Dr. W.M. Wiersinga, 
Mrs. M. Broenink, Academical Medical Centre, Amsterdam, The Netherlands). The rat 
TSH reference preparation NIADDK-rTSH-RP-2 was kindly provided by Dr. Parlow from 
the UCLA Medical Centre, Torrance, and was 176 times more potent than the 
NIADDK-rTSH-RP-1. Thyroid glands were removed and weighed. 
Statistical analysis 
Differences in serum T 3 , T 4 , and TSH were compared by Wilcoxon's rank sum 
test. The correlation between thyroid weight and serum TSH levels were calculated 
using linear regression analysis. 
RESULTS 
Thyroid weight development 
Normal iodine diet (NID) 
The thyroid weight of female Wistar rats kept on a NID increased gradually from 
6.7± 1.1 mg (mean±SD) to 13.3±2.9 mg (mean±SD) after 6 weeks of diet (9 weeks 
of age), remaining constant thereafter (figure 1A). This thyroid weight development was 
in line with the body weight development of the Wistar rats and the thyroid/body 
weight index remained constant namely: 0.07. 
The thyroids of the autoimmune-prone BB rats kept on a NID, grew till the end of 
the experiment and thyroid weights increased from 4.8 ± 0.5 mg (mean± SO) at the 
start of the experiment (3 weeks of age) to reach 18.9±3.5 mg (mean±SD) at 21 
weeks of age (figure 1 B). 
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Figure 1. Thyroid weight and serum T 3 levels. 
Wistar rats and BB rats were kept on a normal iodine diet (NlD) or a low iodine diet (LID) for a 
period of 18 weeks from 3 weeks of age onwards. Rats were sacrificed, thyroids were removed 
and weighed to measure goitre development (A, Wistar rat and B, 88 rat), serum was collected 
to measure serum T 3 by RIA (C, Wistar rat and D, BB rat). The mean and standard error are given 
of 5-18 rats per group. 
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In fact the thyroid weights of the BB rats on a normal iodine diet became higher 
than the thyroid weights of the Wistar rats on a normal iodine diet and a statistical 
significant difference was reached between the two strains at 12 weeks of age (9 
weeks of diet, p<0.05, Wilcoxon's rank sum test). These results of spontaneous BB 
goitre development Qn relation to the Wistar rat) are in agreement with earlier findings 
reported by us6• 
Low iodine diet (LID). 
In the Wistar rats, a LID resulted in a clear weight increase of the thyroid that was 
statistically significantly different from the thyroid weights of Wistar rats kept on a NID: 
alter 6 weeks of diet the Wistar thyroid weight was already 19.1 ±3.0 mg (mean ±SO) 
and the goitre reached maximal values alter 18 weeks of diet, viz. 26.3±7.1 mg 
(mean±SD) (figure 1A). 
In the BB rats the LID caused an even more rapid and more pronounced goitre 
development than in the Wistar rats. Already alter 3 weeks of diet the thyroid weight 
was statistically significantly higher than the thyroid weight of the BB rats on a normal 
iodine diet and also higher than that of the Wistar rats on LID, viz. 19.3±9.3 vs 
9.4± 1.1 and vs 10.8±2.1 mg (mean±SD) respectively (both p<0.05). Maximal goitre 
development was observed alter 9 weeks of LID (32.5 ± 6.0 mg, mean± SD) whereafter 
thyroidal weight slightly decreased to 27.7±4.2 mg (mean ±SO) alter 12 weeks of liD 
and to 25.5±5.4 mg (mean±SD) alter 18 weeks of LID (figure 18). 
Serum thyroid hormone and TSH levels 
Rats kept on a normal iodine diet 
In Wistar rats receiving a normal diet serum T 3 levels were high at the start of the 
experiment (1.6 ± 0.2 nmoljl, mean± SD) and decreased from 6 weeks of age onwards 
to gradually reach 1.2 ± 0.1 nmoljl (mean± SO) at 15 weeks of age, remaining at that 
level thereafter (figure 1C). Serum T4 levels increased during the first 3 weeks of the 
experiment to a level of 50 nmol/1, remaining constant thereafter for the further 
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Figure 2. Serum T4 and serum TSH levels. Wistar rats and BB rats were kept on a conventional 
(COD) or low iodine diet (UD) for a period of 18 weeks from 3 weeks of age onwards. Rats were 
sacrificed, serum was collected to measure serum T 4 (A. Wistar rat and 8, 88 rat) and TSH (C, 
Wistar rat and 0, BB rat). The mean and standard error are given of 5~14 rats per group. 
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Such relatively high serum T 3 (and T 4) levels in prepubertal rats compared to adult 
rats have been described before 7 , and these high thyroid hormone levels were 
regarded by the reporting authors as necessary for optimal brain development in these 
young rats. 
Comparable levels of serum T 3 and serum T 4 were found in the BB rats kept on 
a normal iodine diet (figure 1 D, 28). Serum T 3 levels were as in the Wistar rats high 
to begin with (1.8 ± 0.2 nmoljl, mean± SD) and gradually declined to 0.9 ± 0.2 nmoljl 
(mean± SD) at 21 weeks of age. Serum T 4 levels in the BB rat were around 50 nmoljl 
during the entire experimental period. 
Serum TSH levels were relatively low in both Wistar and BB rats kept on normal diets 
as compared to data reported in the literature, but both were within the normal range3 . 
The TSH levels of BB rats were lower in comparison to those of the Wistar rats 
(p<O.OS, figure 2C, D). 
Rats kept on a low iodine diet. · 
In Wister rats the T 4 output of the thyroid gradually failed during the LID and the 
animals became subclinically hypothyroid after 12 weeks of diet. Serum T 4 levels were 
as low as 28.0±2.5 nmoljl (mean±SD) and remained after 12 weeks of diet 
statistically significantly lower than the levels of the Wistar rats on a normal iodine diet 
(p<0.05, figure 1D). Despite these low serum T4 levels, serum T 3 1evels were normal 
till12 weeks of diet. Nevertheless, after 18 weeks compensation started to fail and a 
slight but statistically significant decrease in serum T 3 was seen when compared to 
the serum T3 level of Wistar rats on a normal iodine diet (figure 1C). 
The fall in serum T 4 (and later T 3) levels in iodine deficient Wistar rats was 
accompanied by a significant rise in serum TSH level. A small rise in serum TSH levels 
could already be detected after 6 weeks of LID, but a more pronounced rise was 
found at 18 weeks of LID (the latter6.4± 1.8 ngjml, mean ±SD, LID vs 2.3±0.3 ngjml 
mean ±SD, NID figure 2C). 
It is worthy to note that the increase in thyroid weight during the first 12 weeks of 
the diet was not related to a meaningful increase in serum TSH levels. 
In BB rats, a LID resulted in a completely different thyroid hormone output when 
compared to the Wistar rats output during a LID. A clear, but short transient subclinical 
hypothyroidal state was observed after introducing the low iodine diet. This subclinical 
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hypothyroidal state only lasted for a period of upto 9 weeks of LID. From 9 weeks of 
LID onwards full euthyroidism was restored. In detail: serum T 4 levels started to drop 
after 3 weeks of LID (from 53.5 ± 8.5, mean± SO to 21.3 ± 2.2 nmol/1, mean± SO) and 
reached a minimal value of 18.1 ±2.4 nmol/1 (mean ±SO) after 6 weeks of LID (figure 
2B). At the same period a steep and clear increase in serum TSH levels was found: 
after 3 weeks of LID serum TSH rose from 1.1 ± 0. 7 (mean± SO) to 4.0 ± 2.1 nmoljl 
(mean±SD) and after 6 weeks of LID a maximal value of 10.7±3.6 nmoljl 
(mean± SO) was reached (figure 20). It must be recalled that during this period of 
subclinical hypothyroidism a rapid goitre development was observed in the BB rat; in 
fact a positive correlation existed between thyroid weight development, rises in serum 
TSH levels and falls in T4 production in this period (r;0.72, p<0.01 and r;-0.70, 
p<0.01 respectively). Serum T3 levels in the BB rat remained in the normal range 
during the entire experimental period (figure 1 D). 
DISCUSSION 
This study shows that BB rats are capable to compensate for moderately low 
dietary iodine intakes. After an initial transient period of biochemical hypothyroidism, 
the BB thyroid was capable to increase its T 4 output, thereby restoring normal serum 
T 4 levels. The initial sharp drop in the serum T 4 level in the BB rat was accompanied 
by an increase in the serum TSH level and a rapid goitre development. This goitre 
development was earlier in time and more pronounced than the goitre development 
of Wistar rats kept on a the same low dietary iodine regimen. In these latter Wistar rats 
the iodine deficiency gradually led to thyroid insufficiency resulting in a state of 
biochemical hypothyroidism at the end of the experimental period. When BB rats are 
kept on a severe iodine deficient diet (continuously KCI04 in the drinking water and 
iodine deficient pellets) there is again a rapid goitre development; however, thyroid 
metabolism fails completely and biochemical hypothyroidism is reached at 2 weeks of 
severe iodine deficient diet (data not shown). 
The mechanisms underlying the capability of the BB rats to compensate for 
moderately low iodine intakes are unknown and remain speculative. It is tempting to 
speculate that the mechanisms are related to the thyroid autoimmune proneness of 
the animals. 
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An intrinsically high metabolism of thyrocytes has been described to be one of the 
prerequisites lor the development of thyroid autoimmunity in the OS chicken8, and 
there are indications that the thyrocyte metabolism, the iodine turnover and the growth 
rate are also intrinsically high in BB rats: 
firstly histological parameters indicate that BB thyrocytes are more active than 
normal Wistar thyrocytes (the nuclear volume of BB thyrocytes is larger and the 
thyrocytes show a high columnar appearance, data to be published), 
secondly, Li et al have reported9 ·that Oodine treated) BB rats have a higher 
radioactive iodine uptake and release than Wistar rats, and 
thirdly, prelimenary data of our own group show that basic thyrocyte proliferation 
and the proliferative response to TSH is higher and much more pronounced in 
cultured BB rat thyroid follicles in comparison to these parameters in cultured 
Wistar rat thyroid follicles (data not shown). 
II there is such an intrinsically high and autonomous metabolism and proliferation 
rate of BB thyrocytes, this autonomously high proliferative and metabolic activity might 
explain the rapid thyroid growth and the early rapid phase of low T 4 output (viz. rapid 
development of failure due to high iodine turnover) in BB rats during iodine deficiency. 
It might also form the basis for the development of the thyroid autoimmune reactivity 
in the BB rat if one envisages that the high metabolic and proliferative activity of the 
BB thyrocytes induces an enhanced expression of autoantigens andjor a significant 
release of antigenic degradation products, thereby triggering the animal's immune 
system (see similar mechanisms in the OS chicken, ref10). 
However, there might also be an other explanation for the observed compensation 
mechanisms of the BB rats to moderate iodine deficiency. This explanation is a direct 
consequence of the thyroid autoimmune response of the animals. The BB rat is 
capable of producing thyroid growth stimulating immunoglobulins (TG1s)2 and the 
presence of these TGis might induce the rapid thyroid growth, possibly in combination 
with the raised TSH. Consequently there might be a higher T 4 output by the larger 
goitre. Research in our laboratory is ongoing to also study this latter hypothesis. 
In conclusion, our experiments show that autoimmune prone BB rats are capable 
of compensating lor mild iodine deficiency (in contrast to Wistar rats). The 
mechanisms for this compensation are speculative. Possibly analogous situations 
exists in human populations, where some individuals are capable to compensate for 
a low iodine intake by rapid goitre development. It is intruiging that these goitrous 
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individuals have been described to show various signs of thyroid autoimmunity viz. 
the presence of TGis, increased numbers of intrathyroidal dendr~ic cells and 
aggregations of these cells and higher incidences of anti-thyroglobulin anti-
bodies11·12·13·14. Again it is the question, whether these thyroid autoimmune 
phenomena form the basis for the goitre development 11 '15 or whether they are 
mere markers of an intrinsically high autonomous thyroid growth rate and metabolism. 
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BB thyrocytes show a high proliferation rate 
INTRODUCTION 
The BB rat is a well known animal model for the study of autoimmune thyroid 
disease. The rat develops a focal thyroiditis, a goitre and shows a variety of thyroid 
reactive autoantibodies 1 •2 . 
In Chapter 3.1 of this thesis we report that the BB rat is capable of compensa-
ting for a moderately low dietary iodine intake (in contrast to normal Wistar rats), 
restoring lull euthyroidism by rapidly growing a large goitre. In the discussion of 
that Chapter we hypothesized that the BB thyrocytes might have an intrinsically 
high metabolism and growth rate. Such an intrinsically high thyroid metabolism has 
been described for the OS chicken, another animal model of autoimmune thyroid 
disease3. 
To verify this hypothesis we isolated thyroid follicles of autoimmune-prone BB 
rats and normal Wistar rats (10-15 weeks of age) and cultured these follicles in the 
absence or presence of TSH. The growth rate and growth rate response to TSH of 
the BB and Wistar rat thyroid follicles were measured using BrdU incorporation. 
MATERIALS AND METHODS 
Animals 
Female Wistar rats were bred at TNO Rijswijk, The Netherlands and kept at the 
central experimental animal housing facilities of the Erasmus University Rotterdam 
under normal conditions. BB rats were kindly provided by Dr. HAM. Verheul and 
Mr. E. Cremers from Organon BV, The Netherlands and were further bred and kept 
at the central experimental animal housing facilities of the Erasmus University 
Rotterdam under normal conditions. BB rats which became diabetic (at the age of 
10 weeks daily controlled by urinary glucose levels using Gluketur-Test sticks, 
Boehringer, Germany) were daily subcutaneously injected with 21U protamine zinc 
insulin (isofane protamine bovine insulin, lnsulinum N.P.H., Organon Oss bv, The 
Netherlands). All rats received commercial food (Am-11, Hope Farms bv, Woerden, 
The Netherlands) and tap water ad libitum. At the age of 10-15 weeks rats were 




Isolation of thyroid follicles 
Thyroid follicles were isolated as described before4 with slight modifications. 
Thyroid lobes of 5 rats (10-15 weeks of age) were removed under sterile conditions 
and placed in Hanks medium without Ca2+ and Mg2+ (Gibco) at room 
temperature. The medium was removed and replaced by 5 ml Hanks (without 
Ca2+ and Mg2+) supplemented with 5 mM CaCL2, 475 U/ml collagenase (type II, 
Sigma) and 0.1 mgjml DNAse (type I, grade 2, Boehringer, Germany). The lobes 
were mechanically dissected using small scissors and incubated for either 30 
minutes (for BB rat thyroids) or 45 minutes (for Wister rat thyroids) at 37°C in a 
95% 0 2, 5% C02 water-saturated atmosphere. After incubation the suspension was 
1 o times gently pipetted using a Pasteurs capillary pipette (short size, 150 mm, WU, 
Mainz, Germany). Thyroid fragments were left to sediment during 1 minute. The 
isolated follicles present in the supernatant were removed and kept at 4°C. 
Undigested fragments were incubated in 5 ml fresh collagenase/DNAse medium for 
either 15 minutes (for BB rat thyroids) or 20 minutes (for Wister rat thyroids) at 
37°C in a 95% 0 2 , 5% C02 water-saturated atmosphere. After incubation the 
suspension was again gently pipetted, thyroid follicles were removed and the 
remaining undigested fragments were incubated with 5 ml fresh 
collagenasejDNAse medium lor the same period as described above. This 
procedure was repeated 3 to 4 times untill the complete thyroid was digested. The 
isolated follicles were centrifuged at 20 x g lor 5 minutes and washed 3 times with 7 
ml ice-cold Hanks (without ca2 + and Mg2 +) supplemented with 5 mgjml bovine 
serum albumin (BSA, Sigma) and 0.1 mgjml DNAse. The final suspension was, 
when necessary, filtered through a 150 J1rr1 mesh nylon filter (Kabel Zaandam BV, 
The Netherlands). The isolated follicles were centrifuged at 500 x g for 5 minutes 
and resuspended in 1 ml Ham's F-12 medium (Flow, ICN Biomedicals BV, The 
Netherlands) supplemented with a 5 hormone mixture (5H) containing 10 pgjml 
insulin (Sigma), 10 nM hydrocortison (Sigma), 5 pgjml transferrin (Sigma), 10 
ngjml glycyi-L-histidyi-L-Iysine-acetate (Sigma), 10 ngjm somatostatin (Sigma), and 
0.5% heat inactivated (30 mins., 56 °C) fetal ca~ serum (FCS, Integra bv, 
Zaandam, The Netherlands), 100 Ujml penicillin G (Seromed, Biochrom, Berlin, 
Germany), 0.1 mgjml streptomycin (Seromed, Biochrom, Berlin, Germany), and 2.5 
pgjmi amphatracin B (Boehringer, Germany). 
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Viability of isolated follicles 
The viability of isolated follicles was routinely assessed by the trypan blue 
exclusion test according to Phillips5. The counting was performed in a Burker-Turk 
hemocytometer using light microscopy (magn. 1 OOX). Directly after the isolation 
procedures 90-98% of the thyroid follicles were viable. 
Cuftering of thyroid follicles 
The isolated thyroid follicles were seeded in 12 wells plates (Costar, 1-4.104 
viable folliclesjml, 1 ml per well) in Ham's F-12 medium supplemented with 5H (see 
before), 0.5% FCS and antibiotics at 37°C in a 95% 0 2, 5% C02 water-saturated 
atmosphere. The medium was refreshed at day 1 and 3. For stimulation 
experiments a concentration of 10 mU jml of bovine TSH (Sigma) was added to the 
culture medium (in a preliminary study this concentration proved to be optimal) at 
day 1. 
Growth of thyroid follicles 
The growth of thyroid follicles was measured using BrdU incorporation 
according to a method that has been described before6. In brief, the follicles were 
harvested (1-4.104 /ml), diluted 10 times in F-12 supplemented with 0.5% FCS and 
antibiotics, and incubated for 2 hours in the presence of BrdU (Sigma) in a final 
concentration of 10 pM at 37°C in a 95% 0 2, 5% C02 water-saturated 
atmosphere. After the incubation period the follicles were washed 2 times (at 500 x 
g for 5 minutes) in phosphate buffered saline (PBS) supplemented with 1% glucose. 
The follicles were fixed for 30 minutes in 70% ethanol at 4 °C and washed 2 times 
(at 500 x g for 5 minutes) in PBS. The incorporated BrdU was visualized by 
incubating the follicles for 60 minutes with a mouse monoclonal antibody directed 
against BrdU (Becton and Dickinson, USA) diluted 25 times in PBS containing 1% 
BSA at room temperature. Follicles incubated in PBS only containing 1% BSA for 
60 minutes served as controls. The follicles were washed 2 times (at 500 x g for 5 
minutes) in PBS containing 10% BSA and incubated for 30 minutes with a 25 times 
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diluted On PBS w~h 1% BSA) rabbit anti-mouse-immunoglobulin monoclonal 
antibody labeled with FITC (fluorescein isothiocyanate, Dako, Denmark) at room 
temperature in the dark. The follicles were washed 2 times in PBS containing 10% 
BSA (at 500 x g for 5 minutes) and the final pellet was resuspended in 100 .ul PBS 
with 10% BSA. 50 .ul of the thyroid follicle suspensions at a concentration of 
1.105 jml were cytocentrifuged (3 minutes, 11 DO rpm ) using a cytospin apparatus 
(Nordic Immunological Laboratories, The Netherlands) and cytocentrifuge 
preparations were embedded in aquamount (Gurr, BDH Limited Poole, England). 
The percentage positive labeled thyroid follicles was counted using a fiuorescense 
microscope. 
RESUlTS 
BB thyroid follicles isolated from 10-15 weeks old animals had a spontaneous 
higher growth rate as compared to Wistar thyrocytes when cultured in the absence 
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Figure 1. The growth rate measured using BrdU incorporation of thyroid follicles isolated from 
5 (1 0-15 weeks old) BB rats Qeft panel) and 5 Wistar rats (right panel) cultured in the absence 
(open circles) or presence (closed circles) of 10 mUjml TSH. The mean and standard 
deviation of 3 experiments are depicted. 
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A maximum of around 20% (the mean of3 experiments) Brdu+ BB rat thyroid 
follicles was observed after a culture period of 72 to 96 hours, whereas thyroid 
follicles of Wistsr rats did not exceed a 14% positivity at 96 hours of cu~ure (the 
mean of 3 experiments, figure 1). 
Figure 1 also show the data of in vitro TSH stimulation, introduced at 24 hours 
of culture. The BB rat thyroid follicles clearly had a higher response to TSH in 
comparison to Wistar thyroid follicles (38.5±5.4% BrdU+ follicles vs 17.7±8.5%, 
the mean of 3 experiments, 48 hours after TSH administration, optimal time; the 
optimal TSH dose was 10mUjml for both rat thyrocyte cultures). 
CONCLUSIONS 
This preliminary study shows that BB rat thyroid follicles had a higher 
spontaneous growth rate in comparison to Wistar rat thyroid follicles when cultured 
in the absence of TSH. The response to an optimal dose of 10 mU jml TSH was 
also in the BB rat thyroid follicle cultures increased compared to the Wistar rat 
thyroid follicle cultures. The slope of the curves suggests that this enhanced activity 
in the BB rat is an intrinsic phenomenon of the BB thyrocytes and not induced by a 
circulating factor outside the BB thyrocytes Qn this case we had expected a strong 
BrdU incorporation in the beginning, declining during the culture period). Howerver, 
additional experiments are needed to clarify this issue. 
We must also keep in mind that only a limited number of experiments were 
performed until! now (3 of each) and more experiments are needed to carry out a 
valid statistical analysis. 
A high intrinsic proliferation rate of BB thyrocytes might indeed explain the rats' 
capability to rapidly grow a large goitre during iodine deficiency and to cope with 
mild iodine deficiency. It may also form the basis of the spontaneously developing 
autoimmune thyroiditis, since it has been shown for the OS chicken that genetically 
determined thyroid abnormalities exist prior to the development of the spontaneous 
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Iodine excess, thymic ectopy and low thyroid autoimmunity in Wister rats 
ABSTRACT 
Evidence is accumulating that the dietary iodine intake is an important 
modulator of autoimmune thyroid reactions. To study this role of iodine intake 
further, female Wistar rats were kept on either an enriched iodine diet (EID, iodine 
intake: 100pg iodine/day), a normal iodine diet (NID, iodine intake 7pg iodine/day) 
or a low iodine diet (LID, 2 days of 1% KCL04 followed by iodine deficient drinking 
water j pellets) for periods up to 18 weeks. 
The low iodine intake resulted - as could be expected - firstly in a gradual 
go~re development: thyroid weights: 27.3±4.2 mg (mean±SD, LID) vs 12.5±2.1 
mg (mean ±SD, NID) after 12 weeks of diet, and secondly in subclinical 
hypothyroidism after 18 weeks of diet: serum TSH: 6.4±2.1 ngjml (mean±SD, 
LID) vs 2.3±0.3 ngjml (mean±SD, NID) and serum T4 : 21.0±4.0 nMjl 
(mean±SD, LID) vs 44.0±10.0 nM/1 (mean±SD, NID). Thyroid autoimmune 
reactions were also enhanced in LID animals and a higher incidence of anti-colloid 
antibodies, viz 60% positivity (vs 36%, NID) after 18 weeks of diet, and a higher 
thyroidal infiltration with lymphoid cells as compared to NID rats were found. 
The enriched iodine intake resulted in a normal thyroid growth and in 
euthyroidism w~h borderline low serum T 3 levels. The excessive iodine diet 
however also resulted in a lowered thyroid autoimmune reactiv~ as compared to 
the NID and LID rats viz. in a lower incidence of anti-colloid antibody production 
(12.5%, EID vs 36%, NID and 60%, LID after 18 weeks) and lower numbers of 
intrathyroidal lymphoid cells, viz number of dendritic cellsjmm2: 34.1, EID vs 36.5, 
NIO and 51.9, LID, number of C04 + cellsjmm2: 1.6, EIO vs 1.8, NIO and 10.3, LID 
and number of cos+ cellsjmm2 : 1.8, EID vs 2.3, NID and 6.4, LID after 3 weeks of 
diet. Remarkable was also the development of a thyroid-associated ectopic thymic 
tissue in the rats on an enriched iodine diet (in 39% of the animals on EID vs 8% in 
NID rats and 0% in LID rats during the first 6 weeks, gradually declining to 16"k in 
EID rats vs 8% in NID rats and 8% in LID rats from 9 to 12 weeks of diet). This 
thyroid-associated ectopic thymic tissue showed a similar marker pattern as normal 
rat thymus concerning TdT expression (positive cells in the cortex), CD4/CD8 
positivity (double positive cells in the cortex, single positive cells in the medulla) and 
MHC class-11 expression (in between the thymocytes). 
It is hypothesized that this thyroid-associated ectopic thymic tissue is related to 




The last two decades it has become clear that a high dietary iodine intake may 
aggravate thyroid autoimmune reactivity in both humans as well as experimental 
animals suffering from thyroid (autoimmune) disease. 
In humans with a preexisting thyroid abnormality, such as an iodine deficient 
goitre, a single administration of a high dose of iodine resulted in an attack of 
thyroiditis positive for anti-thyroglobulin and anti-microsomal antibodies 1 •2•3. A 
chronic excess of dietary iodine led in certain populations (Japan, China) to the 
development of a variant of endemic goitre. Patients with this goitre were lor 60% 
positive for immunoglubulins that stimulate thyrocyte proliferation in vitro4 •5 , the 
socalled thyroid growth stimulating immunoglobulins (TGI). It must be noted 
however, that the character and meaning of these TGis are still under debate6.7_ 
Uptill now experimental animal studies on the effect of the dietary iodine on 
thyroid autoimmune reactivity have predominantly been performed in animals 
genetically prone for autoimmune thyroid disease or in animals with a (mostly 
iodine deficient) hyperplastic goitre. In the Cornell C Strain of chicken and in the BB 
rat it was shown that a high dietary intake of iodine led to an increase in the 
incidence and severity of the thyroiditis8•9 of these animals; a low iodine intake 
ameliorated the disease. A single high administration of iodine to iodine deficient 
hamsters with a hyperplastic goitre or to mice with a methimazole induced 
hyperplastic goitre resulted in an attack of transient thyroiditis 10• 11 • 12, 
positive for thyroid autoantibodies. 
Since it is not clear whether a high iodine intake also precipitates thyroid-
directed autoimmune responses in normal, non-autoimmune animals we kept 
groups of normal female Wister rats on an enriched, normal and low iodine diet lor 
periods of up to 18 weeks from the third week of life onwards. Thyroid weight and 
thyroid hormone values were measured during the experimental period. Thyroid 
autoimmune reactivity was evaluated by measuring anti-colloid antibodies in the 
serum and by enumerating the number of thyroid infiltrated lymphocytes and 
dendritic cells. 
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MATERIALS AND METHODS 
Animals and diets 
Female Wistar rats were purchased from TNO Rijswijk, The Netherlands and 
kept at the central experimental animal housing facilities of the Erasmus University 
Rotterdam under standard conditions. 
Directy after weaning (at the age of 3 weeks) groups of rats (n=S-18) were kept on 
three dietary iodine regimens: 
1. An enriched iodine diet (EID); the rats received normal pellets (Arn-11, Hope 
Farms bv, Woerden, The Netherlands, ± 0.35 mgjkg iodine) as well as an 
extra iodine supplementation of 6.5mg Kl/1 added to the drinking water ad 
libitum. 
2. A for our area normal iodine diet (NID); the rats received normal pellets (Am-11, 
Hope Farms bv) and Rotterdam tap water ad libitum. These groups of rats 
served as controls. 
3. A low iodine diet (LID); the rats received 1% KCL04 in the drinking water for a 
period of 2 days and thereafter distilled water and iodine deficient pellets 
(Modified Remmington diet, Hope Farms bv) ad libitum. 
Groups of above described Wistar rats were sacrificed by aortic exsanguination 
under ether anaesthesia at 3, 4, 6, 9, 12 or 18 weeks after starting the diet. Serum 
was prepared for T 3 , T 4 , TSH evaluation and anti-colloid antibody determination. 
T 3, T 4 , and TSH were measured by RIA (Dr. W. Wiersinga, Margreet Broenink, 
Amsterdam, The Netherlands). The rat TSH reference preparation NIADDK-rTSH-
RP-2 was kindly provided by Dr. Parlow from the UCLA Medical Centre, Torrance, 
USA, and was 176 times more potent than the NIADDK-rTSH-RP-1. Thyroid glands 
were removed, weighed and stored at -80 •c until immunohistological examination. 
Iodine measurement in rat urine 
Rat urine was collected during 24 hours by keeping the rats in metabolic 
cages. Urinary excreted iodine was measured using a modified method described 
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by Benotti et ai13 . In brief, the urine samples were destructed by adding an equal 
volume of 30% chloric acid and incubating the samples lor several hours at 200 
o C. The iodine reacted as a cathalysing agent in the redox reaction between 
cerium ammonium sulphate and arsenic acid. During the reaction the yellow Ce4 + 
was converted into the colourless Ce3 + which was measured using an ELISA 
reader at 405 nm. 
Immunohistological examination 
Immunohistological examination was performed according to Green et al. 14 
with minor modifications. Of each frozen thyroid, one lobe was semiserially cut into 
6 pm thin sections. The sections were airdried overnight and fixed in acetone at 
room temperature for 10 minutes. The sections were incubated with either a 
monoclonal antibody specific for MHC class II molecules, total T cells, CD4 + T 
cells, CDS+ T cells or B cells (see table 1) for 60 minutes, washed with phosphate 
buffered saline (PBS) containing 0.2% bovine serum albumin (BSA, Sigma Chemical 
Co, USA) for 10 minutes, and further incubated with a rabbit anti-mouse Jg-HRP 
labeled conjugate (Dakopatts, Denmark) lor 30 minutes, diluted 300 times in PBS 
containg 1% normal rat serum and 0.2"/o BSA. After washing the slides in PBS 
containing 0.2% BSA (10 minutes) and rinsing them with 0.1 M sodium acetate 
buffer, pH 6.0, the sections were developed with a metal-enhanced 3,3'-
diaminobenzidine (DAB) solution containing 0.05% DAB (Sigma), 1% nickel 
sulphate (Merck), 0.068% imidazole (Sigma), and 0.8% sodium chloride in 0.1 M 
acetate buffer pH 6.0 for 3-5 minutes. Hydrogen peroxide was added to a final 
concentration of 0.01 %. After DAB development, the sections were washed briefly 
in 0.1 M Tris-HCI buffer, pH 7.6, and immersed in a 0.5% solution of cobalt chloride 
in 0.1 M Tris-HCI buffer, pH 7.2 at room temperature for 4 minutes. The slides were 
either counterstained with 0.1% nuclear fast red in 5% aluminium sulphate for 2 
minutes or incubated with acid phosphatase at 37°C for 30 minutes and thereafter 
counterstained with hematoxylin. The slides were dehydrated and embedded in 
DePeX mounting medium (Gurr, BDH Umited Poole, England). 
For the immunohistological detection of terminal deoxynucleotidyl transferase 
(TdT) which is only found on immature lymphoid cells, such as cortical thymocytes, 
bone marrow precursor cells and malignant cells from acute lymphoblastic 
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leukemia patients 15, 16,17, a method described by Gregoire et al was 
used18. In brief, thyroid sections were fixed in methanol at 4° C for 30 minutes. 
Thereafter the slides were washed 5 times with PBS at 4 o C for 5 minutes and 
incubated in icecold PBS at room temperature for a period of 30 minutes. The 
slides were further incubated with a rabbit anti-TdT monoclonal antibody 
(Supertechs Inc. Bethesda, MD, USA) diluted 60 times in PBS containing 0.2% BSA 
at room temperature for 60 minutes. The slides were washed 3 times with PBS for 
10 minutes and incubated with swine anti-rabbit lg-HRP labeled (Supertechs Inc. 
Bethesda, MD, USA) diluted 100 times in PBS containing 0.2% BSA and 1% normal 
rat serum for 30 minutes. Thereafter slides were washed, developed and 
embedded as described above. 
For the quantification of infiltrated leucocytes 4 sections of each thyroid with 
intervals of at least 1 OOpm were reacted with the appropriate marker monoclonal 
antibody. Infiltrated CD4 + and cos+ T cells were counted in each entire thyroid 
section. Infiltrated dendritic cells (DC, identified as strong MHC class-11 positive cells 
with cytoplasmic processes, a reniform nucleus and weak or absent acid 
phosphatase activity) were counted in 10 microscopic fields of each thyroid section 
(total of 40 microscopic fields/thyroid) using light microscopy at a magnification of 
400x. The surface area of the thyroid sections and of the microscopic fields in 
which the infiltrated cells had been counted was measured using a camera 
attached to a Leitz Diaplan light microscope and a Videoplan image processing 
system (Kontron, Bild Analyse GmbH, Germany) (surface area of 10 microscopic 
fields: 1.59 mm2). The number of infiltrated dendritic cells, CD4+ T cells and cos+ 
T cells were expressed per mm2 surface area of a thyroid section. It is of 
importance to note that similar results were obtained when the number of dendritic 
cells and T cells were not expressed per mm2 surface area of the section but for 
instance expressed per observed thyroid follicle in the plane of section or per 
surface area of thyrocyte parenchyma. 
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Table 1. Monoclonal antibodies (MoAbs) used for the detection of leucocytes 
MoAb 
OX6 (Seralab, UK) 






OXS (Seralab, UK) 
HIS 14 (F.G.M. Kroese) 
anti·human TdT 
(Supertechs, USA) 

















6 pm thin frozen porcine thyroid sections were cut, airdried overnight and fixed 
in cold acetone (-20 °C) for 10 minutes. The sections were preincubated with 
normal rabbit serum (DAKO-immunoglobulins, Denmark) (diluted 50 times in PBS 
with 1% BSA) for 10 minutes. Subsequently, the rat sera were applied Qn duplicate, 
diluted 10 times in 0.9% NaCI) and the slides were incubated at room temperature 
for 60 minutes. Porcine tissue was used , since it gave optimal results as compared 
to rat or human tissue. After washing in PBS, the sections were incubated with 
rabbit anti-rat immunoglobulins, fiuorescein-isothiocyanate-(FITC)-Iabeled (DAKO 
immunoglobulins, Denmark) for 30 minutes (diluted 25 times in PBS with 1% BSA). 
After this second step and rewashing, the slides were embedded in aquamount 
(Gurr, BDH Limited Poole, England) and examined using a fluorescense 
microscope. Three control slides were included; one without incubation of rat 
serum, another incubated with a rat serum previously scored as negative and a 
third incubated with a rat serum previously scored as positive. The staining intensity 
of each serum was arbitrarily and blindly scored (under code, by two independent 
investigators) as negative, positive or strongly positive. 
The indirect immunofiuorencense technique to detect anti-colloid antibodies has 
the advantage that it also directly provides data on various other antigenic 
compartments: in the same simple, cheap and reliable test anti-colloid, anti-
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cytoplasmic and anti-nuclear antibodies are simultaneously detected. The test can 
be performed in titration, however it is our experience that scoring the sera as 
negative, positive or strongly positive correlates well with titration or in other words, 
strongly positive sera in the dilution described above are of high titre. 
Statistical analysis 
Differences in serum T 3 , T 4 , and TSH, and number of intrathyroidal dendritic 
cells and T cells were compared by Wilcoxon's rank sum test. The incidence of 
anti-colloid antibody production and the incidence of thyroid associated ectopic 
thymic tissue was tested by X2 analysis. 
RESULTS 
Thyroid endocrine performance 
The enriched iodine diet (EID) had no observable thyroidal endocrine effects 
(figure 1A, B, C, D) and for our area normal thyroid weights and serum thyroid 
hormone levels were recorded (with borderline low serum T 3 levels in EID rats, 
figure 1 C). The urinary iodine excretion rate in EID rats was however high: an 
excretion of 50 pg 1/day was measured after 1 week of diet which reached a 
plateau of 100 pg 1/day after 3 weeks (6 weeks of life), reflecting the estimated 
daily iodine intake. The urinary iodine excretion of rats on a NID was 7 pg of iodine 
per 24 hours. 
The low iodine diet (LID) resulted, as could be expected, in a statistically 
significantly increased thyroid weight after 6 weeks of diet and a lowered thyroidal 
T 4 output after 12 weeks of diet (p < 0.05, Wilcoxon's rank sum test, figure 1A and 
D). Serum T 3 levels stayed within the normal range (figure 1 C) and the animals 
showed a normal body weight development (data not shown). Serum TSH levels 
started to increase after 12 weeks of diet (p<0.05, figure 18). After 1 week of diet 
the urinary iodine excretion was already under the lower limit of detection of our 
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Figure 1. Thyroid weight and endocrine status. Female Wistar rats were kept on a normal 
iodine diet (NID), a low iodine diet (UD} or an enriched iodine diet (EID) for a period of 18 
weeks from 3 weeks of age onwards. Rats were sacrified and thyroids were removed and 
weighed to measure goitre development (A), serum was collected to measure serum TSH (B), 
serum T 3 (C), and serum T 4 (D) levels by RIA The mean and standard deviation are given of 
5-18 animals per group. 
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Signs of thyroid autoimmune reactivity 
Anti-colloid antibody production 
At the start of the experiment (3 weeks of age) the incidence of anti-colloid 
antibodies was 4% (n~24). The anti-colloid antibodies showed a floccular staining 
pattern in the indirect immunofluorescence test and therefore most likely represent 
thyroglobulin-specific autoantibodies. Anti-cytoplasmic or anti-nuclear antibodies 
were not found in any of the groups of rats tested. 
In rats receiving an EID, the incidence of anti-colloid antibodies did not increase 
in the period from 3 weeks to 8 weeks of life, and remained thereafter at a level not 
exceeding a 12.5% incidence (n~S-16, figure 2A). 
The rats on a NID however, showed from three weeks of life onwards an 
increase in the incidence of anti-colloid antibodies to reach 30% of positivity (n ~25) 
after 5 weeks of diet. The incidence remained at that level thereafter (figure 2A). 
The rats kept on a LID had up to 5 weeks of diet an incidence of anti-colloid 
antibodies similar to that of rats kept on a NID. However, the LID rats reached a 
higher level of 60% incidence of positivity at 18 weeks of diet; this latter value is 
statistically significantly higher than the incidence in rats kept on an EID at that time 
(figure 2A, p<0.05, x2 analysis). 
lntrathyroidal infiltrates of dendritic cells and T lymphocytes 
During the EID a very low intrathyroidal infiltration of dendritic cellsjmm2 and T 
cellsjmm2 was observed after 3 weeks of diet; number of DCjmm2: 34.1 ±5.3, 
mean±SD, EID vs 36.5±13.6, mean±SD, NID and 51.9±7.2, mean±SD, LID; 
number of CD4+ T cellsjmm2 : 1.6±0.7, mean±SD, EID vs 1.8±0.9, mean±SD, 
NID and 10.3±3.5 mean±SD, LID; number of cos+ T cellsjmm2: 1.8±0.9, 
mean±SD, EID vs 2.3±1.9, mean±SD, NID and 6.4±1.7, mean±SD, LID (figure 
28, C, D). 
In fact a drop in the number of CD4 + T cells (from around 5 to 2 cellsjmm2) 
was observed after 3 weeks of diet, numbers staying at that low level throughout 
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Figure 2. Thyroid autoimmune reactivity. The incidence of anti-colloid antibody production is 
given of various age groups of female Wistar rats (n=S-20 per age group) kept on a nonnal 
iodine diet (NID), a low iodine diet (UD) or an enriched iodine diet (EID) from 3 weeks of age 
onwards for a period of 18 weeks (A). • P<O.OS, compared to EID, X2 analysis. The mean 
number and SD (n=S-12) of intrathyroidal dendritic cells (B). CD4 + T cells (C) and cos+ T 
cells (D) are expressed per mm2 counted in 4 semiserial cut sections for each thyroid. 
Statistical significances using the Wilcoxon's rank sum test are indicated with* and •. 
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With regard to the intrathyroidal infiltrates of dendritic cells and T cells, the 
normal iodine diet (NID) and more pronounced the UD resulted in a higher 
infiltration with these cells (see above). The latter diet showed two peaks of cell 
infiltration as compared to the normal and enriched iodine diet (figure 2B, C, D) 
namely at 3-6 weeks after starting the diet and at 12-18 weeks after starting the 
diet. The occurrence of these two peaks coincided w~h the higher prevalences of 
anti-colloid antibodies found in these groups of animals (figure 2A). 
Incidence of thyroid associated ectopic thymic tissue 
Remarkable in the EID rats was the occurence of a special lymphoid tissue in a 
high proportion of the animals in the early weeks of the diet (see table 2). 
Table 2. Incidence of thyroid-associated ectopic thymic tissue 
weeks on diet EID NID LID 
0 weeks 0/10 (0%) 0/10 (0%) 0/10 (0%) 
3 weeks 8/14 (57%). 2/14 (14%) 0/8 (0%) 
6 weeks 7/14 (50%). 1/14 (7%) 0/13 (0%) 
9 weeks 3/14 (21%) 1/16 (6%) 
12 weeks 1/8 (12.5%) 1/5 (20%) 1/9 (11%) 
18 weeks 1/8 (12.5%) 0/5 (0%) 0/4 (0%) 
Thyroid lobes of groups of rats (n=S-16) kept on an enriched iodine diet (EID), a normal iodine diet 
(NID) or a low iodine diet (LID) were removed, frozen and sections of 6pm were incubated with anti-
MHC-11, anti-CD4 and CDS and anti-TdT monoclonal antibodies. The_ number of rats with ectopic 
thymic tissue of each group is presented. The incidence of ectopic thymic tissue is given between 
brackets. 
• p<O.OS versus NID and LID, x2 analysis. 
This observed lymphoid tissue was in contact with the thyroid and showed a 
marker pattern specific for thymus tissue. It occurred in 57% of the animals after 3 
weeks, in 50% of the animals after 6 weeks, gradually declining to 12.5% of the 
animals after 12 weeks of excessive iodine diet, remaining at this level thereafter. 
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The cells of this ectopic thymic tissue reacted with monoclonal antibodies 
specific for MHC class-11 molecules, some cells were double positive for CD4/CD8 
and the tissue clearly showed a cortex and medulla (figure 3 A-F). 
c 
Figure 3. Thyroid associated ectopic thymic tissue. Frozen thyroid (A, C and E) and thymus 
(B, 0 and F) sections of rats kept on an ElD of 6prn were incubated with several monodonal 
antibodies directed against CD4 antigens (A and 8, magn 200x}. CDS antigens (C and D, 
magn 200x) and MHC class·ll molecules (E and F, magn SOOx). Note the similarity of the 
thyroid associated ectopic thymic tissue with rat thymus. 
120 
Iodine excess, thymic ectopy and low thyroid autoimmunity in Wistar rats 
To verify whether the observed lymphoid tissue was indeed thymic tissue, 
immuno-histochemistry was performed using a monoclonal antibody directed 
against the enzyme TdT, known to be present in immature cortical thymocytes. The 
staining pattern observed in the lymphoid tissue attached to the thyroid using the 
anti-TdT monoclonal antibody was exactly the same as in rat thymus (figure 4 A-F). 
Therefore it can be concluded that the observed lymphoid tissue was indeed 
thyroid-associated ectopic thymic tissue. 
_\jl\, 
Figure 4. Thyroid associated ectopic thymic tissue. Frozen thyroid (A, C and E) and thymus 
(8, D and F) sections of rats kept on an El D of 6pm were routinely stained with heamatoxylin 
and eosin (A and 8, magn 200x) or incubated with a monoclonal antibody specific for the 
enzyme TdT (C and D. magn 200x, E and F, magn 800x). Note the similarity of the thyroid 
associated ectopic thymic tissue with rat thymus. 
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Also in rats kept on a normal iodine diet (NID) this thyroid-associated ectopic 
thymic tissue could be observed, although only sporadically, incidences not 
exceeding a 20% level (table 2). 
Only in a few rats on a LID this thyroid-associated ectopic thymic tissue could 
be observed (levels not exceeding 11% at 12 weeks of diet, table 2). 
The occurrence of the thyroid-associated ectopic thymic tissue in EID rats is 
accompanied (see before) by the virtual absence of anti-colloid antibodies and low 
numbers of thyroid infiltrated MHC class-11 positive dendritic cells and T cells (figure 
2). 
DISCUSSION 
This study shows that a high dietary iodine intake in young female Wistar rats 
resulted in 57% of the animals in the development of a thyroid-associated ectopic 
lymphoid tissue. This ectopic lymphoid tissue showed a clear medulla and cortex, 
showed double CD4/CDS positive cells in the cortex, single CD4 positive and CDS 
positive cells in the medulla, showed TdT activity (an enzyme known to be present 
in immature T cells) in the cortex and MHC class-11 expression in between the 
thymocytes. We therefore concluded on the basis of the histology that the thyroid-
associated lymphoid tissue must be thymic tissue. The thyroid-associated ectopic 
thymic tissue found in rats on an excessive iodine diet was histomorphologically 
entirely normal, and showed the same marker pattern as normal rat thymus with 
regard to the expression of MHC class-11 molecules, of double CD4/CDS positive 
cells, single CD4 positive and CDS positive cells and of the enzyme TdT. The 
presence of this tissue coincided with a very low infiltration into the thyroid of 
lymphoid cells and a minimal production of anti-colloid antibodies. 
A for our area normal and a low dietary iodine intake lacked such effects, and 
a higher production of anti-colloid antibodies together with a limited but clear 
intrathyroidal infiltration of single dendritic cells and lymphocytes was present. It 
must be noted in this respect that the Wistar rats did not show any clear 
histological signs of thyroiditis (noticable lymphocytic infiltration in heamatoxylin-
eosin staining and damage of thyroid follicles) although the rats did show some 
thyroid autoimmune reactions, such as anti-colloid antibody production On 30% of 
the rats). It has also been reported that normal Wistar rats possess thyroid-specific 
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T cells in their circulation26. 
In humans w~h autoimmune thyroid disease and in the autoimmune-prone BB 
rat, areas of lymphoid tissue in the thyroid have been found before27•28. 
However, these areas of socalled '1ocal thyroiditis" are histologically clearly different 
in respect to marker pattern and structure from the thyroid-associated ectopic 
thymic tissue found in this study. The areas of '1ocal thyroiditis" consist of an 
organized lymphoid tissue tbat is composed of B cell follicles surrounded by a zone 
of T cells in which high endothelial venules, dendritic cells and macrophages are 
present. The thyroid-associated ectopic thymic tissue on the other hand consists of 
immature (double CD4/CD8 positive) and mature (single CD4 or CDS positive) T 
cells arranged in a medulla and a cortex. 
A similar thyroid-associated ectopic thymic tissue has been described as early 
as 1970 in the OS chicken29•30 and it was then speculated by the authors that 
the tissue represented a breakdown of the thymus-thyroid barrier leading to the OS 
autoimmune thyroiditis. However, the incidence of the occurrence of the ectopic 
thymic tissue in the OS chicken was much lower (4 out of 64) than the incidence of 
thyroiditis (up to 90%) and its presence can thus not be considered as the cause 
for the development of the OS autoimmune thyroiditis. Furthermore many germinal 
centres were observed in the OS thyroid associated ectopic thymic tissue. Germinal 
centres do normally not occur in the normal thymus and the presence of these 
germinal centres may be taken as indicative for a gross abnormality of the thyroid-
associated ectopic thymic tissue in the OS chicken. The thymus of the OS chickens 
itself is also abnormal {thymic nurse cell deficiencl\ 
The mechanisms underlying the development of the thyroid-associated ectopic 
thymic tissue triggered by the high dietary iodine intake remain speculative. 
Recently, Many et a132 observed the development of thyroid-associated ectopic 
thymic tissue in NOD mice. These autors speculated that the development of the 
tissue was due to a form of dysembryogenesis, since the thyroid and the thymus 
are embryonically related, both being derived from the third endodermal pouch and 
ectodermal clett33. It is indeed possible that fragments of the thymic "anlage" 
stay behind, close to the ductus thyroglossus to later develop into mature thymic 
tissue during a high dietary iodine intake. Vladutiu et al34 also described ectopic 
thymic tissue in rat and mouse thyroid, showing the close embryological evolution 
of the two organs. 
This report is special in that we showed that the development of ectopic thymic 
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tissue is influenced by an environmental factor such as the dietary iodine intake. 
Iodine has been described as having direct stimulating effects on various lymphoid 
cells35•36•37; whether it has also effects on thymic tissue is unknown. 
The thymus plays a prominent role in the shaping of the T cell repertoire and 
the generation of tolerance induction. It has been described that intrathymic 
transplantation of pancreatic islets prevents autoimmune diabetes in BB 
rats38•39, and in NOD mice40. Since the Wistar rats with the thyroid-
associated ectopic thymic tissue had low thyroid (auto)immune reactivity, we like to 
hypothesize that the occurrence of the thyroid-associated ectopic thymic tissue 
represents tolerance induction towards thyroidal antigens and hence linked to the 
observed low thyroid autoimmune reactivity. 
Our observations of the suppressive effects of a high iodine diet on thyroid 
autoimmune reactions in normal Wistar rats are in contrast to the observations of 
others on the stimulating effects of a high iodine diet in animals/individuals with 
spontaneously developing forms of autoimmune thyroiditis (such as the Obese 
Strain of chicken and the BB rat). In these thyroid autoimmune animals an excess 
of iodine induced a higher incidence and more severe forms of thyroiditis8·9 . 
There are two hypothetical explanations for this discrepancy: 
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Firstly, there might be a direct effect of iodine on the dysregulated immune 
system of the autoimmune prone animals. In normal, non-autoimmune animals, 
autoreactive T and B cells are present in the periphery, but these cells are 
suppressed by several control mechanisms. In BB rats and OS chickens 
however, several abnormalities in immunoregulation exist, by which eventually 
the thyrocyte becomes the victim of an autoimmune-mediated assault by these 
autoreactive cells. It has for instance been described that the BB rat becomes 
lymphopenic mainly because of a lack of RT6 positive regulator (suppressor) T 
cells41 .42, which are normally generated in the thymus. In the Obese 
Strain of chicken hyperreactive T cells, hyperreactive macrophages and a high 
density of 11-2 receptor expression were found31 . Since iodine has direct 
stimulatory effects on lymphoid cells (see above), it is possible that a high 
dietary iodine intake results in a complete dysregulation of an already 
malfunctioning immune system in autoimmune prone animals, this in contrast to 
the situation in non-autoimmune prone animals where in fact a suppression of 
the autoimmune reactivity was observed (see this report). 
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Secondly, iodine may be toxic for the thyrocytes of the autoimmune prone 
animals. 
Not only abnormalities in the control mechanisms ol the immune system are 
important for the development of autoimmune thyroid disease in thyroid 
autoimmune animal strains. There are genetically determined abnormalities in the 
thyroid cells themselves that are essential before fully blown thyroiditis can develop 
in BB rats and OS chickens. An autonomous high thyrocyte function (iodine 
uptake) has been described in the OS strain of chicken4 3·44•45. Our 
histomorphological observations (high thyrocyte epithelium) and observations of U 
et al. 46 show that also the metabolic activity of BB thyrocytes is high before 
thyroid autoimmunity develops. It is therefore also possible that a high dietary 
iodine intake is toxic for BB and OS thyrocytes, leading to thyrocyte destruction, 
release ol autoantigens and an enhanced stimulation of thyroid autoimmunity. A 
similar toxic action of iodine has been observed by Many et al in thyroid 
hyperplastic mice 11 • 12, resulting in thyrocyte destruction, inflammation of the 
thyroid and aggrevation of autoimmune thyroiditis47• 
In the here described Wistar rats, the high iodine intake is apparently not toxic 
for the thyrocytes and might indeed be more optimal for the function of the cells, 
resulting in a low thyrocyte metabolism and a lower release of antigenic 
degradation products and autoantigens. Histomorphology indeed shows a low 
thyrocyte metabolism in Wistar rats on a high iodine diet, viz a fiat thyrocyte 
epithelium (data not shown). 
In conclusion, this study shows that in female Wistar rats a high iodine intake 
results in the development ol a thyroid-associated ectopic thymic tissue. This 
development is accompanied by a low thyroid autoimmune reactivity. Further 
investigations on this thyroid-associated ectopic thymic tissue might lead to a better 
understanding of the mechanisms of tolerance induction and the role of dietary 
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Iodine excess accelerates TALT in 88 rats 
ABSTRACT 
It has been described before that dietary iodine enhances the severity and 
incidence of thyroiditis in autoimmune BB rats and OS chickens. It has however not 
been studied in detail which lymphoid cells are involved in the iodine induced focal 
thyroiditis and what the consequences are for the anti-colloid antibody production. 
We therefore performed a study in which female BB rats were kept on either an 
enriched iodine diet {EID; iodine intake: 100pg iodine/day) or a normal iodine diet 
(NID; iodine intake 7pg iodine/day) for a period of 18 weeks starting at 3 weeks of 
age. The intrathyroidal lymphoid tissue was immunohistologically studied using 
monoclonal antibodies specific for MHC class-11 antigens, various subsets of T 
cells, B cells and various subsets of macrophages. Immunohistological data were 
compared to thyroid hormone status and anti-colloid antibody production. 
Our data confirm that a high dietary iodine intake results in an accelerated 
development of the focal lymphoid cell infiltrates in the thyroid of the BB rat After 
12-18 weeks of an EID 50% of the BB rats developed these infiltrates. Our data 
additionally shOw that a) · the process started with increases in the number of 
infiltrating MHC class-11 positive dendritic cells (from 51.8±2.3 cellsjmm2, 
mean ±SD, at the start of the experiment tot 79.8±9.0 cellsjmm2, mean ±SD, at 9 
weeks of diet) and a clustering of these cells w'rth T cells, B cells and some 
macrophages and b) that the focal infiltrates were highly organized and consisted 
of central B cell follicle-like structures (positive for the monoclonal antibodies HIS-14 
and OX-33) surrounded by rims and areas ofT cells (6115-5 positive) that were 
mainly CD4+ {6115-4). Dendritic cells (MHC class-11 positive, OX-41 and OX-42 
positive) and macrophages positive for ED1, ED?, ED8 and ED9 were mainly found 
in the T cell areas. Only minor signs of thyrocyte destruction were observed at the 
edges of the organized focal lymphoid cell accumulations (consisting of 
macrophages and CD4 + T cells) and the BB rats remained eurthyroid. 
Since the architecture of the focal lymphoid cell infiltrates is very similar to 
mucosa associated tissue and secondary lymphoid organs (spleen and lymph 
node) and since only minor signs of thyrocyte destruction were observed, we 
prefer the term "thyroid-associated lymphoid tissue". The presence of the thyroid-
associated lymphoid tissue in the BB rats was positively correlated to the incidence 
of anti-colloid antibodies in the serum of the BB rats. 
To explain the accelerated development of the thyroid-associated lymphoid 
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tissue in BB rats on an enriched iodine diet, it is speculated that the dietary iodine 
might have direct effects on cells of the immune system or on cells forming the 
microenvironment of lymphoid tissue (reticulum cells). An effect of highly iodinated 
thyroglubulin on the accelerated development of thyroid-associated lymphoid tissue 
is also possible. 
INTRODUCTION 
The last few decades it has become clear that the dietary iodine intake can be a 
modulator of the autoimmune reactivity towards thyroidal antigens: 
a. A high dietary iodine intake in individuals with a preexisting thyroid abnormality, 
such as an iodine deficient goiter, results in a proportion of the individuals in 
the development of an attack of thyroiditis; those affected show anti-
thyroglobulin and anti-microsomal antibodies in their serum 1 ' 2•3. 
b. In animals that spontaneously develop thyroid autoimmune disease, such as 
the Cornell C Strain of chicken, the Obese Strain of chicken and the BB rat, a 
high dietary iodine intake results in an increase in the incidence and severity of 
the thyroiditis4 •5 . The OS chicken rapidly becomes severely hypothyroid 
under circumstances of high dietary iodine intake; the BB rat however, only 
shows minor signs of thyrocyte destruction6 and the rats remain euthyroid 
during and after the dietary regimen5. 
It has not been studied in detail which subtypes of lymphocytes and which 
subtypes of mononuclear phagocytes contribute to the iodine induced thyroiditis 
and what the precise consequences of the diet are for the incidence of anti-colloid 
antibodies. We therefore performed a study in which BB rats were either kept on a 
high iodine diet or a for-our-area-normal iodine diet for a period of 18 weeks. The 
thyroid was studied immunohistologically at various time intervals after introducing 
the diet using monoclonal antibodies specific for MHC class-11 antigens, various T 
cell markers, B cell markers, and markers for monocyte/macrophage subsets. 
Immunohistological infiltration data were compared to the thyroid performance 
(thyroid weight, T 3, T 4 and TSH levels) and the incidence of anti-colloid antibodies 
in the serum of the various groups of animals. 
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MATERIALS AND METHODS 
Animals and diets 
BB rats were kindly provided by Dr. H.A.M. Verheul and Mr. E. Cremer from 
Organon BV. The Netherlands. The rats were further bred and housed in the 
central animal facilities of the Erasmus University of Rotterdam under standard 
conditions. Rats that became diabetic (recorded by urinary glucose levels using 
Gluketur-Test sticks, Boehringer, Germany) were daily treated with subcutaneous 
injections of 2 IU Protamine Zinc Insulin Qsofane protamine bovine insulin, 
lnsulinum N.P.H., Organon Oss bv, The Netherlands). 
Directly after weaning (at the age of 3 weeks) groups of rats (n=8) were kept on 
two dietary iodine regimens: 
1. A for-our-area-normal iodine diet (NID); the rats received normal pellets (Am-11, 
Hope Farms bv, Woerden, The Netherlands, ± 0.35 mgfkg iodine) and 
Rotterdam tap water ad libitum. The daily iodine intake in this group was about 
7 JJg of iodine, measured by the urinary iodine excretion (see for details of 
technique ref\ These groups of rats served as controls. 
2. An enriched iodine diet (£/D); the rats received normal pellets (Am-11, Hope 
Farms bv) ad libitum and an extra iodine supplementation of 6.5mg Kl/1 added 
to the drinking water. Consequently the daily iodine intake was about 1 DOJJg of 
iodine, measured by the urinary iodine excretion (see for details of technique 
reP). 
Groups of BB rats were sacrificed by aortic exsanguination under ether 
anaesthesia at 3, 6, 9, 12 or 18 weeks. Serum was prepared for T 3, T 4 , TSH 
evaluation and anti-colloid antibody determination. T 3, T 4 , and TSH were measured 
by RIA (Dr. W. Wiersinga, Margreet Broenink, Amsterdam, The Netherlands). The 
rat TSH reference preparation NIADDK-rTSH-RP-2 was kindly provided by Dr. 
Parlow from the UCLA Medical Center, Torrance, USA, and was 176 times more 
potent than the NIADDK-rTSH-RP-1. Thyroid glands were removed, weighed and 




Immunohistological examination was performed according to Green et al.8 
with minor modifications. Of each frozen thyroid, one lobe was semiserially cut into 
6 pm thin sections. The sections were airdried overnight and fixed in acetone at 
room temperature for 10 minutes. The sections were incubated with either a 
monoclonal antibody specific for MHC class II molecules, dendritic cells (DC), 
macrophages, CD5+ cells, CD4 + cells, cos+ cells orB cells (see table 1) for 60 
minutes, washed with phosphate buffered saline (PBS) containing 0.2% bovine 
serum albumin (BSA, Sigma Chemical Co, USA) for 10 minutes, and further 
incubated with a rabbit anti-mouse lg-HRP labeled conjugate (Dakopatts, Denmark) 
for 30 minutes, diluted 300 times in PBS containing 1% normal rat serum and 0.2% 
BSA. 
After washing the slides in PBS containing 0.2% BSA for 10 minutes and rinsing 
them with 0.1 M sodium acetate buffer, pH 6.0, the sections were developed with a 
metal-enhanced 3,3' -diaminobenzidine (DAB) solution containing 0.05% DAB 
(Sigma), 1% nickel sulphate (Merck), 0.068% imidazole (Sigma), and O.S% sodium 
chloride in 0.1 M acetate buffer pH 6.0 for 3-5 minutes. Hydrogen peroxide was 
added to a final concentration of 0.01 %. After DAB development, the sections were 
washed briefy in 0.1M Tris-HCI buffer, pH 7.6, and immersed in a 0.5% solution of 
cobalt chloride in 0.1 M Tris-HCI buffer, pH 7.2 at room temperature for 4 minutes. 
The slides were either counterstained with 0.1% nuclear fast red in 5% aluminum 
sulphate for 2 minutes or incubated with acid phosphatase at 37°C for 30 minutes 
and subsequently counterstained with hematoxylin. The slides were dehydrated and 
embedded in DePeX mounting medium (Gurr, BDH Limited Poole, England). 
Since the infiltrates in the thyroids of the BB rats consisted predominantly of 
dendritic cells, T cells and B cells, we have counted the number of these cells in 
the BB thyroid sections. The number of infiltrated dendritic cells (identified as strong 
MHC class-11, OX-6, positive cells with cytoplasmic protrusions, a reniform nucleus 
and weak or absent acid phosphatase activity), CD4+ T cells (B115-4 positive 
round cells), CDS+ T cells (OX-8 positive round cells) and B cells (OX-33 or His-14 
positive cells) were counted in 4 complete sections of each thyroid, with section 
intervals of at least 1 OOpm and using light microscopy at a magnification of 400x 
(this sampling procedure covered almost the entire thyroid). The surface area of 
the thyroid sections in which the infiltrated cells had been counted was measured 
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using a camera attached to a Leitz Diaplan light microscope and a Videoplan image 
processing system (Kontron, Bild Analyse GmbH, Germany). 
Table 1. Monoclonal antibodies (MoAbs) used for the detection of intrathyroidal leucocytes 
MoAb Specificity Source Reference 
OX-6 MHC class-11 Seralab. UK 9 
8115-5 CDS antigen Holland Biotech, 10 
The Netherlands 
8115-4 CD4 antigen HoHand Biotech 10 
OX-8 CDS antigen Seralab. UK 11 
HIS-14 leucocyte Common Antigen FGM Kroese 12,13 
(LCA) on 8 cells 
OX-33 LCA on B cells Serotec, UK 14 
ED1 mainly monocytes, CD Dijkstra 15 
(some macrophages, 
dendritic cells) 
ED2 tissue macrophages CD Dijkstra 15 




ED7 granulocytes CD Dijkstra 16 
monocytes, macrophages 
EDS granulocytes, CD Dijkstra 16 
monocytes, macrophages 
ED9 granulocytes, CD Dijkstra 16 
monocytes, spleen red 
pulpa macrophages 
OX-41 macrophages, granulocytes, Serotec, UK 17 
dendritic cells 




The number of infiltrated cells was expressed per mm2 surface area of a 
thyroid section. It is of importance to note that similar results were obtained when 
the number of DC, T cells and B cells were not expressed per mm2 surface area of 
the section but were expressed per observed thyroid follicle in the plane of section 
or per surface area of thyrocyte parenchyma. 
In some experimental animals a dense, packed lymphoid cell infiltration into the 
interfollicular area of the thyroid occurred (see figure 2-4; these infiltrates had in fact 
an architecture of peripheral lymphoid tissue). The dense packing of the lymphoid 
cells hampered a detailed counting of the cells. A semiquantification of the number 
of lymphoid cells in such areas of organized lymphoid tissue was made and scored 
as- (no cells), ± (1-10 cells),+ (10-25 cells),++ (25-50 cells),+++ (>50 cells) 
per focal infiltrate (see table 3). 
Anti-colloid antibody determination 
6 pm thin frozen porcine thyroid sections were cut, airdried overnight and fixed 
in cold acetone (-20 °C) for 10 minutes. Porcine thyroid tissue was used, since it 
gave optimal results as compared to rat or human tissue. The sections were 
preincubated with normal rabbit serum (DAKO-immunoglobulins, Denmark), diluted 
50 times in PBS with 1% BSA, for 10 minutes. Subsequently, the rat sera were 
applied 0n duplicate, diluted 10 times in 0.9% NaCI) and the slides were incubated 
at room temperature for 60 minutes. After washing in PBS, the sections were 
incubated with rabbit anti-rat immunoglobulins, fluorescein-isothiocyanate-(FITC)-
Iabeled (DAKO immunoglobulins, Denmark) for 30 minutes (diluted 25 times in PBS 
with 1% BSA). After this second step and rewashing, the slides were embedded in 
aquamount (Gurr, BDH limited Poole, England) and examined using a fluorescence 
microscope. Three control slides were included; one without incubation of rat 
serum, another incubated with a rat serum previously scored as negative and a 
third incubated with a rat serum previously scored as positive. The staining intensity 
of each serum was arbitrarily and blindly scored (under code, by two independent 
investigators) as negative or positive. 
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Statistical analysis 
Differences in thyroid weight, serum T 3 , T 4 , and TSH, and number of single 
infiltrated intrathyroidal dendritic cells, small clusters of these cells and T cells were 
compared by Wilcoxon's rank sum test. The incidence of anti-colloid antibody 
production was tested by x2 analysis. 
RESUlTS 
Thyroid weight 
The thyroid weights of BB rats kept on an enriched iodine diet (E/0) were not 
statistically significantly different from the thyroid weights of such rats kept on a tor-
our-area-normal iodine diet (NIO) and gradually increased from 4.8±0.5 mg 
(mean±SD) at the start of the experiment to 18.9±3.5 mg (mean±SD) after 18 
weeks (figure 1A); this weight increase could be expected from the normal 
development of the body weight of the rats 0n fact thyroid/body weight index 
remained constant, namely: 0.08). The thyroid weights of the BB rats were higher 
than the thyroid weights of age and sex matched groups of Wister rats, indicating 
that normal BB rats developed a small goiter in relation to Wister rats. This 
observation has earlier been reported18•19. 
Thyroid hormone and TSH levels 
In BB rats receiving a N/0 serum T 4 levels slightly increased the first 3 weeks 
of the experiment from around 40 nM/1 to around 50 nM/1 and remained around 
this level during the entire experimental period (figure 1D). Serum T 3 levels were 
high (1.8±0.2 nM/1, mean±SD) at the start of the experiment and gradually 
decreased to 0.9±0.2 nM/1 (mean±SD) at 18 weeks of diet (figure 1C). Such 
relatively high serum T 3 levels in prepubertal rats compared to adult rats have been 
described by others before20 and these high thyroid hormone levels were 
regarded as necessary for optimal brain development in these young rats. Serum 
TSH levels were low during the entire observation period ranging between 1.1 ±0.7 
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ngjml (mean± SD) and 1.9 ± 1.2 ngfml (mean± SD, figure 1 B), both values were 
however within the normal range. 
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Figure 1. Thyroid weight and serum TSH and thyroid hormone revels. BB rats were kept on a 
nonnal iodine diet {NID) or an enriched iodine diet (EID) for a period of 18 weeks from 3 
weeks of age onwards. Rats were sacrificed, thyroids were removed and weighed to measure 
goiter development (A) and serum was collected to measure serum TSH (B), T 3 (C) and T 4 
(D) by RIA The mean and standard error are given of 5-18 rats per group. 
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In BB rats kept on an EID the serum T 4 and T 3 levels were the same as in rats 
kept on a NID (see figure 1C and D). Serum TSH levels in the EID rats were in the 
normal range (between 1.4±0.4 (mean±SD) and 2.2±0.8 ngjml, mean±SD) 
during the entire experimental period (figure 1 B). 
The development and architecture of focal infiltrates of lymphoid cells in the 
thyroids of BB rats kept on an enriched iodine diet (EID) 
In 50% of the BB rats, areas of extensive, focal accumulation of lymphoid cells 
were found to develop 12 to 18 weeks after introducing the enriched iodine diet 
(viz. at 15-21 weeks of age, table 2). In BB rats that were shorter than 12 weeks on 
an enriched iodine diet ( < 15 weeks of age) such focal accumulations could not be 
detected. 
Table 2. Incidence of focal infiltrates of lymphoid cells in the thyroid of BB rats 
weeks on diet NID EID 
0 0/5 
3 0/5 0/5 
6 0/5 0/5 
9 0/5 0/5 
12 0/5 2/5 
18 0/5 3/5 
The typical architecture of these focal accumulations was as follows: All the 
lymphoid cells in the focal infiltrates showed varying degrees of MHC class-11 
positivity, indicating their activation (table 3 and figures 3B and 48). The majority of 
the lymphoid cells were B cells that were positive for the monoclonal antibodies 
His-14 and OX-33. These B cells were found grouped together. The groups of B 
cells (reminiscent of early B cell follicles) were surrounded by rims and areas ofT 
cells (figures 2A and B, 3C and D, 4C and D) of which many were CD4 + cells and 
only a few cos+. 
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Figure 2. An area of ''thyroid-associated lymphoid tissue~ in a thyroid of a BB rat 18 weeks on 
a diet of excessive iodine. Note the distinguishable areas of 8 cells (A, His-14 positive cells) 
and T cells (8, 8115-5 pos~ive cells). Magn. x160. 
Figure 3. Two areas of ''thyroid-associated lymphoid tissue ln a thyroid of a BB rats 12 weeks 
on a diet of excessive iodine. A: control (hematoxylin, eosin staining), 8: MHC class-ll positive 
cells (OX-6 pcsttive cells), C: B cells (OX-33 posttive cells), D: T cells (8115-5 pos~ive cells). 
Magn. xso. Note the sharp demarcations of the lymphoid tissue in the thyroid, the MHC class-
11 positivity of this tissue and the beginning of distinguishable areas of B cells and T cells. 
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Figure 4. An area of "thyroid-associated lymphoid tissueM in a thyroid of a BB rat 12 weeks on 
a diet of excessive iodine. A: control (hematoxylin, eosin staining), B: MHC class-11 positive 
cells (OX-6 positive cells), C: B cells (OX-33 posttive cells), D: T cells (8115-5 posttive cells), E: 
macrophages and dendritic cells (OX-42 positive cells) and F: macrophages (ED7 positive 
cells). Magn. x160. Note the MHC class-!! positivity of the lymphoid tissue, the beginning of 
distinguishable areas of 8 cells and T cells, the accumulation of macrophages and dendritic 
cells particularly in the lymphoid tissue, and the accumulation of ED7 positive macrophages at 




Table 3. Locations of dendritic cells. T cells, 8 cells and subsets of macrophages in the focal 
infiltrates of lymphoid cells in the thyroid of BB rats kept on an EID 
MoAb Specificity B cell T cell Surrounding areas 
area area of minor destruction 
OX-6 MHC class-11 +++ +++ ++ 
His-14 6 cells +++ 
OX-33 B cells +++ 
6115-5 CDS antigen + +++ + 
6115-4 C04 antigen ± +++ + 
OX-8 CDS antigen ± ± 
ED1 mono, m¢, DC ± ++ + 
ED2 tissue m¢ 
ED3 m¢ 
ED7 granule, mono, m¢ ± + + 
EDS granule, mono, m¢ ± + + 
ED9 granule, mono, m¢ ± + + 
OX-41 granulo, m¢, DC + + 
OX-42 granule, m¢, DC ± + + 
Mono: monocytes, mt,f): macrophages, DC: dendritic cells, granule: granulocytes. 
-no cells stained,± 1~10 cells stained,+ 10-25 cells stained,++ 25-50 cells stained,+++ >50 
cells stained per area of focal infiltrate. 
Dendritic cells and macrophages (ED1, ED?, EDB, ED9, OX-41 and OX-42 
positive) were also abundantly present in these areas of focal lymphoid cell 
infiltration_ These dendritic cells and macrophages were mainly found in the T cell 
areas (figure 4E and F), but a few could also be observed inside the B cell follicle 
structures (apart from OX-41 that was not found in the B cell areas, table 3). Only 
ha~ of the ED?, EDS, ED9 and OX-42 positive cells were positive for acid 
phosphatase. 
Lymphoid tissue with a similar architecture has earlier been reported by us in 
the BB rats of our colony that where on a normal diet21 . However, these BB rats 
that developed such intrathyroidal lymphoid tissue were much older (24 weeks of 
age and older). 
At the edges of the focal lymphoid cell infiltrates of the BB rats on EID minor 
signs of thyroid follicle destruction were observed. At these sites some T cells and 
macrophages positive for ED?, EDS, ED9 and OX-42 were present, sometimes 
completely filling a thyroid follicle (figure 4F). The majority (75%) of these 
macrophages were positive for acid phosphatase. 
The thyroid epithelium that was adjacent to the areas of focal lymphoid cell 
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infiltrates a more cuboidal appearance than the thyrocytes remote from these 
areas. The adjacent thyrocytes sometimes also showed a weak MHC class-11 
positivity. 
The goiter development of BB rats in comparison to Wistar rats (see before) 
had nothing to do with the development of the focal lymphoid cell accumulations, 
since BB rats that did not develop these accumulations also had a weight increase 
of their thyroids as compared to Wistar rats. 
The number of single dendritic cells, T cells and B cells in the thyroids of BB rats 
prior to the development of the focal infiltrates of lymphoid cells 
Since we earlier reported21 that the development of the lymphoid tissue in 
older BB rats on a normal iodine diet started with the accumulation of dendritic cells 
in the thyroid and a clustering of such cells with T lymphocytes, and since the focal 
lymphoid cell accumulations found in BB rats kept on an enriched iodine diet were 
predominantly composed of dendritic cells, T cells and B cells, we investigated the 
number and infiltration pattern of these lymphoid cells in the interfollicular area of 
the thyroids of EID-BB rats prior to the time of the development of the focal 
lymphoid cell infiltrates (viz at 3, 6 and 9 weeks after introducing the diet). 
In the interfollicular connective tissue area of the 3 weeks old BB rats - before 
starting the diet - the number of dendritic cells was already considerable (51.8 ± 2.3 
DCfmm2 , mean±SD, figure 5A). In BB rats kept on an EID the number of 
interfollicular dendritic cells started to increase after introducing the diet to reach 
levels of 71.2±3.7 DC/mm2 (mean±SD) at 3 weeks, 75.8±11.4 DC/mm2 
(mean±SD) at 6 weeks and 79.8±9.0 DC/mm2 (mean±SD) at 9 weeks of diet 
(statistically significantly different from NID values, p<0.05, Wilcoxon's rank sum 
test). Thereafter the number of interfollicular dendritic cells declined to normal 
values in those rats not developing the focal infiltrates of lymphoid cells (to 
49.5±10.6 DC/mm2, mean±SD, 18 weeks after introducing the diet). However, in 
the rats that did develop these infiltrates, numbers of dendritic cells increased to 
uncountable numbers {figure 5A). 
It is worthy to note that DC are capable of forming clusters with themselves 
and with lymphocytes (this process is adhesion molecule dependent22, and 
essential for the initial phases of antigen presentation23). 
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Figure 5. Number of lymphoid cells in the interfollicular area of the thyroid. 
BB rats were kept on a normal iodine diet (NID) or an enriched iodine diet (EID) for a period 
of 18 weeks from 3 weeks of age onwards (5 rats per age group). Rats were sacrificed, 
thyroids were removed and immunohistologically examined. The number of MHC class-11 + 
dendrttic cells (A), MHC class-11• cell clusters (B). CD4+ cells (C) and coe+ cells (D) were 
counted in 4 thyroid sections for each thyroid. Data are expressed as mean± SO per surface 
area (mm2). The j j interrupted lines represent the uncountable numbers of lymphoid cells in 
the ''thyroid-associated lymphoid tissue". 
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Also in the thyroid specimen of the here investigated 66 rats, cluster formation 
of the interfollicular dendritic cells was evident (figure 56). The number of 
interfollicular clusters of 3-6 lymphoid cells was higher in EID 66 rats than in NID 
66 rats (P<0.05, Wilcoxon's rank sum test). 
After 3 weeks of an EID 4.7±1.3 (mean±SD) clustersjmm2 (vs 0.4±0.2, 
mean±SD, clustersjmm2, NID) were found which increased to 6.1 ±1.4 
(mean±SD) clustersjmm2 (vs 3.1 ±0.8, mean±SD, clusters/mm2, NID) after 9 
weeks of diet (see figure 56). In those rats not developing the focal lymphoid cell 
infiltrates, cluster formation declined to reach levels of 3 clustersjmm2. In the rats 
that did develop the focal lymphoid cell infiltrates, the small lymphoid cell clusters 
were grouped into larger clusters as well as large areas of lymphoid cell 
accumulations with the architecture as described above. The larger lymphoid cell 
clusters were mainly composed of dendritic cells, CD4 + T cells, 6 cells and a few 
ED1, ED7, EDS and ED9 positive macrophages (see above). 
The number of interfollicular CD4 + T lymphocytes increased in the first 9 
weeks after introducing the diet from nil to around 2 cellsjmm2 in both EID and 
NID 66 rats. Numbers. remained constant in animals that did not develop focal 
lymphoid cell infiltrates; however in those animals that did develop these infiltrates, 
CD4 + T lymphocytes became uncountable (figure 5C). 
The number of CDS+ interfollicular T lymphocytes was and remained very low 
in both dietary groups, apart from the EID-66 rats that developed the focal 
lymphoid cell infiltrates (figure 50). 
6 cells were absent from 66 thyroids at the start of the experiment and 3, 6, 
and 9 weeks after introducing the diet Only after 12 weeks of an EID when larger 
focal lymphoid cell infiltrates were detected, 6 cells could be identified and occurred 
only in these larger focal infiltrates together with dendritic cells, CD4 positive T cells 
and ED1, ED7, EDB and ED9 positive macro phages. 
Correlation between the presence of anti-colloid antibodies in the serum and the 
presence of the intrathyroidal focal lymphoid cell infiltrates in the BB rats kept 
on an enriched iodine diet 
At the start of the experiment none of the rats were positive for anti-colloid 
antibodies (n=S). It is however well known that 66 rats spontaneously develop 
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these antibodies, and indeed at 12 weeks of age (9 weeks of NID) 36% of the rats 
had become positive for anti-colloid antibodies, which incidence gradually increased 
to 58% at 15 weeks of age (12 weeks of NID), and to 93% at 21 weeks of age (18 
weeks of NID, figure 6). We earlier reported that these anti-colloid antibodies are 
mainly produced outside the thyroid during the early phases of the autoimmune 
process 0n the thyroid draining lymphnode) and not inside the thyroid6. 
The incidence of anti-colloid antibodies of rats kept on an enriched iodine diet 
was not statistically significantly different from the rats kept on a NID during the first 
9 weeks of the experiment (figure 6). However, after 12 weeks of diet, the incidence 
of anti-colloid antibodies in rats kept on an EID developing intrathyroidal focal 
lymphoid cell infiltrates was 100%, whereas in those rats not developing these 
infi~rates, incidences of anti-colloid antibodies gradually declined to O% after 18 
weeks of diet (figure 6). 
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Figure 6. incidence of anti-colloid antibody. The incidence of anti-colloid antibody production 
is given of various age groups of female BB rats (n=S-14) kept on a normal iodine diet (NlD) 
or an enriched iodine diet (EJD) from 3 weeks of age onwards for a period of i 8 weeks. From 
9 weeks of an EJD and onwards the incidences of anti-colloid antibodies are given of the rats 
devetoping focal accumulations of lymphoid cells in the thyroid (represented by the I I 
interrupted line), of rats not developing focal lymphoid cell accumulations (represented by the 
solid line) and of all the rats kept on an EID together (represented by the dashed line). 
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Table 4 shows the positive correlation between the development of 
intrathyroidal focal lymphoid cell infiltrates and the incidence of anti-colloid 
antibodies. It must be noted that the correlation could only be made for those 
animals from which the thyroid was immunohistochemically studied (5 of each 
group). 
Table 4. Correlation between the presence of anti-co!!oid antibodies in the serum and the presence 















At an earlier occasion we have reported that BB rats of our colony develop a 
highly organized lymphoid tissue in their thyroids starting at the age of 22-24 
weeks, when kept on a for-our-area-normal iodine diet6•21 . The process started 
with an increase in the number of interfollicular dendritic cells and a clustering of 
these cells, followed by a local trapping and accumulation in the clusters of T cells 
and B cells. At 24 weeks of BB rat age and older these aggregates of lymphoid 
cells start to show an organization and are composed of T cell areas wr.h dendritic 
cells and high endothelial venules (HEVs), of B cell follicles adjacent to or in the 
center of the T cell areas and of plasma cells at the outer rims of the areas24. 
The structure of these lymphoid cell accumulations is hence very similar to the 
structure of mucosa associated lymphoid tissue (MALT) and of secondary lymphoid 
organs Oymphnodes, spleen). 
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The present study shows that a high dietary iodine intake of the BB rats (viz. 10 
times the normal iodine intake) accelerates the development of this highly 
organized lymphoid tissue in the thyroids of the rats. The process again starts with 
an increase in the number and clustering of dendritic cells in the interfollicular area, 
and in 50% of the BB rats on an EID these clusters start to grow into the larger 
areas of lymphoid tissue at the age of 15 to 21 weeks. 
Our observations support studies of the groups of Braverman and Sundick1 •2, 
who earlier showed that a high iodine intake in BB rats and OS chickens resulted in 
an increase of the incidence and severity of - what these authors called - focal 
'thyroiditis". In addition, the present report extends the findings of these authors by 
detailing the immunohistological composition of the areas of focal "thyroiditis". 
Although many cells of the infiltrates exhibited macrophage characteristics, only 
minor signs of thyrocyte destruction were found. These small areas of destruction 
affected only few follicles which were located at the edges of the organized 
accumulations of lymphoid cells. We therefore consider the term "thyroiditis" as 
inappropriate, and prefer the term "thyroid-associated lymphoid tissue". Since the 
"thyroiditis" component was small, it is also not surprising that the BB rats on the 
enriched iodine diet remained euthyroid. 
The majority of the cells in the areas of 'thyroid-associated lymphoid tissue" 
were in fact B cells organized in structures reminiscent of early lymphOid follicles 
surrounded by rims and areas of T cells. The function of a B cell follicle is 
immunological memory formation and isotype switching. T cell areas in lymphoid 
tissue are normally involved in the generation of T helper 1, T helper 2 and T 
cytotoxic cells. We favor the idea that the organized lymphoid structures in the 
thyroid are responsible for the generation of thyroid autoreactive T cells and the 
production of thyroid autoantibodies. An indication for this function of the thyroid-
associated lymphoid tissue is given by the fact that every rat which showed this 
intrathyroidal lymphoid tissue had anti-colloid antibodies in its serum. 
The EID rats that did not develop thyroid-associated lymphoid tissue, showed a 
decline in the infiltration of dendritic cells and a decline in the cluster formation of 
these cells. Remarkably, these rats were almost all negative for anti-colloid 
antibodies. A similar suppressive effect of excess dietary iodine on the production 
of anti-colloid antibodies and the thyroidal infiltration with lymphoid cells has been 
found by us before in non-autoimmune Wistar rats25 . It must also be noted in 
this respect that in earlier phases of the thyroid autoimmune process (at 6-18 
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weeks of age) anti-colloid antibody production mainly occurs in the thyroid draining 
lymphnode of the BB rat6 and it seems therefore likely that the thyroid-associated 
lymphoid tissue developing in 50% of the BB rats kept on an enriched iodine diet is 
engaged in a further continuation of the thyroid autoimmune response, when the 
lymphnodal response subsides. 
The mechanism by which the dietary iodine is capable of influencing the thyroid 
autoimmune reactivity and accelerating the development of the thyroid-associated 
lymphoid tissue in a proportion of the BB rats remains speculative. 
A first possibility by which the dietary iodine might accelerate the development 
of the thyroid-associated lymphoid tissue is via a direct effect of iodine on dendritic 
cellsjmacrophages or T cells and B cells26•27•28. Iodine has been described 
as stimulating the myeloperoxidase activity of macrophages. It also increases the 
number of a circulating subset of T cells 0nvolving both CD4 and CDS positive T 
cells) and of MHC class-11 positive T cells, and it induces a higher production of 
immunoglobulins from B cells/plasma cells. Recently we were able to demonstrate 
that highly iodinated proteins are capable of accelerating the maturation of dendritic 
cells from precursors in the blood29•30. Whether iodine has an effect on the 
stromal cells forming the microenvironment of lymphoid tissues (reticulum cells) 
needs further investigation. 
A second possibility is that the enhanced antigenicity of highly iodinated 
thyroglobulin plays a role in accelerating the development of the thyroid-associated 
lymphoid tissue31 . It has been shown that a high dietary iodine intake results in a 
high iodination grade of thyroglobulin and this highly iodinated thyroglobulin was 
proven to be (in vitro) more antigenic than thyroglobulin with a low iodination 
grade32•33. Together with a disturbed immune regulation in the BB rats caused 
by a lack of RT6+ regulator (suppressor) T cells34•35, and a disturbed 
immune-endocrine feedback loop36 the highly iodinated Tg might accelerate the 
development of thyroid-associated lymphoid tissue in the BB rat. 
A third possibility for the accelerated intrathyroidal development of lymphoid 
tissue is that the high iodine diet induces the thyrocytes to produce more antigenic 
material. Li et al reported that iodine treated BB/W rats have a higher radioactive 
iodine release in comparison to non iodine treated BB/W rats or Wistar rats, 
indicating a leakage of autoantigen37. 
Toxic effects of iodine on metabolically active thyrocytes resulting in lymphoid 
cell infiltration have also been described38•39. However, the histological signs 
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of thyrocyte destruction were minor in our study and were only observed at the 
edges of the areas of the thyroid-associated lymphoid tissue. Toxicity of iodine with 
subsequent thyrocyte destruction and the release of antigenic material, thereby 
activating the thyroid autoimmune reactivity do not seem to play a prominent role in 
the here described study. 
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Thyroid hormones, monocytes and dendritic cells 
ABSTRACT 
We earlier reported that a pretreatment of blood monocytes with metrizamide 
(30 min, 37°C, non-adhering conditions) resulted in an enhanced maturation of 
monocytes into veiled/dendritic cells (DC) after an overnight culture (37°C, non-
adhering conditions'). Since metrizamide is an iodinated compound structurally 
related to the thyroid hormones T 3 and T 4 , we investigated the effect of these 
hormones on the maturation of monocytes into veiled/dendritic cells, as well as that 
of metrizamide, rT3 and iodinated thyroglobulin (Tg). Since cytokines are essential 
for the differentiation and survival of blood dendritic cells in vitro2 we also studied 
the effect of administration of a-GM-CSF, a-TNFa, a-IL-6, a-M-CSF, and a-IL-1P on 
the dendritic cell transition. The production of GM-CSF, IL-6 and IL-1P by the 
stimulated monocytes was measured in a limited series of experiments. 
A stimulation of the blood monocytes with T 3 and T 4 enhanced their capability 
to mature into cytological and functional characteristic veiled/dendritic cells (cells 
with actively moving veiled and dendritic cytoplasmic protrusions, strongly positive 
for MHC class-11 antigens with weak or absent acid phosphatase acivity, and good 
stimulators in the MLR). Veiled/dendritic cell transition induced by T3 and T4 was 
dependent on GM-CSF, TNFa and IL-6 produced in the culture since a-GM-CSF, a-
TNFa and a-IL-6 had blocking effects, a-M-CSF and a-IL-1P had no effects. 
Contaminating T cells and B cells were not necessary for the transition and it is 
therefore likely that GM-CSF, TNFa and IL-6 were produced by the monocytes 
themselves. There was indeed a considerable production of cytokines in the culture 
system. Since the production of these cytokines was not increased in the thyroid 
hormone stimulated monocyte cultures, it is likely that the thyroid hormones 
influence monocyte to veiled/dendritic cell transition on the cytokine receptor level 
or on a post cytokine receptor level. 
A stimulation of the blood monocytes with an optimal concentration of 
metrizamide (14.5%), rT3 (2.10-10M) and highly iodinated Tg (2.10'11 M) also 
resulted in an increased transition of monocytes to cytological and functional 
characteristic veiled/dendritic cells, but to a lesser extent in comparison to the 
thyroid hormones (T3: 31 ±6%, T4 : 25±5% vs rT3 : 22±8% and 0.37% I Tg: 
20 ±4% veiled/dendritic cells). Remarkably, a-GM-CSF, a-TN Fa and a-11-6 
administration to the culture system had also blocking effects on the transition from 
monocytes to veiled/dendritic cells induced by the iodinated compounds, but again 
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an enhanced production of these cytokines under the influence of the iodinated 
compounds was not found. The mechanisms by which such compounds act on the 
monocyte to veiled/dendritic cell transition can only be speculated on. 
Our data nevertheless show that: 
a. exposure to thyroid hormones stimulates monocytes to mature into antigen-
presenting veiled/dendritic cells; this observation is in line with earlier observati-
ons that thyroid hormones are necessary for optimal immune function, and 
b. that iodinated compounds like metrizamide, rT 3 and iodinated Tg are also 
capable to enhance the transition of monocytes into veiled/dendritic cells; 
these latter observations are in line with earlier observations of a direct effect of 
iodine on cells of the immune system, such as T cells, B cells and 
macrophages. 
INTRODUCTION 
Dendritic cells (also called veiled cells when free in body fluids3) are excellent 
antigen presenting cells4 •5. The cells play a crucial role in the initiation of normal 
as well as of autoimmune responses6•7 Knight et al8 showed that autoimmune 
thyroiditis could be induced in Balbjc mice by the transfer of as few as 105 
dendritic cells pulsed with thyroglobulin (Tg). Furthermore, the development of 
autoimmune lesions, such as arthritis9• 1 0• 11 , thyroiditis 12• 13 or 
insulitis 14 starts with an increase in the number of dendritic cells and a local 
clustering of these cells with other lymphoid cells before autoantibodies can be 
detected in the circulation. 
The precursor of the dendritic cells has not yet been fully characterized. We 1 
and others 15• 16 have reported that cells with a veiled or dendritic morphology, 
MHC class-11 positivity and weak to absent acid phosphatase positivity, can be 
maturated from cells belonging to the blood monocyte pool: it was possible to 
induce 30-40% of veiled/dendritic cells from elutriator purified blood monocyte 
fractions {over 98% nonspecific esterase positive cells) after an exposure of these 
cells to 14.5% metrizamide for 30 minutes followed by an overnight culture under 
nonadhering conditions 1. These monocyte-derived veiled/dendritic cells had an 
increased capability to act as stimulator cells in a MLR when compared to the 
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control, non-pulsed monocyte populations 1• 17. The veiled/dendritic cells were 
also less phagocytic and expressed less CD14. Since metrizamide is an iodinated 
compound structurally related to the thyroid hormones T 3 and T 4 we speculated 
that thyroid hormones - a:-~d maybe iodinated compounds in general - play a role in 
enhancing the transition of monocytic cells to veiled/dendritic cells. 
The here reported study describes the effect ol the thyroid hormones T 3 and 
T 4 and ol a few iodinated compounds besides metrizamide, such as reverse T 3 
(rT 3 , the hormonally inactive form of T 3) and highly- low- and non-iodinated 
thyroglobulin (fg), on the maturation of human peripheral blood monocyte fractions 
into functionally active veiled/dendritic cells. Since cytokines, and in particular 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumour necrosis 
factor a (fNFa), have been described as essential for the differentiation and survival 
of blood dendritic cells in vitro2• 18• 19, we also measured in a series of 
experiments the effect of the administration of a-GM-CSF, a-TNFa, a-interleukin-6 
(a-IL-6), a-macrophage colony-stimulating factor (a-M-CSF) and a-IL-1/1, on the 
monocyte to veiled/dendritic cell transition. The production ol GM-CSF, IL-6 and IL-
1P by the stimulated monocytes was measured in a limited series of experiments. 
MATERIALS AND METHODS 
The isolation of human peripheral blood monocytes 
Peripheral blood monocytes from healthy volunteers were isolated by Ficoll-
lsopaque (density 1.077 gjml, Pharmacia, Uppsala, Sweden) density gradient 
centrifugation, followed by Percoll20 (density 1.063 gjml, Pharmacia) gradient 
centrifugation. In brief, heparinized blood was diluted with an equal volume 
phosphate buffered saline (PBS), pH 7.4, placed on Ficoll lsopaque and centrifuged 
for 15 minutes at 1000 g. The cells were collected from the interface and washed 
twice with PBS (5 minutes, 500 g). The cells were resuspended in RPMI 1640 (with 
25 mM HEPES and L-glutamin, GIBCO, USA) containing antibiotics (100 Ujml 
penicillin G and 0.1 mgjml streptomycin, Seromed, Biochrom, Berlin, Germany) and 
counted in a Burker-Turk hemocytometer using light microscopy (magn 250x). 10-
20.1 o6 cells were placed on 2 ml Percell and centrifuged for 40 minutes at 400 g. 
The collected cells from the interface were washed twice (5 minutes, 500 g) in 
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RPMI 1640 supplemented with antibiotics. The percentage of monocytes was 
determined by positive staining with non specific esterase (NSE) according to 
Mullink et ai21 . The cell suspension contained 60-80% NSE positive monocytes, 
the contaminating cells mainly consisted of CD3 + T cells. 
In some experiments a) elutriator-purified monocytes were used (purity >98% 
of NSE positive monocytes, for technical details see ref1) or b) Percell purified 
monocyte preparations freed from contaminating T and 8 cells using a MAGS 
(Magnetic Cell Separation system, Miltenyi Biotec GmbH, Germany) with mouse 
anti-human CD3 (Becton and Dickinson, USA) and CD19 (Cou~er, England) 
monoclonal antibodies coated onto biotin labeled magnetic beads (Becton and 
Dickinson) via streptavidin (Zymed Laboratories Inc, USA) and a goat anti-mouse 
biotin labeled conjugate (Dakopatts, Denmark) yielding monocyte suspensions with 
a purity >95% NSE positive monocytes, this to verify whether contaminating T cells 
or B cells were necessary to provide stimuli for the monocyte-to-veiled/dendritic cell 
transition. 
Incubation of human peripheral blood monocyte suspensions with hormones or 
iodinated compounds to obtain veiled or dendritic cells 
From the purified monocyte suspensions a cell suspension containing 1.106 
cellsjml was made in serum free culture fluid (ISCOVE's Modified Dulbecco's 
Medium, Gibco) supplemented with SF-1 (Costar, USA) and antibiotics. 
A total of 3-4.1 o5 NSE + monocytes were incubated with culture fluid alone or were 
stimulated under nonadhering conditions (polypropylene tubes Falcon, Becton & 
Dickinson, USA) (37°C, 5% C02, 100% humidity) for 30 minutes with the following 
stimuli: 
a. with metrizamide (14.5% wjv, Serva, Heidelberg, Germany) according to Kabel 
1 et al. , 
b. with T 4 , T 3, rT 3 (Sigma) and 
c. with highly-iodinated Tg (0.37% 1), low-iodinated Tg (0.2% I) and non-iodinated 
Tg (0% 1), kindly provided by JJM de Vijlder (Academical Medical Centre, 
Amsterdam, The Netherlands). 
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The concentrations of the thyroid hormones and the iodinated compounds 
ranged from 2.10"18M to 2.1o·9M. 
After exposure to the hormones or iodinated compounds, the cells were 
washed 3 times in RPMI 1640 (5 minutes, 500 g) and further cu~ered in 
supplemented ISCOVE's for a period of 16 hours (overnight) under nonadhering 
conditions (polypropylene tubes, 37°C, 5% C02, 100% humidity). 
To determine the influence of endogenous produced cytokines on the 
monocyte to veiled/dendritic cell transition, several concentrations of the 
monoclonal antibody o·GM-CSF (Genzyme Corporation, Boston, USA), o·TNFa 
(Genzyme), o·IL--6 (kindly provided by Dr. W.A. Buurman, University of Limburg, 
Maastricht, The Netherlands), o·M·CSF (Genzyme) and o·IL·111 (Giaxo, Geneva, 
Switzerland) were added 2 hours after starting the overnight culture period, the 
antibody remained present in the culture fluid during the further culture period (in a 
series of prelimenary experiments this time schedule proved to be the most optimal 
to reach the effects described in the results section). 
Determination of the percentage of monocyte derived veiled or dendritic cells 
After the 16 hour overnight culture period, cells were centrifuged (5 minutes, 
500 g), the supernatant was removed and stored at ·20°C until! the measurement 
of produced GM·CSF. The cells were resuspended and the morphology of the 
living cells was studied using light microscopy at a magnification of x400. Large 
cells, with actively moving, veiled cytoplasmic processes andjor dendritic 
extensions were considered as veiled/dendritic cells (figure 1). 
figure 1. Typical morphology of T3-induced living veiled/dendritic cells in suspension using 
phase contrast microscopy. Note the irregular cytoplasmic protrusions. Magn XSOO. 
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The number of living veiled/dendritic cells counted directly in suspension were 
verified using cytocentrifuge preparations: 50 pi of the cellsuspensions at a 
concentration of 0.5. 106 jml were cytocentrifuged (3 minutes, 800 rpm ) using a 
Cytospin apparatus (Nordic Immunological Laboratories, The Netherlands). 
Cytocentrifuge preparations were airdried for at least 1 hour and fixed in 100% 
acetone for 10 minutes. Thereafter, indirect immunoperoxidase staining was 
performed using the monoclonal antibody HI.A-DR in a dilution of 1:50 (specific for 
MHC class-11 antigens, Becton and Dickinson, USA). After washing the slides a 
rabbit-anti-mouse lgG peroxidase labeled conjugate (1 :50, Dako lmunoglobulins, 
Denmark) in 1% normal human pool serum was applied to the slides. The 
cytocentrifuge preparations were developed with a 3,3' -diaminobenzidine {DAB) 
solution containing 0.05% DAB (Sigma) for 3-5 minutes. Hydrogen peroxide was 
added to a final concentration of 0.01 %. After DAB development, the cytospin 
preparations were incubated with acid phosphatase (with naphtol AS-BI phophate 
as substrate and hexazotized pararosanilin as diazoniumsalt) at 37°C for 30 
minutes, counterstained with hematoxylin, dehydrated and embedded in DePeX 
mounting medium (Gurr, BDH Umited Poole, England). Cells with long 
cytoplasmic protrusions, a reniform nucleus, strong MHC class-11 positivity but 
absent or weak acid phosphatase reactivity were considered to be the 
veiled/dendritic cells (this criterium is used by us before in fixed histological 
preparations22,23,24,25,26). 
Purification of the veiled/dendritic cell suspensions 
In a few experiments veiled/dendritic cells were enriched in the suspensions 
using the following technique (based on the characteristic of veiled/dendritic cells 
not to spontaneously adhere to surfaces, but to actively move around in the culture 
fiuid3): after the overnight culture period under nonadhering conditions, the cell 
suspension containing monocytes and induced veiled/dendritic cells was washed 
(5 minutes, 500 g in polypropylene tubes) and cells were resuspended in RPMI 
1640 supplemented with 10% fetal calf serum (FCS, lntegro BV, Zaandam, The 
Netherlands). The cell suspension was placed in a Boyden chamber system 
seperated by a polycarbonate microfilter (5pm, Nuclepore, polyvinylpyrrolidone free, 
Costar Corp, USA) in which the top chamber (polypropylene) contained the 
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washed monocyte/dendritic cell suspension in RPMI 1640, 10% FCS and the 
bottom chamber RPM I 1640, 10% FCS and 10 nM of the chemoattractant IMLP (n-
formyl-methionyl-leucyl-phenylalanine, Sigma). 
Cells in the top chamber were allowed to adhere to the polycarbonate filter and 
to migrate through the filter towards the fMLP gradient in the bottom chamber 
during a 2.5 hour incubation period (37°C, 5% C02 , 100% humidity). Subsequently 
the cells were collected from the top chamber and the bottom chamber. The 
percentage of cells with a veiled/dendritic morphology were counted in both cell 
suspensions as described above under light microscopy (magn 400x). 
Mixed leucocyte reaction (MLR) 
To verify whether the monocyte derived cells with a veiled or dendritic 
morphology were functionally active veiled/dendritic cells capable of stimulating T 
cells to proliferate, an allogeneic mixed leucocyte reaction (MLR) was performed 
(details in ref1) with the veiled/dendritic cells as stimulator cells. 
To obtain the responder population, a T lymphocyte isolation was performed 
according to standard procedures with subsequent Ficoll-isopaque, Percell density 
gradient centrifugation (the pellet containing T and B lymphocytes and NK cells) 
and nylon wool adherence27 (Leuko-Pak, fenwall Laboratories, II, USA). The 
nonadhering cells were >90% positive for the marker CD3. 
The mixed lymphocyte cultures were performed in triplicate in 96 wells flatbottomed 




non cultered, freshly isolated Percell monocytes, 
Percoll-purified monocytes cultured overnight at 37°C under nonadhering 
conditions, 
Percoll-purified monocytes cultured overnight at 37°C under nonadhering 
conditions after a pulse with T3, T4 , rT3 or the iodinated Tgs (containing raised 
numbers of veiled/dendritic cells), in some instances these populations were 
enriched lor veiled/dendritic cells by the Boyden chamber method (see above) 
and 
d. blood veiled/dendritic cell populations obtained according to the well 
established separation method described by Knight et a128 (control). 
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Three.1 04 of stimulator cells were cultured with 1.5.1 o5 allogeneic T 
lymphocytes in a total volume of 200 pi RPM I 1640 supplemented with 10% human 
A+ serum and antibiotics for 5 days at 37°C, 5% C02 . Three.104 x-irradiated 
monocytesjdendritic cells alone or 1.5.105 T lymphocytes in the presence of 10-50 
pgjml phytoheamagglutinin (PHA, Wellcome Diagnostics, UK) served as controls. 
Stimulator and responder populations were of various healthy donors. 
During the last 16 hours 0.5 pCi 3 H-thymidine was added to each well, the cells 
were harvested on filter paper and 3H-thymidine incorporation was measured in a 
liquid scintillation analyzer (Packard tricarb 2500 TR). 
Cytokine production 
The cytokine production was measured in a limited series of experiments in 
stored supernatants of various monocyte cultures after the over night culture 
period. Frozen samples were thawed and GM-CSF, IL-6 and IL-1P were measured 
using an enzyme amplified sensitivity immuno assay system (EASIA, MEDGENIX, 
Diagnostics, Belgium) following the instructions of the manufacturer. 
Statistical analysis 
Differences in monocyte to veiled/dendritic cell transition were analyzed using 
the Wilcoxon's rank sum test. Differences in the stimulating capability of monocyte 
or veiled/dendritic cell populations in the MLR and the cytokine production by 
these cell populations were tested using a paired binomial test. 
RESUlTS 
The enhancing effect of thyroid hormones and other iodinated compounds on 
the transition of monocytes to veiled/dendritic cells 
Incubation of Percoll-purified monocytes in the defined serum free culture fluid 
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alone resulted after an overnight culture period (non-adhering conditions, 37°C, 5% 
C02) in 13.2±2.7% (mean±SD) cells with a veiled or dendritic morphology (figure 
2, represented by the hatched area). The incubated cells showed a viability of 
>90% (trypan blue exclusion). 
An exposure of the monocytes to the thyroid hormones T 3 and T 4 prior to the 
overnight culture enhanced the capability of the blood monocytes to mature into 
veiled/dendritic cells in a dose-dependent manner (figure 2). A stimulation of the 
blood monocytes with optimal T3 or T4 concentrations (2.10"10 M) resulted in 
30.5±5.7% (mean±SD) veiled/dendritic cells or 24.5±4.8% (mean±SD) 
veiled/dendritic cells respectively. Thyronine (T 0 , the non-iodinated backbone 
molecule of thyroid hormones) was unable to enhance the transition of monocytes 
into veiled/dendritic cells (figure 2): at best (at a T 0 concentration of 2.10·10 M) 
13.5 ±3.4% (mean± SO) dendritic/veiled cells were found; this value is not 
statistically significantly different from the spontaneous maturation (during 
incubation with serum free culture fluid, represented by the hatched area in figure 
2). 
In two series of experiments Percoll-purified monocyte suspensions that had 
been freed of contaminating T cells and B cells (using a MAGS, yielding over 95% 
NSE+ monocytes), or elutriator purified monocytes (yielding over 98% NSE+ 
monocytes) were used. The thyroid hormone T 3 also gave in these experiments a 
clear enhanced monocyte to veiled/dendritic cell transition and 41% (MAGS 
separation) and 29 ± 10% (n= 10, elutriator purification) veiled/dendritic cells were 
found respectively, 2.10.11 M being the optimal T3 concentration (data not shown). 
These experiments using almost pure monocyte suspensions show that T cells and 
B cells contaminating the monocyte population or products of these T or B cells 
are not necessary for the transition of monocytes to veiled/dendritic cells. 
A pretreatment of the monocytes with metrizamide prior to the overnight 
culture, increased - as expected - the monocyte to veiled/dendritic cell transition, 
and 26.8 ± 2.9% (mean± SD) dendritic/veiled cells were found, as has been 
reported before1 (although in cultures containing 100/o fetal calf serum). Reverse T3 
(rT 3) and both iodinated forms of thyroglobulin (Tg) were also capable of 
enhancing the monocyte to dendritic cell transition, although to a somewhat lesser 
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Figure 2. The monocyte into veiled/dendritic cell transition induced by an exposure to thyroid 
hormones or other iodinated compounds (mean±SD, n=4-20). The hatched area represents 
the mean±SD (n=20) of the spontaneous monocyte to dendritic cell transition (monocytes 
exposed to culture fluid alone). The open circles give the mean±SD (n=3-6) of the monocyte 
to veiled/dendritic cell transition after a-GM-CSF treatment * p<O.OS induced vs spontaneous 
transition (hatched area), Wilcoxon's rank sum test. • p<O.OS induced transition vs induced 
transition after a-GM-CSF treatment, Wilcoxon's rank sum test. 
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At a concentration of 2.10"10M of rT3 (optimal concentration) 22±7% 
(mean±SD) veiled/dendritic cells were found. With regard to the iodinated forms of 
Tg at a concentration of 2.10"11 M Tg 0.2%1 (optimal concentration) 22±2% 
(mean±SD) veiled/dendritic cells were found and at a concentration of 2.10"11 M 
Tg 0.37%1 (optimal concentration) 20±4% (mean±SD) veiled/dendritic cells were 
found. Non-iodinated Tg was practically not capable of stimulating the transition of 
monocyte to veiled/dendritic cells and low values of 19±3% and 17±2"k 
veiled/dendritic cells (mean±SD) were maximally found (figure 2, note however the 
much lower concentrations, namely at 2.10"15 and 2.10"12 M Tg where this 
transition was induced; at these concentrations also the iodinated Tg gave similar 
values and one may wonder whether this transition is induced lor instance by the 
ingestion of the large Tg molecule). 
Immunocytochemistry 
To verirt the character of the veiled/dendritic cells counted directly in the wet 
cell suspensions, immunocytochemical studies were performed on fiXed 
cytocentrifuge preparations of the cell populations alter overnight culture. Cells with 
cytoplasmic protrusions, strong MHC class-11 positivity and weak or absent acid 
phosphatase activity were considered as veiled/dendritic cells in the fixed and 
stained preparations. 
A strong correlation was found (r=0.87, p<0.01) between the percentage of 
veiled cells counted directly in suspension (cells with actively moving veils or 
dendritic cytoplasmic protrusions in the wet preparations) and the percentage of 
MHC class-11 positive, acid phosphatase negative dendritic cells counted in the 
cytocentriluge preparations (figure 3). 
The mixed leucocyte reaction (MLR} 
To verily the functional capacity of the induced veiled/dendritic cells, MLRs 
were carried out. 
With regard to the control cultures, PHA was able to stimulate T lymphocytes to 
proliferate depending on the concentration used and 114.103 ± 20.103 cpm could 
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be reached in our assay at 50pgjml of PHA. Irradiated monocyte suspensions and 
suspensions containing veiled/dendritic cells alone (other control cultures) were 
unable to proliferate and the cells did virtually not incorporate 3H-thymidin (1 00-300 
cpm). Purified T lymphocytes incubated with culture fluid alone (without stimulator 
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Figure 3. Correlation between percentage of living veiled/dendritic cells (VCJOC) counted 
directly in wet preparations (x~axis) and fiXed veiled/dendritic cells (VC/DC) counted in 
cytocentrifuge preparations using immunocytochemistry (y~axis). Slope = 0.85, r = 0.87, 
p<0.01. 
In figure 4 the results of the MLRs are depicted as proliferation indices (PI) of the 
tests which were calculated as follows: 
cpm of incorporated 3 H~thymidin in T lymphocyte suspensions stimulated with cell suspensions 
containing monocytes and veiled/dendritic cells as stimulator cells 
cpm of incorporated 3H-thymidin in the same T lymphocyte suspensions but without any stimulating 
cell suspension. 
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Figure 4. Mixed leucocyte reaction depicted as proliferation indeces (PI) ofT cells stimulated 
with cultured monocytes, T cells with T 3-pulsed monocytes and T cells with T 3-putsed 
monocytes treated with a-GM-CSF. The results are given of monocytes pulsed with 2.1 o·ll M 
T3 (A) and wtth 2.10.10 M T3 (6). 
First it must be noted that we found a high range of Pis depending on the 
donor-stimulator combination used. Figure 4 further shows that monocyte 
suspensions exposed to T 3 prior to the overnight culture and contaning the highest 
percentages of veiled/dendritic cells (viz around 30%, see figure 2) were more 
potent stimulator populations in the MLR in comparison to cell suspensions that 
had not been exposed to any compound prior to the overnight culture On 11 out of 
12 cases, p<0.003, paired binomial test); the latter preparations only contained 
13±3% (mean±SD) veiled/dendritic cells (see figure 2, hatched area). It must be 
noted however that this increase in MLR stimulator capacity is in fact minor and not 
proportional to the increases in the number of veiled/dendritic cells. 
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Wrth regard to pretreatment of the monocytes with thyroxine, rT 3 and highly 
iodinated Tg it must be noted that this procedure yielded higher numbers of 
veiled/dendritic cells in comparison to non-pulsed monocyte populations and that 
such pretreated cell suspensions were more effective than the non-pulsed 
monocyte suspensions in stimulating allogeneic T cell proliferation in the MLR. 
However, statistical significant differences in the MLRs could not be reached (data 
not shown), probably because the increases in the number of veiled/dendritic cells 
are too low to give significant increases in the apparently insensitive MLR (see 
before). 
In a series of other MLR experiments (figure 5) veiled/dendritic cell 
suspensions maturated via a pulse with T 3 and containing in this series of tests 
relatively high percentages of veiled/dendritic cells (viz 46 ±5%, mean±SD) were 
again potent stimulators in the MLR. 
Stimulator population: 
mono's pulsed with 2.10-11 MT3 











DC purified using Boyden Chamber: 
• non migrating cells 


















Figure 5. Mixed leucocyte reaction depicted as proliferation indeces of T cells stimulated with 
cultured monocytes, T cells with 2.1 o· 1 1 M T 3-pulsed monocytes, T cells with dendritic cells 
purified according to the method of Knight et al. and T cells with T 3-pulsed monocytes further 
purified using the Boyden chamber technique (yielding migrating cells and non-migrating 
cells). 
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In fact they were as potent MLR stimulators as veiled/dendritic cell suspensions 
obtained via the well established purification method of Knight et al (based on 
density purification); the latter "Knight" cell suspensions also contained around 40% 
veiled/dendritic cells in this experiment. 
The cell suspensions enriched for veiled/dendritic cells with the purification 
technique based on adherence and chemotaxis in the Boyden chamber (non-
adhered and non-migrated cells in the top chamber) contained 56% of 
veiled/dendritic cells and these cell suspensions belonged to the most potent 
stimulators in the MLR (figure 5). The cells chemotactically attracted and migrated 
through the membrane in this purification method Qnto the bottom chamber) only 
contained 15% of cells with a veiled/dendritic morphology and these cell 
populations only weakly stimulated T cells in the MLR (see figure 5). 
Effects of a-cytokine administration on the transition of monocytes to 
veiled/dendritic cells 
The enhanced monocyte to veiled/dendritic cell transition induced by the pulse 
with the thyroid hormones T 3 and T 4 was dependent on the endogenous 
production of GM-CSF, TNFo and IL-6 in the culture; figure 2 and 6 show that a 
treatment of the pulsed cells with 5 pgjml (optimal concentration) a-GM-CSF, o-
TNFa (optimal effects at dilution 1 :10) and a-IL-6 (optimal effects at dilution 1 :2500) 
during overnight culture (from 2-16 hours) prevented the transition of monocytes to 
dendritic/veiled cells. a-G-CSF (data not shown), a-M-CSF and o-11-1,8 did not have 
such effects. 
With regard to functional effects, in the MLR, a-cytokine treated T 3-pulsed 
monocyte suspensions (containing fewer veiled/dendritic cells, viz around 15%) 
were considerably less effective as stimulator cell populations (in 10 out of 10 
cases, p<0.001 paired binomial test, figure 4). 
a-GM-CSF, a-TNFo and o-IL-6 treatment also had effects on the metrizamide 
induced monocyte to veiled/dendritic cell transition (figure 6). These blocking 
effects were however more variable than in the case of T 3 induced maturation. 
In the case of other induction pulses, namely rT 3 and Tg 0.37% I less 
consistent data were obtained (figure 2), probably due to the fact that these 
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Figure 6. Inhibition of the veiled/dendritic cell transition (hatched area) of nonpulsed 
monocytes. T 3 pulsed monocytes and metrizamide pulsed moncytes by a-GM-CSF (a: 
10pgfml, b: Spgfml, c: 1pgfml, d: O.Spgfml), a-TNFa (a: 1:5, b: 1:10, c: 1:50, d: 1:100), a-IL-6 
(a: 1:500, b: 1:2500, c: 1:10000, d: 1 :25000), a-M-CSF (a: 50 pgjml, b: 5 pgfml, c: 0.5 pgfml, 
d: 0.05pgfml, e: 0.05 pgfml) and a-IL-1,8 (a: 1:500. b: 1:2500, c: 1:10000, d: 1:25000). 
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The production of GM-CSF, IL-6 and IL-1/1 by the pulsed monocytes 
The GM-CSF, IL-6 and IL-1/1 production in the monocyte cultures was only 
tested in a limited series of experiments. The cytokine production of monocytes 
incubated in culture fluid alone was clear but varied considerably depending on the 
donor (n=S-10) and the time of collection; GM-CSF values were found between <1 
and 1800 pgjml/1.106 cells, IL-6 values between 200 and 500 ngjml/1.106 cells 
and IL-1.8 values between 2 and 20 ngjml/1.106 cells alter an overnight culture 
period. Exposure of the monocytes to thyronine (T0), T3 , T4 , Tg or metrizamide for 
half an hour did neither have quantitative important nor statistical significant effects 
on the cytokine production. 
DISCUSSION 
This study firstly shows that a pretreatment of blood monocytes for 30 minutes 
with thyroid hormones, and in particular with the bioactive thyroid hormone T 3 , 
enhances the capability of the monocytes to mature into cytologically and 
functionally active veiled or dendritic cells when further cultured overnight under 
nonadhering conditions. The dendritic cell maturation during the culture was 
dependent on the endogenous production of GM-CSF, TN Fa and IL-6 since a-GM-
CSF, a-TNFa and a-IL-6 had blocking effects on the transition. Indeed, GM-CSF, IL-
6 and IL-1.8 were produced in the cultures and these cytokines are most likely 
produced by the monocytes themselves since a removal of the lew contaminating T 
cells and B cells did not affect the monocyte to veiled/dendritic cell transition. 
The percentage of veiled/dendritic cells with long, actively moving cytoplasmic 
protrusions counted directly in the wet preparations correlated well with the 
percentage of "histologically classical" dendritic cells in fixed and stained 
cytocentriluge preparations, viz cells with a dendritic morphology that were strongly 
MHC class-11 positive and acid phosphatase negative. Also cell suspensions with 
the highest percentages of T3-induced-veiledjdendritic cells, including the Boyden 
chamber purified cell fractions containing over 40% of T 3 induced veiled/dendritic 
cells, were the most potent stimulators in the MLR (comparable to effects of 
stimulator populations purified accordng to the classical "Knight" procedure). It 
must be admitted however that the increases in stimulator capacity in the MLR 
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were often minor and not proportional to the increases in the number of 
veiled/dendritic cells. We nevertheless feel justified to conclude that the cells with a 
veiled morphology in the wet preparations and induced by the action of the thyroid 
hormone must be considered as morphological and functional typical antigen-
presenting accessory cells of veiled/dendritic type22•23•24•25•2s. 
Remarkable are also the relatively low thyroid hormone concentrations at which 
the optimal effects were noticable, e.g. at 2.1o-10M. In other systems (liver) often 
concentrations in the micromolar to nanomolar range are optimal29. The thyroid 
hormone T 3 functions as a signalling substance by regulating the transcription of 
certain T 3-responsive genes
30
. Cellular responses to this hormone depend on 
the concentration of T 3 within the cell. This concentration is regulated by different 
mechanisms such as the intracellular synthesis from T 4 and the transport of T 3 
through the cell membrane. Intracellular T 3 can only mediate its function through 
binding to nuclear T 3 receptors, which receptors are encoded lor by the c-erbA 
proto-oncogene family. The T 3 receptors act as transcription factors and their 
activity not only depends on the availability of thyroid hormone, but also on the 
concentration of the receptor within the nucleus. Only after dimerization with certain 
T 3 receptor auxiliary proteins (or TRAPs), including retinoid receptors, a functional 
hormone-occupied T 3 receptor monomer can regulate transcription of certain 
genes by binding to specific DNA elements the so-called T 3-responsive elements 
(TRE). The retinoic acid receptors are hence also able to regulate T 3 regulated 
transcription. 
It is therefore clear that further experiments are needed to unravel the exact 
mechanisms of the T3-induced enhancement of monocyte to veiled/dendritic cell 
transition, in particular the transport mechanisms of thyroid hormone into 
monocytes, the role of the deiodinase activity of monocytes (conversion of T 4 into 
bioactive T3), the concentrations of T3 receptor isolorms and of TRAP isoforms in 
monocyte nuclei and the effect of the monocytic T 3 receptors on the transcription 
of genes that are involved in the here described GM-CSF, IL-6 and TN Fa effects. T3 
apparently does not have an effect on the transcription of genes regulating the 
production of cytokines, since the production of GM-CSF, IL-6 and IL-1,8 was not 
increased in the cultures. T 3 might have an effect on genes regulating cytokine 
receptor expression or post cytokine receptor effects. 
Veiled/dendritic cells are excellent antigen presenting cells and play a crucial 
role in the initiation of immune responses. Our observations that particularly T 3 
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stimulates antigen-presenting function is in agreement with earlier observations of 
Balazs et ai31 who showed that T3 supplements enhanced PHA stimulation of 
human lymphocytes in vivo and in vitro and of Chatterjee et ai32 who found an 
increased blastogenic response of lymphocytes from thymus, peripheral blood and 
· mesenteric lymphnodes to pokeweed mitogen (PWM) after in vivo T 3 and T 4 
administration. Additionally, the observations of Fabris et a133 that hypothyroidism 
induces immunodeficiency, which is corrected by thyroid hormone supplements 
demonstrate that thyroid hormonal activity is necessary for optimal immune 
function. 
Our study also shows that iodinated compounds such as metrizamide, rT3 and 
iodinated Tg are capable to enhance the monocyte to veiled/dendritic cell 
transition. It is clear that such capability can not be transmitted via the T 3 receptor. 
Our observation is nevertheless in agreement with earlier observation that iodinated 
compounds can have direct stimulating effects on cells of the immune system, such 
as the T celis34, the B cells35 and the macrophages36. 
When monocytes were exposed to the highly iodinated compound metrizamide 
(containing 3 iodine atoms per molecule) high numbers of veiled/dendritic cells 
were induced (comparable to the numbers found after the exposure to T3). These 
veiled/dendritic cells were capable of significantly stimulating the MLR (earlier 
experiments, see ref1) and GM-CSF, TNFa and IL-6 played a role in the transition, 
since the a-cytokines had blocking effects. 
The transition induced by rT 3 and iodinated Tg was however not as 
pronounced as the transition that was induced by metrizamide and T 3; also in the 
MLR, significant stimulation could not be observed (probably because the increases 
in MLR are minor and not proportional to the increases in number of 
veiled/dendritic· cells). One can only speculate about the mechanisms that are 
involved in the enhancement of the monocyte to dendritic/veiled cell transition 
under for instance the influence of metrizamide or rT 3. It is possible that iodonium 
groups (I+) may be irritants lor monocytes and it is tempting to speculate that 
these active redox groups are capable of interfering with myeloperoxidase and the 
H20 2 generating system in the monocytes, thereby triggering the monocyte to 
maturate into a cell with a less active H20 2 generating system, the dendritic cell. In 
support of such a view we found in a few experiments the peroxidase interfering 
drug methimazole also capable of enhancing the monocyte to veiled/dendritic cell 
transition (data not published). How a-cytokines exert their effects in such an 
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irritative action clearly needs further study. 
With regard to a direct effect of the iodinated compounds on cells of the 
immune system, it has been described that a high dietary iodine intake may 
accelerate autoimmune thyroid disease, particularly in individuals or animals with a 
preexisting thyroid abnormality37•38•39 .4°.41 • An enhanced antigenicity 
of highly iodinated thyroglobulin has been suggested to play a role in such 
acceleration of the thyroid autoimmune response42 It was for instance shown 
that a high dietary iodine intake resulted in vivo in a high iodination grade of 
thyroglobulin and highly iodinated thyroglobulin was proven to be On vitro) more 
antigenic than thyroglobulin with a low iodination grade43•44• Since dendritic 
cells play a crucial role in the initiation of thyroid autoimmune responses6•7•8 and 
since a high iodine diet (viz highly iodinated Tg) accelerates the development of 
focal thyroiditis in the BB rat41 , it is tempting to speculate that an enhanced iodine-
induced monocyte-veiled/dendritic cell transition may play at least an additional role 
in such an accelerated development of thyroiditis. 
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CONCLUSIONS AND GENERAl DISCUSSION 

Chapter 7.1 
GENERAl CONClUSIONS OF THE EXPERIMENTS 
DESCRIBED IN THIS THESIS 
Our study firstly shows that dietary iodine deficiency may lead, apart from 
goitre formation and hypothyroidism, to a triggering of the thyroid autoimmune 
reactivity: an accumulation of dendritic cells was found in the thyroids of normal 
female Wistar rats, followed by intrathyroidal increases in T cells, and higher 
incidences of anti-colloid antibodies and thyroid growth stimulating antibodies 
(TGAbs) in the serum of the animals (see table 1). These observations in the Wistar 
rat are in agreement with observations made in human populations, in which a low 
dietary iodine intake led to goitre formation 1 , hypothyroidism2 •3•4 , increased 
numbers of intrathyroidal aggregations of dendritic cells, epitheloid cells and giant 
cells 1 , an increased incidence of anti-thyroglobulin (Tg) antibodies5 and a high 
incidence of TGAbs6•7 . 
Not every individual, however, shows such reactivity to iodine deficiency and 
the response is variable8•9•10•11 • 12 Indeed in our hands females of 
another rat strain, eg the autoimmune prone BB rat, showed a different response to 
iodine deficiency in comparison to the normal Wistar rat. To our surprise, the BB rat 
was capable of compensating a relatively mild low dietary iodine intake by a rapid 
and increased goitre formation, and after 9 weeks of iodine deficient diet full 
euthyroidism was restored (see table 1 ). In Chapters 3.1 and 3.2 we suggest that 
the basis for this rapid goitre formation may be attributed to a higher intrinsic 
growth rate of the BB thyrocytes or to the effects of TGAbs or other growth factors 
in the circulation of the animal. During iodine deficiency, the BB goitres showed 
higher numbers of intrathyroidal dendritic cells and T cells as compared to BB rats 
kept on a normal iodine diet. It should also be noted that numbers of such cells in 
BB rats on a normal iodine diet are already higher than in Wistar rats on a normal 
iodine diet (see table 1). The fact that this rat strain with a clear genetically 
determined proneness for thyroid autoimmunity is capable of coping with mild 
iodine deficiency may be helpful in explaining the heterogeneous response to iodine 
deficiency observed in random human populations. There might be individuals with 
a "BB likeness (autoimmune-proneness)" who, upon a moderately low dietary 
iodine intake, remain euthyroid, however, at the expense of rapid goitre formation 
with various signs and symptoms of involvement of the immune system. 
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00 Table 1. The effects of several Iodine regimens on thyroid endocrine reactions, thyroid autoimmune reactions and the Immune system. 
0 
Thyroid Thyroid Reaction of the 
endocrine reactions autoimmune reactions Immune system In general 
Wlstar rat BB rat Wlstar rat BB rat Wlstar rat BB rat 
(normal) (At-prone) (normal) (At-prone) (normal) (AI-prone) 
/odino doficioncy 
Mild goitre + goitre + + Abs t (TGAb,collold) Abs 1 (colloid) 
hypothyroid + euthyroid DCI,Tcellsl DC It, Tcells t 
Severe goitre + + goitre + + Abs t t (TGAb,colloid) Abs II (colloid) II II 
hypothyroid + + hypothyroid + + DC t, Tcells It ND ~ 
Iodine excess ~ 
" 
Mild chronic euthyroid euthyroid, Abs I I (colloid) 50% of animals: 
tendency to DC I, Tcells I Abs t t (colloid) 
become hypo- ectopic thymus DC It, Tcells tt 
thyroid (upto 57%) TALT 
Severe acute on hyperthyroidism, outburst of DC tt, m¢ tt DCit,mQ>tt 
hyperplastic followed by thyroiditis, (transient) (permanent, ND ND 
goitre hypothyroidism followed by induction of 
(transient outburst thyroid AID thyroid AID) 
of thyroldnls) (hypothyrodlsm) 
Reference point normal Wistar rat of our colony on a normal Iodine diet (urinary Iodine excretion 7 pg per day). 
1: Increase, 1: decrease, ~:no difference, NO: not done, AI: autoimmune, Abs: antibodies, TGAb: thyroid growth stimulating antibodies, DC: 
dendritic cells, AID: autoimmune disease, TALT: thyroid-associated lymphoid tissue. 
Conclusions and general discussion 
Iodine excess also resulted in a complex modulation of thyroid autoimmune 
responsiveness: there was a depression of thyroid autoimmune reactivity in the 
normal Wistar rat, but an acceleration of thyroid autoimmune reactivity in the 
autoimmune-prone 88 rat. 
The Wistar rat developed in the early phases of the experiment a thyroid-
associated ectopic thymic tissue (of which we speculated in Chapter 4 that it is 
related to tolerance induction), together with a low intrathyroidal infiltration with 
lymphoid cells and a low production of anti-colloid antibodies (table 1). There were 
no disturbances in thyroid function. This relatively high dietary iodine intake 
therefore seems to be the most optimal iodine intake for female Wistar rats of our 
colony. 
The same relatively high dietary iodine intake in the 88 rat, however, resulted in 
an acceleration of the intrathyroidal development of the thyroid-associated lymphoid 
tissue (TALT) that normally occurs in 50% of 88 rats older than 18-22 weeks of 
age13•14. The architecture of TALT suggests that it plays a prominent role in 
the production of autoantibodies and autoreactive T cells and therefore in the 
continuation of the thyroid autoimmune process (Chapter 5 and table 1 ). 
Our observations on the high dietary iodine intake in rats are again in 
agreement with observations in human populations. In areas with a relatively high 
iodine intake (for instance in the United States and Japan), the incidence of 
classical Hashimoto's thyroiditis is higher in comparison to areas with a normal or 
relatively low iodine intake 15• 16• 17• 18• 19 . The observations in the 
autoimmune-prone 88 rat - in contrast to the normal Wistar rat - suggest that the 
individuals already genetically prone to thyroid autoimmunity easily develop thyroid 
autoimmune disease under the influence of a high iodine diet, whereas those 
without such proneness may even be protected by the high iodine intake (table 1 ). 
It has been nicely shown by the group of Wick et ai20, using the Obese strain 
(OS) of chicken, that the genetic predisposition to thyroid autoimmune disease and 
the factors involved in such an abnormality are complex and multifactorial: 
a. Firstly, the basis for the genetic predisposition to thyroid autoimmune disease is 
formed by a preexisting abnormality of the thyroid. For the OS chicken21 
there is ample evidence that this is an intrinsic higher iodine uptake by the 
thyrocytes. For the 88 rat Li et a122 have also described such a higher 
thyrocyte iodine uptake. We observed a higher growth rate and a higher 
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responsiveness to TSH of 88 thyrocyte follicles in suspension culture (that 
might be intrinsic) when comparised to Wister thyrocyte follicles (Chapter 2.2). 
b. Secondly, there are clear and often extensive abnormal~ies in the regulation of 
the immune response. These abnormalities play an important role in the 
actually enhanced production of autoreactive antibodies and T cells. In the 
Obese strain of chicken, hyperreactive T cells, with a higher expression of IL-2 
receptors and a higher production of IL-2 have been observed23 •24, as 
well as hyperreactive macrophages20. Furthermore, a thymic nurse cell 
deficiency in the thymus of OS chickens may be responsible for a disturbed T 
cell development in which autoreactive T cells may not be deleted within the 
thymus20. 
In the 88 rat, a lymphopenia has been described, due to loss of RT6+ T 
regulator (suppressor) cells25•26. Additionally, thymic epithelial cells devoid 
of MHC class-11 antigens have been observed in the BB rat, which can explain 
the presence of autoreactive T cells in the periphery27. 
A malfunctioning immune-endocrine feedback loop plays an additional role in 
the disregulation of immune responses in such animals. In the OS chicken 
decreased basal glucocorticoid levels have been found, together with a 
decreased level of glucocorticoids in response to immunological stimuli20. Also 
in 88 rats a decreased response of glucocorticoids to endotoxin was found, 
probably due to a deficient production of sufficient IL-1 by macrophages28. 
c. Thirdly, for the above described thyroidal and immunological abnormalities to 
fully develop into overt thyroiditis it is necessary that the thyroid gland becomes 
susceptible to the excessively produced autoantibodies and autoreactive T 
cells. It is not yet known what this - in the OS chicken genetically determined -
susceptibility is. Possibilities that have been suggested are an abnormal 
expression of MHC class I or II molecules or an abnormal susceptibility of the 
thyrocytes to cytokines20. 
In the OS chicken iodine - as well as the sex hormones - were clear modulators 
of the spontaneously occurring thyroid autoimmune response. The iodine and the 
sex hormones were, however, of minor importance (and thus modulators) in 
comparison to the major factors of genetically determined target organ abnormality 
and susceptibility and the genetically determined immune disregulation. Our data in 
fact support such a view, clearly stating only a modulating role of the dietary iodine 
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intake in Wistar rats and in an animal model of thyroid autoimmune disease, the BB 
rat. 
W~h regard to the differences between the Wistar rat and the BB rat it is likely 
that the outcome of the dietary iodine intake is different, depending on the different 
setpoints in regulation of the immune system, and differences in target organ 
(thyroid) metabolism and target organ susceptibility. 
To explain at least part of the effects of the dietary iodine intake on thyroid 
autoimmune reactivity in both Wistar and BB rats our study shows that iodinated 
compounds such as iodinated Tg, metrizamide29 and rT 3 have direct effects on 
the immune system, eg on the maturation of dendritic cells from blood cell 
precursors (probably the monocytes, see Chapter 6). Such a direct effect has been 
described before by other investigators in the case of B cells30, T cells31 and 
macrophages32. This phenomenon may play a role in the accelerated 
development of the thyroid-associated lymphoid tissue in the BB rats kept on a 
high dietary iodine regimen (Chapter 5), as well as the development of the thyroid-
associated thymic tissue in the Wistar rats on a high dietary iodine regimen 
(Chapter 4). 
Hypothyroidism in rats Qnduced by an extremely low dietary iodine regimen) 
had a clear immune suppressive effect. Furthermore, lowered thymic, splenic and 
thyroid draining lymph nodal weights were found (table 1, data not shown). This is 
in agreement w~h the observations of Fabris33 who reported that hypothyroidism 
in the rat induces immunodeficiency, which is restored by thyroid hormone 
supplements. 
Other investigators also stated that thyroid hormones are necessary for optimal 
immune function. Balazs et al34 showed that T 3 supplements enhanced PHA 
stimulation of human lymphocytes in vitro and in vivo. In addition, Chatterjee et 
afl5 found an increased blastogenic response of lymphocytes from thymus, 
peripheral blood and mesenteric lymph nodes to pokeweed mitogen after T 3 or T 4 
administration in vivo. 
Our findings that thyroid hormones are necessary for the transition of 
monocytes into veiled/dendritic cells are in agreement with these observations 
(Chapter 6). 
In conclusion, both a low dietary iodine intake as well as a high dietary iodine 
intake have influences on the immune system and may lead to the development of 
thyroid autoimmune reactions. Other factors, such as genetically determined target 
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organ (thyroid) abnormalities and susceptibilities of the thyroid and a genetically 
determined disregulation of the immune network determine the actual 
consequences of the iodine intake. In this way reactivity ranges from tolerance (the 
Wistar rat with a high dietary iodine intake) to thyroid autoimmune reactivity (the 
Wistar rat on a low iodine diet) that may be helpful to cope with iodine deficiency 
(the BB rat on a low iodine diet) and overt thyroid autoimmune disease (the BB rat 
with a high dietary iodine intake). 
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CRITICICAL REMARKS ON THE TECHNIQUES USED 
TO COME TO OUR GENERAL CONCLUSIONS 
7. 2. 1 Related to the rat strains used 
In our experiments we only used two rat strains, and one has therefore to be 
careful to draw general conclusions. In our studies we took the BB rat as the 
prototype of an autoimmune-prone individual and the Wistar rat as the prototype of 
a normal non-autoimmune individual. The Wistar rat is indeed the ancestral strain of 
the BB rat and by selectively breeding diabetic Wistar rats, a new rat strain 
emerged that spontaneously developed an insulitis and a '~hyroiditis", namely the 
BB rat. However, we must keep in mind that the observed results of the dietary 
iodine regimens in the Wistar rat and the BB rat may be specific characteristics of 
each particular rat strain not directly or indirectly related to thyroid autoimmunity. It 
is therefore necessary in the future to perform the same dietary studies in other 
"normal" rat strains such as the AUG36, PVG or the Brown Norway rat and 
"autoimmune rat and. mouse strains like the Buffalo rat strain37 and the non 
obese diabetic (NOD) mouse38• 
7.2.2 Related to the time schedule of iodine administration and the age of the 
rats 
The time schedule of iodine administration and histological examination of the 
thyroid might also be critical in determining the outcome of the results of the 
different iodine regimens. In our study with Wistar and BB rats we used very young 
animals and the diet was introduced directly after weaning (3 weeks of age): the 
thyroid was studied histologically every 3 weeks. 
The group of Braverman et al39 also found that a high dietary iodine intake in 
young BB/W rats resulted in the acceleration of thyroiditis (we confirmed their 
observations by finding an acceleration of the development of TALT in the BB rats, 
Chapter 5). However, when Braverman et al introduced their diets in adult BB/W 
rats, they did not observe such acceleration. We never performed any dietary 
iodine studies in older animals. 
Using Wistar rats of 3 weeks of age we observed a rapid development of a 
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thyroid-associated ectopic thymic tissue. This tissue was not present anymore at 12 
weeks of age (9 weeks after starting the high iodine diet). The group of Braverman 
did not observe this thyroid-associated ectopic thymic tissue in their Wistar group 
on diet. We like to believe that this discrepancy is because they started to 
investigate the thyroids at a Wistar age of 11-12 weeks (at 8 weeks of diet). 
In their hands a low dietary iodine intake resulted in BB/W rats in a decrease of 
the spontaneously developed ""thyroiditis"'. We were not able to confirm these 
observations, in fact a slight increase in thyroid autoimmunity was observed (data 
not shown). 
Differences in the BB rat strains used might also play a role. The BB/W strain 
used by the group of Braverman already spontaneously developed their TALT from 
9 weeks of age and onwards, whereas in the BB rat strain of our colony 
characteristic TAL T developed not earlier than at 18-22 weeks of age and onwards. 
Using the very young Wistar rats we also observed an increase in thyroid 
autoimmune reactivity, viz higher numbers of intrathyroidal dendr~ic cells and T 
cells and an increased anti-colloid antibody production and thyroid growth 
stimulating antibodies, when these Wistar rats were kept on a low dietary iodine 
regimen (chapter 2 and addendum 1). 
Braverman et a139 did not observe such an effect of low dietary iodine 
regimens in Wistar rats. However, they did not study the thyroid 
immunohistologically and in fact their experiments need to be prolonged in order to 
be able to observe the effect of the moderately low iodine intake on anti-colloid 
antibody production. 
7.2.3 Related to the preexisting thyroidal state 
The thyroidal state at the beginning of the experiment, and in relation to that, 
the acuteness of the high dietary iodine administration and the dose of iodine 
administered will also have clear influences on thyroid autoimmune reactiv~. At the 
start of our experiments, all rats were euthyroid, had a normal thyroid weight and 
the thyrocytes were at a metabolically basal level (although there are probably 
differences in the latter respect between Wistar rats and BB rats, Chapter 3.2). We 
chronically administered a moderately high iodine dose (10 pgljday) during 18 
weeks. During this time no histological signs of thyrocyte destruction were 
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observed in both Wistar and BB rats. 
It has been described, however, that an acute high dose of iodine administered 
i.p. during 8 days to iodine deficient C3H mice40 or hamsters41 showing an 
iodine deficient hyperplastic goitre (with metabolically active thyrocytes), does result 
in goitre involution, together with thyrocyte destruction. During the iodine-induced 
goitre involution and thyrocyte destruction, a transient increase in the numbers of 
intrathyroidal macrophages and dendritic cells was observed. When autoimmune 
prone NOD mice were used for the experiments, the numbers of intrathyroidal 
macrophages and dendritic cells became permanently increased38. These 
experiments are again in agreement with observations made in humans: individuals 
with an iodine deficient goitre are highly susceptible for thyroid autoimmunity after a 
high dose of iodine supplementation42A3•44. 
The experiments also highlight the differences between the outcomes of our 




THE POSSIBLE MECHANISMS BY WHICH IODINE MODULATES 
THYROID AUTOIMMUNE REACTIVITY 
7.3. 1 Toxicity for thyrocytes 
One of the mechanisms by which iodine may precipitate thyroid autoimmune 
reactivity is demonstrated in the earlier mentioned experiments of Mahmoud et al40 
and Follis et al41 . These investigators administered a high dose of iodine to iodine 
deficient mice and hamsters with a hyperplastic goitre. The thyrocytes of the 
hyperplastic goitres are metabolically highly active and are damaged by the iodine. 
The investigators argued that excessive amounts of the iodide ion in the 
hyperplastic thyrocytes were rapidly oxidized by TPO thereby producing excessive 
amounts of either hypoiodous acid or oxigen radicals, reactive elements reported 
as intermediates in TPO catalyzed oxidation of iodide45 (see Chapter 1). These 
oxidative elements damage thyroid cell membranes by the oxidation of membrane 
lipids or proteins46•47. This mechanism probably only plays a role in acute and 
high iodine supplementation in iodine deficient individuals with a hyperplastic goitre. 
However, there is some indirect evidence that oxidative damage is an early event in 
the development of the spontaneous thyroiditis of the OS chicken as well; treating 
the OS chickens from hatching with anti-oxidants reduced the intrathyroidal 
lymphocytic infiltration and anti-Tg antibody synthesis. The drugs were ineffective 
after disease initiation48. 
In our experiments using a chronic high iodine diet only minor signs of 
thyrocyte destruction could be observed in the BB rat thyroids after an excessive 
iodine intake (this might, however, be due to the autoimmune process, see Chapter 
5). In the Wister rats the thyroid autoimmune reactivity was even reduced after an 
excessive iodine intake. In our studies we used animals with a normal thyroidal 
state. It is therefore unlikely that oxidative damage of thyrocytes plays a major role 
in the acceleration of thyroid autoimmune phenomena (quicker TALT development, 
development of ectopic thymic tissue) observed in our studies. 
7.3.2 lmmunogenicity of highly iodinated thyroglobulin 
The creation of immunogenic epitopes in the Tg molecule by the ingestion of 
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excess iodide can explain the acceleration of the iodine-induced thyroid 
autoimmune phenomena observed in our studies. It has been demonstrated that 
highly iodinated Tg is a better immunogen than Tg of low iodine content, both in 
vivo49 and in vitro 5°. Champion et al showed that immunization of mice with 
highly iodinated Tg and adjuvant, but not poorly iodinated Tg, induced autoimmune 
thyroiditis51 •52. 
Although there is thus some evidence emphasizing the importance of highly 
iodinated Tg as an immunogen, it must be noted that real autoimmune thyroiditis 
could only be elicited with this immunogen in genetically susceptible rats53. 
Also in OS chickens and in patients suffering from Hashimoto's thyroiditis it is 
not clear whether highly iodinated Tg is a major causal factor for the development 
of autoimmune thyroid reactivity. 
In OS chickens it is evident that 
a. small amounts of iodine within the thyroid are sufficient to cause lymphocytic 
infiltration54, 
b. intrathyroidal Tg of OS chickens has a lower than normal iodine content 
(although it still has many iodine atoms per molecule of Tg)55 and 
c. antibodies to Tg in OS sera react equally well to highly-iodinated Tg and Tg of 
low iodine content49. 
Patients suffering from Hashimoto's thyroiditis have 
a. poorly iodinated Tg56, 
b. antibodies to various thyroidal antigens next to Tg and even occasionally 
antibodies to such antigens in the absence of antibodies to Tg. 
If antigens play a role in the development of ectopic lymphoid tissue (both 
thymus and TALT), it is possible that this is related to an increase in the antigenicity 
of iodinated Tg. 
7.3.3 Direct stimulating effects of iodine on cells of the immune system 
Direct stimulating effects of iodine on immune cells, such as macrophages57, 
T cells 58 and B cells59 , have been described to play a role in the development 
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of thyroid autoimmune reactivity. In Chapter 6 we found an enhancing effect of 
metrizamide, rT 3 and iodinated Tg on the transition from monocyte to 
veiled/dendritic cell. This phenomenon may play a role in the iodine effects on the 
thyroid autoimmune processes observed in the B8 rat and the Wistar rat and in the 
higher antigenicity of highly iodinated Tg. 
One should also keep in mind that it is possible that iodine may have direct 
stimulating effects on cells forming the microenvironment (epithelial and reticulum 
cells) of lymphoid organs since such cells are probably more important in the 
development of thyroid-associated ectopic thymic tissue in the Wistar rat and TALT 
in the 88 rat. Further investigations are necessary to resolve this. 
7.3.4 Increased release of antigenic degradation products during iodine 
deficiency 
Our study also shows that cells belonging to the dendritic cell family are 
normally present in low numbers in the thyroid and increase in number during 
iodine deficiency in both the Wistar rat and the BB rat60. Recent data from our 
group and from others indicate that dendritic cells are also normally present in 
other endocrine tissues (the pituitary, the ovary), and that such cells are capable of 
protecting endocrine cells from overstimulation61 •62-63. 
One might therefore hypothesize that the above described intrathyroidal 
accumulation of dendritic cells during iodine deficiency is involved in the protection 
of the stimulated thyrocytes 0odine deficiency) from overstimulation and does 
therefore not necessarily represent an autoaggressive infiltration in the Wistar rat. A 
possible explanation for the attraction of the dendritic cells into the thyroid is an 
increased release of antigenic degradation products from the metabolically highly 
active thyrocytes induced by the iodine deficiency. These degradation products 
could act as chemotactic and phlogistic agents for macrophages and dendritic cells 
resulting in their enhanced accumulation. Interestingly, the dendritic cell infiltration in 
the iodine-deficient Wistar rats was followed by the production of anti-colloid 
antibodies and an increased intrathyroidal infiltration with T cells. There are 
indications that these immune phenomena might also be involved in the regulation 
of the hyperfunctioning thyroid tissue. A "physiological" role of Tg autoantibodies in 
the clearance of waste Tg in situations of overproduction of this thyroidal product 
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has been described as early as 1959 by Grabar et al64. Furthermore, high titres 
of monoclonal anti-Tg antibodies have been reported to result in mice in the 
hypofunction of thyroid glands without inflammatory leukocyte inflammation65. 
Cytokines produced by thyroid infiltrating T cells (such as IFN-y) are known to be 




CLINICAL RECOMMENDATIONS BASED ON THE EXPERIMENTS 
DESCRIBED IN THIS THESIS 
The studies described in this thesis again clearly establish that for optimal 
thyroid function and growth every individual should strive for an optimal daily 
dietary iodine intake, in other words should not use too much or too little iodine 
intake. This optimal daily iodine intake can be assessed considering that the daily 
human thyroidal thyroid hormone production is around 120 nmol T 4 and around 10 
nmol T3 
67
. To produce this amount of thyroid hormones, 4 x 120 + 3 x 10 = 
510 nmol iodide is needed, which means an intake of around 60-70 pg of iodide 
per day. The amount of iodide necessary for normal thyroid hormone production 
without using the buffer capacity of the thyroid and preventing goitre formation can 
be estimated as follows: under normal circumstances the thyroid clears 1/3 of the 
anorganic iodide in the blood68 (the daily iodine intake must therefore be around 
3 x 60 = 180 pg); around 10-20 pg of iodide is daily excreted in the faeces as 
thyroid hormone or thyroid hormone metabolites (the daily iodine intake must 
therefore be 180 + 10 = 190 pg). However, around 50 pg of iodide can be reused 
after proteolytic degradation of iodinated Tg and MIT and DIT residues during 
thyroid hormone secretion (see figure 1 General Introduction, page 12). The 
estimated daily iodine intake is thus 190 - 50 = 140 pg of iodide. The mandatory 
daily iodine intake given by the World Health Organization (WHO) is at least 150 pg 
for adults and adolescents, 175 pg for pregnant women and 200 pg of iodide for 
nursing women. 
An iodine intake below this level will result in goitre formation, sometimes 
hypothyroidism, and in the development of all sorts of thyroid autoimmune 
phenomena such as thyroid growth blocking antibodies2•3•4 , thyroid growth 
promoting antibodies6•7 , intrathyroidal accumulations of dendritic cells 1 and higher 
incidences of anti-Tg antibodies5. However, these autoimmune phenomena may 
not be necessarily harmful. During pregnancy a low iodine intake may lead to 
retarded brain and bone development of the fetus and cretinism can be the result. 
Our data, however, indicate that some individuals will be able to cope with some 
aspects of the low dietary iodine intake (the autoimmune-prone individuals?) such 
as the hypothyroidism at the expence of large goitre formation. 
An iodine intake above the recommended level bears the risk to induce an 
acceleration of thyroid autoimmune phenomena in some individuals (the 
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autoimmune-prone individuals who are able to cope with moderately low iodine 
diets?). However. since the individual reaction patterns cannot yet be predicted, the 
best is to strive for a general optimal iodine intake of 150 pg per day. 
Our data are also of relevance when treating individuals with iodine in a fall-out 
zone after a nuclear explosion or when treating endemic goitre patients with iodine. 
A single high iodine dose is often administered to these populations through iodine 
tablets or iodine injections, thereby saturating the thyroid with iodine Qn the case of 
the fall-out to prevent a thyroidal accumulation of radioactive iodine). 
Extrapolating our animal data and other literature data to these situations it is 
not surprising that some individuals will develop thyrocyte destruction and transient 
forms of thyroid autoimmunity, while others will even have more permanent forms 
of thyroid autoimmune reactivity (the "autoimmune prone" individuals?). However, 
one may argue that such thyroid damage caused by a transient or permanent 
thyroid autoimmune reaction elicited by the high iodine gift is preferable to late 
damage (tumour growth) caused by the radioactive iodine accumulating in the 
thyroid during a nuclear fall-out when iodine tablets are not taken. It is clear that in 
the case of iodine deficient endemic goitre one has to take special precautions to 
minimize the damage infiicted by reintroducing iodine. It is advisable to start with a 
relatively small iodine supplementation in the beginning, followed by a gradual 
increase of the daily iodide dose. Ideally it would be an advantage to be able to 
indicate those individuals that will react with a permanent thyroid autoimmune 
response (the "autoimmune-prone ones") before reintroducing the iodine in the diet. 
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Chapter 1: General introduction 
Iodine is an essential trace element and part of the thyroid hormones. The thyroid 
function, the thyroid hormone production and the metabolism of iodine are hence 
highly interconnected. 
Thyroid Stimulating Hormone (TSH or thyrotropin) is an important regulator of the 
synthesis and release of the thyroid hormones T 3 and T 4 . TSH is secreted by the 
thyrotrophic cells of the anterior pituitary gland. The synthesis ofTSH by these pituitary 
cells is regulated by Thyrotropin Releasing Hormone (TRH), synthesized in the 
hypothalamus. Negative feedback loops exist, via which the T 3 and T 4 concentrations 
in the circulation regulate the synthesis and secretion of both TSH and TRH. 
Regulation of thyroid hormone synthesis and release by dietary iodine 
An excessive dietary iodine intake 
Besides the regulation byTSH, an autoregulation of the thyroid exists, particularly 
in respect to the dietary iodine intake. An acute, prominent increase of the dietary 
iodine intake results in an acute but transient decrease of the iodide transport 
mechanism over the thyrocyte membrane and hence in a decrease in the iodination 
of thyroglobulin (Tg, the main storage protein of iodine in the thyroid and the matrix 
for thyroid hormone synthesis). This leads to a decreased iodothyronine formation and 
thyroid hormone secretion. This phenomenon is known as the Wolff-Chaikoff effect. 
When the high levels of plasma iodide are maintained, the inhibitory effects of iodide 
disappears and iodothyronine formation is restored (the so-called "escape from the 
Wolff-Chaikoff effect"). The precise mechanisms causing this escape are still unknown. 
The long term effects of a chronically excessive dietary iodine intake are largely 
unknown. Clear abnormalities of thyroid function have not been observed in the 
majority of normal individuals receiving high dosages of iodine over longer periods, 
subtle changes do, however, occur. A small, significant decrease in the serum 
concentrations ofT 4 and T 3 with a small rise in serum TSH have been observed, but 




A deficient dietary iodine intake 
During iodine deficiency, the degree of iodination of the Tg molecule is lower, 
which leads to more MIT than DIT residues in the Tg molecule and thus to the 
production of more T3 than T4 . In this way an enhanced synthesis of the biological 
active T 3 at the expense of the production of the prohormone T 4 occurs, thereby 
allowing an efficient usage of the small amounts of iodine available with an optimal 
biological potency per Tg molecule. This compensatory mechanism of the thyroid is 
thought to be able to maintain euthyroidism during relatively mild iodine deficiency. 
Only during more severe forms of iodine deficiency these mechanisms will fail and 
hypothyroidism will be the result. Since thyroid hormones are essential for brain 
development of the fetus, iodine deficiency during pregnancy can lead to impaired 
brain development resulting in mental retardation and cretinism. 
The role of iodine in thyroid autoimmunity 
Besides having an effect on thyroid hormone synthesis and release, there are 
strong indications that abnormalities in the dietary iodine intake influence thyroid 
autoimmune responses. 
Iodine deficiency in human populations has been described to lead to: 
a. a higher incidence of anti-thyroglobulin (fg) antibodies, 
b. the generation of antibodies that affect the growth of thyrocytes in vitro (the so-
called TGAbs) in individuals characterized by disturbances in thyroid growth 
(endemic goitre, thyroid atrophy) in such iodine-deficient regions and 
c. the presence of aggregates of lymphoid cells (epithelioid cells and dendritic cells) 
in endemic goitres. 
An excessive dietary iodine intake has also been described to lead to thyroid 
autoimmune reactivity: 
a. In individuals with a preexisting thyroid abnormality, such as an iodine deficient 
goitre, an excessive dietary iodine intake results in a proportion of the individuals 
in the development of an attack of thyroiditis; those affected by the thyroiditis 
show anti-Tg and anti-microsomal antibodies in their serum, and 
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b. In animals that spontaneously develop thyroid autoimmune disease, such as the 
Cornell C Strain of chicken, the Obese Strain of chicken and the BB rat, a high 
dietary iodine intake results in an increase in the incidence and severity of the 
thyroiditis. 
The existence of a certain degree of immune autoreactivity towards thyroid cells 
and other body components is nowadays considered to be normal in healthy 
individuals. This autoreactivity is controlled by various suppressor mechanisms 
(deletion of the majority of autoreactive T cells in the thymus, the existence of 
regulatory circuits of T and B lymphocytes, T cell and B cell anergy). Malfunction of 
these suppressor mechanisms, an otherwise hyperreactive immune system, target 
organ (thyroid) abnormalities (such as a higher iodine metabolism, resulting in a higher 
release of antigenic degradation products) and target organ susceptibilities to an 
autoimmune attack are thought to be factors disturbing the delicate mechanisms 
controlling the low levels of normal autoreactivity. 
Outline of the thesis 
The mechanisms underlying the thyroid autoimmune phenomena induced by an 
excessive or iodine deficient dietary intake are only partly understood. This thesis is 
particularly meant to study the relationship between the dietary iodine intake, the 
metabolism and growth of thyrocytes and the thyroid autoimmune response in vivo 
and in vitro. 
Chapter 2.1: Iodine deficiency induces thyroid autoimmune reactivity in wistar 
rats 
The effects of iodine deficiency on thyroid performance and thyroid autoimmune 
reactivity in normal Wistar rats are described in Chapter 2.1. 
Moderate and severe iodine deficiency led to goitre development, hypothyroidism 
and an increased thyroid autoimmune reactivity: higher numbers of intrathyroidal 
dendritic cells, clusters of these cells, higher numbers of intrathyroidal CD4 + and 
cos+ cells and a higher incidence of anti-colloid antibodies in the serum of the 
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animals were observed. 
Chapter 2.2: Thyroid growth stimulating activity in ammonium sulphate 
precipitates of the serum of Wistar rats kept on a low dietary iodine regimen. A 
preliminary report 
The thyroid growth stimulating activity of ammonium sulphate precipitates of the 
iodine-deficient Wistar rat sera is described in Chapter 2.2. Sera of moderate and 
severe iodine deficient rats showed thyroid growth stimulating activity, in contrast to 
the sera of normal rats or rats with a high dietary iodine intake. Whether this growth 
stimulating activity is caused by an immunoglobulin and not by other growth factors 
(such as EGF and IGF) present in the ammonium sulphate precipitates, is presently 
under investigation. 
Conclusion: iodine deficiency leads to thyroid autoimmune reactivity in normal 
Wistar rats. 
Chapter 3.1: Thyroid autoimmune prone BB rats are capable of compensating 
for moderately low iodine regimens, restoring full euthyroidism 
The effect of a moderate low iodine diet on thyroid performance in the 
autoimmune-prone BB rat as compared to the normal Wistar rat is described in 
Chapter 3.1. Moderately iodine deficient Wistar rats gradually developed goitres, 
reaching their maximal weight (27 mg) after 12 weeks of diet. The Wistar rats became 
subclinically hypothyroid after 18 weeks of diet (decreased serum T3 and T4 and 
increased serum TSH levels). The moderately iodine deficient BB rats, on the other 
hand, developed more rapidly goitres, reaching maximal weights (31 mg) after 6 weeks 
of diet. The BB rats showed a transient period of hypothyroidism (during the first 9 
weeks of diet). Full euthyroidism was restored after 12 weeks of diet. Conclusion: the 
autoimmune-prone BB rat is better capable of compensating for a moderately low 
dietary iodine intake as compared to the Wistar rat. It is likely that the autoimmune 
background of the animal is linked to this capability (target organ abnormalities, such 
as a higher iodine metabolism, a higher thyrocyte proliferation rate or TGAbs). 
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Chapter 3.2: BB rat thyrocytes show a high proliferation rate in vitro. A 
preliminary report 
In Chapter 3.2 the basal proliferation rate and the proliferation rate in response to 
TSH of BB rat thyroid follicles and Wistar rat thyroid follicles are described. BB rat 
thyroid follicles cultured in vitro showed a higher proliferation rate and a higher 
response to TSH in comparison to Wistar rat thyroid follicles. This phenomenon (that 
might be an inborn phenomenon of the BB rat thyrocytes, or induced by TGAbs) may 
explain the rapid goitre development of BB rats during moderate iodine deficiency and 
the capability to compensate for this moderate iodine deficiency (described in Chapter 
3.1). Further investigations are necessary the confirm and clarify these preliminary 
experiments. 
Chapter 4: A high iodine intake in Wistar rats results in the development of a 
thyroid-associated ectopic thymic tissue and is accompanied by a low thyroid 
autoimmune reactivity 
The effect of a high dietary iodine intake on thyroid performance and thyroid 
autoimmune reactivity in normal Wistar rats is described in Chapter 4. 
The high dietary iodine intake had no effect on thyroid performance: the animals 
did not develop a goitre and remained euthyroid. Remarkable was in 50-57% of these 
animals the occurrence of a thyroid-associated ectopic thymic tissue during the first 
6 weeks of the experiments. Concomitant with this ectopic thymic tissue was the low 
level of thyroid autoimmune reactivity in animals with a high dietary iodine intake: lower 
numbers of intrathyroidal CD4 + and CDS+ cells and a lower incidence of anti-colloid 
antibodies were found in comparison to Wistar rats on a normal or iodine deficient 
diet It is suggested that this ectopic thymic tissue is involved in the low thyroid 
autoimmune reactivity via mechanisms of thymus related tolerance induction. 
Chapter 5: An excess of dietary iodine accelerates the development of a thyroid-
associated lymphoid tissue in autoimmune-prone BB rats 
In Chapter 5 the effects of a high dietary iodine intake in the autoimmune-prone 
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BB rat on thyroid performance and thyroid autoimmune reactivity are described. 
The high dietary iodine intake lacked - as in the normal Wistar rat - an effect on 
thyroid performance. The effect of the excessive dietary iodine intake on thyroid 
autoimmune reactivity was however remarkable and completely different from that in 
the normal Wistar rat (described in Chapter 4). The high iodine intake led to an 
acceleration of the development of lymphoid cell infiltrates in the thyroid, that normally 
arise in our BB rat colony at the age of 21 weeks and older (these infiltrates could be 
observed from 15 weeks of age onwards). Chapter 5 gives a detailed description of 
the histology of these lymphoid infiltrates. In fact they consisted of T cell areas with 
interdigitating cells and B cell areas, showing the organized structure of the lymphoid 
cell infiltrates, comparable to the lymphoid structures seen in mucosas such as the gut 
mucosa (mucosa-associated lymphoid tissue, MALT). At the edges of the lymphoid 
tissue in the thyroid of the BB rats on an excessive iodine diet, minor signs of 
destruction were observed, in which area macrophage-like cells were found. The 
presence of this thyroid-associated lymphoid tissue (TAL T) was correlated with the 
presence of anti-colloid antibodies in the serum. It is speculated that the TALT is 
involved in the production of these antibodies and in the continuation of the thyroid 
autoimmune reactivity. 
Chapter 6: The effect of thyroid hormones and other iodinated compounds on 
the transition of monocytes into veiled/dendritic cells, a role of GM-CSF, TN Fa 
and IL-6 
The effect of the thyroid hormones T 3 and T 4 and a few other iodinated 
"hormonally inactive" compounds, such as rT 3, metrizamide and iodinated Tg, on the 
maturation of human peripheral blood monocytes into functionally active dendritic cells 
is described in Chapter 6. 
A pretreatment of blood monocytes for 30 minutes with the thyroid hormones, and 
in particular with the active thyroid hormone T 3, enhances the capability of the 
monocytes to mature into immunocytologically typical and immunologically active 
(MLR) veiled or dendritic cells, when further cultured overnight under nonadhering 
conditions. The dendritic cell maturation during the culture was dependent on the 
endogenous production of various cytokines, since a-GM-CSF, a-TNFa and a-IL-6 had 
blocking effects on the transition. Since there is no increased cytokine production 
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induced by T 3, the bioactive thyroid hormone T 3 probably excerts its effects via 
binding to the nuclear T 3 receptor at the cytokine receptor level (up regulation 
receptor expression) or expression at the post cytokine receptor level. 
The iodinated compounds metrizamide, rT 3 and iodinated Tg were also capable 
to enhance the monocyte to veiled/dendritic cell transition, but to a lesser extent than 
T 3. A possible mechanism involved in the enhanced monocyte to dendritic cell 
transition induced by these hormonally inactive iodinated compounds is an interaction 
of the iodinated compounds with the H20 2 generating system of the monocytes. In 
what way such interaction leads to a higher expression of cytokine receptors or have 
effects at the post cytokine receptor level is completely unknown. Since dendritic cells 
play a crucial role in the initiation of thyroid autoimmune responses and since a high 
iodine diet (viz highly iodinated Tg) accelerates the development of the thyroid 
autoimmune reaction (fALT, see before) in the BB rat, it is speculated that an 
enhanced iodine-induced monocyte-veiled/dendritic cell transition may play at least an 
additional role in such an accelerated development. 
Chapter 7: Conclusions and general discussion 
In Chapter 7 general conclusions as well as some critical remarks on the studies 
are given. The experiments described in this thesis show that the dietary iodine intake 
has clear effects on thyroid autoimmune reactivity. Both stimulation as well as 
suppression of thyroid autoimmune reactions have been observed, depending on the 
diet (chronic too low or too high) and the genetically determined susceptibility of the 
animal for thyroid autoimmune disease. Together with data from the literature it is clear 
that the dietary iodine intake must hence be considered as a modulator of thyroid 
autoimmune reactivity. Other factors such as genetically determined disturbances in 
the regulation of immune responses, intrinsic thyroid metabolic abnormalities (such as 
an intrinsic higher iodine uptake and metabolism, maybe resulting in a higher release 
of antigenic degradation products) and an abnormal susceptibility of thyrocytes to an 
autoimmune attack are probably of major importance. 
The possible mechanisms by which the dietary iodine modulates thyroid autoimmune 
reactivity are: 
a. an increased immunogenicity of highly iodinated thyroglobulin, 
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b. direct stimulating effects of iodine on cells of the immune system and 
c. stimulation of the immune system via an increased release of degradation 
products of the thyrocytes during iodine deficiency. 
The data in this thesis again highlight the notion that a daily optimal intake of 
iodine (around 150pg) will preserve optimal thyroid performance in a given population. 
The data in this thesis however do also show that individual differences (depending 
on the genetic background and susceptibility to thyroid autoimmune disease) can be 
expected in response to a given dietary iodine regimen. 
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Hoofdstuk 1: Algemene introduktie 
Jodium is een essentieel sporeelement en maakt deel uit van de schildklier 
hormonen T 3 en T 4 . De schildklier funktie, de schildklier hormoon produktie en 
jodium metabolisms zijn daarom sterk met elkaar verbonden. 
De synthase en afgifte van de schildklier hormonen wordt gereguleerd door 
"Thyroid Stimulating Hormone" (TSH of thyrotropine). TSH wordt uitgescheiden 
door de thyrotrofe cellen in de hypofyse. De synthese van TSH door deze hypofyse 
cellen wordt gereguleerd door "Thyrotropin Releasing Hormone" (TRH), 
gesynthetiseerd door de hypothalamus. De concentraties van de schildklier hormo-
nen T 3 en T 4 in de circulatie reguleren de synthase en secretie van zowel TRH als 
TSH via negatieve terugkoppelings mechanismen. 
Regulatie van schildklier hormoon synthese en secretie door jodium 
Een te hoge jodium inname 
Naast de regulatie door TSH bestaat er een autoregulatie van de schildklier met 
betrekking tot de jodium inname. Een acute overmaat aan jodium leidt tot een 
acute maar tijdelijke afname van het jodide transport mechanisms over de 
schildklier celmembraan en dus in een afname van de jodering van thyreoglobuline 
(Tg, het belangrijkste opslag eiwit van jodium in de schildklier en de matrix voor 
schildklier hormoon synthase). Dit leidt tot een afname van de vorming van 
jodothyronines en dus een afname van de synthese en secretie van schildklier 
hormoon. Dit fenomeen is bekend als het Wolff-Chaikoff effect. Wanneer de plasma 
jodide concentratie hoog blijft, verdwijnen de remmende effecten van het jodium en 
de schildklier hormoon synthese is genormaliseerd (ontsnappen aan het Wolff-
Chaikoff effect). De mechanismen die leiden tot deze "ontsnapping" zijn nog niet 
bekend. 
De effecten op lange termijn van een chronische overmaat aan jodium zijn nog 
voor een groot gedeelte onduidelijk. Ernstige abnormaliteiten van de schildklier 
funktie zijn niet waargenomen in de meeste individuen die hoge doseringen jodium 
gedurende een langere periode binnenkrijgen. Geringe veranderingen komen 
echter voor. Een Iichte daling van de serum T 3 en T 4 concentraties met een 
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geringe stijging van de TSH spiegel zijn waargenomen, hoewel deze veranderingen 
meestal binnen de grenzen van de normaal waarden vallen. 
Een te !age jodium in name 
Tijdens jodium deficientie is er een lagere jodering van het thyreobloguline (Tg) 
molekuul, wat leidt tot de vorming van meer MIT dan DIT residuen en dus tot de 
produktie van meer T 3 dan T 4 . Op deze manier wordt een optimaal gebruik 
gemaakt van het beperkte aanbod van jodium en een verhoogde produktie van het 
aktieve schildklier hormoon T3 ten koste van het inaktieve schildklierhormoon T4 
vindt plaats. Gedurende relatieve milde jodium deficientie zal op deze manier 
euthyreoidie gehandhaafd blijven, echter tijdens ernstige jodiumdeficientie zal de 
compensatie niet voldoende zijn en is hypothyreoidie het gevolg. 
Daar schildklier hormoon essentieel is voor de ontwikkeling van de hersenen 
van de foetus, kan hypothyreoidie tijdens de zwangerschap leiden tot een slechte 
hersen ontwikkeling en mentale redardatie en cretinisme zijn het gevolg. 
De rol van jodium in schildklier autoimmuniteit 
Een tekort of een overmaat aan jodium belnvloeden niet aileen de funktie van 
de schildklier, schildklier hormoon synthese en secretie, er zijn ook sterke 
aanwijzingen dat jodium effecten heel! op schildklier autoimmuun responsen. 
Het is beschreven dat een tekort aan jodium in humane populaties leidt tot: 
a. een hogere incidentie van anti-Tg antilichamen, 
b. de ontwikkeling van antilichamen die de groei van thyreocyten in vitro be"invloe-
den {de zogenaamde schildklier groeistimulerende immuunglobulinen), in 
individuen gekarakteriseerd door afwijkingen in schildkliergroei (endemisch 
struma en schildklier atrofie) en 
c. de aanwezigheid van aggregaten van lymfolde cellen (epithelo"ide cellen en 
dendritische cellen) in endemisch struma's. 
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Het is ook beschreven dat een overmaat aan jodium leidt tot schildklier 
autoimmuun reaktiviteit: 
a. In een deel van individuen met een schildklier abnormaliteit, zoals een jodium 
deficient struma, leidt een te hoge jodium inname tot een aanval van 
thyreoiditis. De patienten vertonen anti-Tg en anti-TPO antilichamen in de 
circulatie. 
b. Een te hoge jodium inname in diermodellen die spontaan schildklier 
autoimmuun ziekten ontwikkelen, zoals de Obese Strain (OS) van de kip en de 
BB rat, leidt tot een toename van de incidentie en een verergering van de 
thyreoiditis. 
Een geringe mate van autoimmuunreaktiviteit gericht tegen schildklier cellen en 
andere lichaamseigen componenten in gezonde individuen wordt tegenwoordig als 
normaal beschouwd. Deze geringe autoreaktiviteit wordt normaal gesproken 
gecontroleerd door verscheidene suppressor mechanismen (deletie van de meeste 
autoreaktieve T cellen in de thymus, regulatie door netwerken van T en B 
lymfocyten, T eel en B eel anergie). Wanneer deze suppressor mechanismen niet 
goed funktioneren, het immuunsysteem daardoor hyperaktief is of wanneer het 
doelwit orgaan (in dit geval de schildklier) zelf niet goed funktioneert (verhoogde 
jodium metabolisms wat mogelijk leidt tot een hogere expressie en uitscheiding van 
autoantigenen) of overgevoelig is voor de autoimmuun reaktiviteit, worden de 
mechanismen die de autoreaktiviteit normaliter controleren verstoord. De schildklier 
autoimmuun reaktiviteit kan dan uiteindelijk leiden tot schildklier autoimmuun ziekte. 
Doe/ van het onderzoek 
De mechanismen die ten grondslag liggen aan de schildklier autoimmuun 
fenomenen ge'induceerd door een te hoge of een te lage jodium inname zijn nog 
niet geheel duidelijk. 
Dit onderzoek houdt zich bezig met de verdere bestudering van de relatie 
tussen jodium inname, het metabolisme en de groei van de schildklier cellen en de 
schildklier autoimmuun respons in vivo en in vitro. 
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Hoofdstuk 2.1: Jodium deficientie induceert schildklier autoimmuun 
reaktiviteit in de Wistar rat 
In hoofdstuk 2.1 wordt het effect van jodium deficientie op schildklier groei en 
funktie en op schildklier autoimmuun reaktiviteit beschreven in de normale Wistar 
rat. Milde en extreme jodium deficientie leidde tot een struma vorming, 
hypothyreoidie en tot schildklier autoimmuun reaktiviteit: een verhoogd aantal 
intrathyreoidale dendritische cellen, clusters van deze cellen, een verhoogd aantal 
intrathyreoidale CD4 + en CDS+ cell en en een verhoogde incidentie van anti-collo'id 
antistoffen in het serum van de dieren werd waargenomen. 
Hoofdstuk 2.2: Schildkliergroei stimulerend vermogen van ammonium sulfaat 
precipitaten van het serum van Wistar ratten met een lage jodium inname. 
Een preliminaire studie 
Het schildkliergroei stimulerend vermogen van ammonium sulfaat precipitaten 
van de jodium deficiente Wistar ratte sera wordt in hoofdstuk 2.2. beschreven. De 
sera van milde en extreem jodium deficients ratten vertoonden schildkliergroei 
stimulerende aktiviteit, die van ratten met een normale of een hoge jodiuminname 
niet of nauwelijks. Of deze groei stimulerende aktiviteit oak veroorzaakt wordt door 
een immuunglobuline en niet door andere groeifaktoren (zoals EGF of IGF), 
aanwezig in de ammonium sulfaat precipitaten, wordt op het ogenblik bestudeerd. 
Conclusie: jodium deficientie leidt tot schildklier autoimmuun reaktiviteit in 
normale Wistar ratten. 
Hoofdstuk 3.1: Schildklier autoimmune BB ratten zijn in staat mil de jodium 
deficientie te compenseren, waardoor euthyreoidie volledig wordt hersteld 
Het effect van een milde jodium deficientie op de schildklier funktie van de 
autoimmune BB rat in vergelijking tot de Wistar rat wordt beschreven in hoofdstuk 
3.1. Milde jodium deficients Wistar ratten ontwikkelden geleidelijk struma's die hun 
maximale gewicht (27 mg) na 12 weken bereikten. De Wistar ratten werden 
uiteindelijk (na 18 weken dieet) subklinisch hypothyreoot (verlaagde serum T 4 en 
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T3 en een verhoogde TSH spiegel). De milde jodium deficients BB ratten 
daarentegen ontwikkelden snel struma's, die hun maximale gewicht (31 mg) na 6 
weken bereikten. De BB ratten vertoonden een tijdelijke periode van hypothyreoidie 
(gedurende de eerste 9 weken van het experiment). De euthyreote status was na 
12 weken dieet volledig hersteld. Conclusie: de autoimmune BB rat is beter in staat 
de milde jodium defrcientie te compenseren in vergelijking tot de Wistar rat. 
Waarschijnlijk heeft de autoimmune achtergrond van de BB rat (een intrinsiek hoger 
jodium metabolisms, een snellere groei van de schildklier cellen of schildklier groei 
stimulerende immuunglobulinen) te maken met de mogelijkheid te kunnen 
compenseren voor milde jodium defrcientie. 
Hoofdstuk 3.2: BB ratte thyrocyten vertonen een hoge proliferatie in vitro. Een 
preliminaire studie 
In hoofdstuk 3.2 wordt de basale proliferatie en de proliferatieve respons op 
TSH van BB ratte schildklier follikels en Wistar ratte schildklier follikels beschreven. 
BB ratte schildklier foliikels gekweekt in vitro, hadden een hogere basale proliferatie 
en een hogere proliferatieve respons op TSH dan Wistar ratte schildklier follikels. 
Dit fenomeen (dat een aangeboren fenomeen van de BB schildkliercellen zou 
kunnen zijn of geinduceerd door schildklier groei stimulerende antistoffen) zou de 
snelle struma vorming van de BB rat tijdens milde jodium deficientie en de 
mogelijkheid om deze milde jodium defrcientie te compenseren (beschreven in 
hoofdstuk 3.1) kunnen verklaren. Verder onderzoek is echter nodig om deze 
preliminaire gegevens te verifieren en te verhelderen. 
Hoofdstuk 4: Een hoge jodium inname in de Wistar rat leidt tot de 
ontwikkeling van een schildklier-geassocieerd ectopisch thymus weefsel, 
vergezeld van een !age schildklier autoimmuun reaktiviteit 
Het effect van een chronisch te hoge jodium inname op de schildklier funktie 
en op de schildklier autoimmuun reaktiviteit in normale Wistar ratten wordt 
beschreven in hoofdstuk 4. Een chronisch te hoge jodium inname had geen effect 
op de schildklier funktie: de dieren bleven euthyreoot en er was geen struma 
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ontwikkeling. Opvallend was in 50-57% van deze dieren de aanwezigheid van een 
schildklier-geassocieerd ectopisch thymus weefsel gedurende de eerste 6 weken 
van het experiment. Dit ectopisch thymus weefsel was vergezeld van een !age 
schildklier autoimmuun reaktiviteit: een Iegere incidentie van anti-colloid antistoffen 
en een lager aantal intrathyreoidale CD4 + en CDS+ cell en werd waargenomen in 
vergelijking tot normale en milde jodium deficients Wister ratten. Er wordt 
gesuggereerd dat dit ectopisch thymus weefsel betrokken zou kunnen zijn bij de 
waargenomen !age schildklier autoimmuun reaktiviteit via thymus gerelateerde 
tolerantie inductie. 
Hoofdstul< 5: Een te hoge jodium inname versnelt de ontwikkeling van een 
schildklier-geassocieerd lymfciid weefsel in de autoimmune BB rat 
In hoofdstuk 5 wordt het effect van een chronisch te hoge jodium inname op 
de schildklier funktie en schildklier autoimmuun reaktiviteit in de autoimmune BB rat 
beschreven. Net als in de Wister rat had een chronisch te hoge jodium inname in 
de BB rat geen effect op de schildklier funktie. De BB ratten bleven euthyreoot en 
hadden een normaal schildklier gewicht. Het effect van een hoge jodium inname op 
de schildklier autoimmuun reaktiviteit was in de autoimmune BB rat daarentegen 
aanzienlijk en compleat verschillend van dat in de normale Wister rat (beschreven in 
hoofdstuk 4). Een chronisch te hoge jodium inname leidde tot een versnelling van 
de ontwikkeling van lymfoide celinfiltraten in de schildklier, die normaal op een 
leeftijd van 21 weken of ouder in onze BB ratte stam voorkomen (nu werden deze 
infiltraten op een leeftijd van 15-21 weken waargenomen). In hoofdstuk 5 wordt een 
nauwkeurige en gedetailleerde beschrijving van de histologische opbouw van de 
lymfoide celinfiltraten gegeven. Ze bestonden uit T eel gebieden met 
interdigiterende cellen en B eel gebieden, wat de georganiseerde opbouw van de 
lymfoiae infiltraten weergeeft, vergel~kbaar met lymfo'ide strukturen in de slijmvliezen 
van bijvoorbeeld de darm ("mucosa-associated lymphoid tissue, MALT''). Aan de 
randen van het lymfoi'de weefsel in de schildklieren van de BB rattan met een te 
hoge jodium inname werd geringe destructie van schildklier follikels waargenomen. 
Hier werden macrofaag achtige cellen gevonden. De aanwezigheid van het 
schildklier-geassocieerde lymfoide weefsel ("thyroid-associated lymphoid tissue, 
TAL T') was gecorreleerd aan de aanwezigheid van anti-colloi'd antistoffen in het 
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serum van de ratten. TALT zou een rei kunnen spelen in de produktie van deze 
antilichamen en in de continuatie van de schildklier autoimuun reaktiviteit. 
Hoofdstuk 6: Het effect van schildklier hormonen en andere gejodeerde 
stoffen op de uitrijping van monocyten tot sluier of dendritische cellen. Een 
ro! voor GM-CSF, TIIIFa en !l-6 
Het effect van de schildklier hormonen T 3 en T 4 en een aantal andere 
gejodeerde, hormonaal inaktieve stoffen (zeals rT 3, gejodeerd thyreoglobuline en 
metrizamide) op de uitrijping van perilere bleed monocyten tot funktionele 
dendritische cellen wordt beschreven in hoofdstuk 6. Een voorbehandeling van 
bleed monocyten met de schildklier hormonen, voornamelijk het bioaktieve T 3, 
verhogen de mogelijkheid van monocyten uit te rijpen tot immunocytologisch 
typische en immunologisch aktieve Qn de MLR) dendritische cellen. De uitrijping is 
waarschijnlijk alhankelijk van verscheidene cytokinen, omdat a-GM-CSF, a-TNFa en 
a-IL-6 blokkerende effecten hadden. Omdat er geen verhoogde cytokine produktie 
wordt gelnduceerd door T 3, heeft het bioaktieve schildklier hormoon T 3 
waarschijnlijk, via binding aan de T 3 kernreceptor, effecten op de cytokine receptor 
expressie (op regulatie) of effecten op het post cytokine receptor nivo. 
De gejodeerde stoffen metrizamide, rT 3 en gejodeerd Tg waren oak in staat de 
uitrijping van monocyten tot dendritische cellen te verhogen, echter in mindere 
mate dan T 3. Een mogelijk mechanisme dat een rei zouden kunnen spelen bij de 
verhOogde monocyt uitrijping ge·induceerd door de hormonaal inaktieve gejodeerde 
stoffen is een interaktie van de gejodeerde stoffen met het H20 2 systeem van de 
monocyt. Hoe dergelijke interakties zouden kunnen leiden tot een hogere expressie 
van de cytokine receptoren of effecten kunnen hebben op het post cytokine 
receptor nivo, is geheel onbekend. 
Daar dendritische cellen een cruciale rei spelen bij de initiatie van schildklier 
autoimmuun responsen en omdat een te hoge jodium inname (leidend tot een 
hoog gejodeerd Tg molekuul) de ontwikkeling van de schildklier autoimmuun 
reaktie (fALT, zie eerder) in de 66 rat versnelt, zou een verhoogde uitrijping van 
monocyten tot dendritische cellen onder invloed van gejodeerde stoffen en 
schildklier hormonen een rei kunnen spelen bij deze versnelde ontwikkeling van 
schildklier autoimmuun reaktiviteit. 
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Hoofdstuk 7: Conclusies en algemene discussie 
In hoofdstuk 7 worden conclusies van de studies met enige kritische 
kanttekeningen gegeven. De experimenten beschreven in dit proefschrift Iaten zien 
dat de jodium inname duidelijke effecten op de schildklier autoimmuun reaktiviteit 
heeft. Zowel stimulatie als onderdrukking van schildklier autoimmuun reakties is 
waargenomen, afhankelijk van de jodium inname (chronisch te veel of te weinig) en 
de genetisch bepaalde gevoeligheid van de dieren voor schildklier autoimmuun 
ziekte. Samen met literatuur gegevens wordt het duidelijk dat de jodium inname via 
het dieet beschouwd moet worden als een modulator van schildklier autoimmuun 
reaktiviteit. Andere faktoren, zoals genetisch bepaalde afwijkingen in de regulatie 
van immuun responsen, intrinsieke metabolische schildklier afwijkingen (zoals een 
hogere jodium opname en metabolisms waardoor mogelijk een hogere uitscheiding 
van antigene afval stoffen plaats vindt) en een abnormale gevoeligheid van de 
schildklier cellen voor een autoimmologische aanval spelen waarschijnlijk een veel 
belangrijkere rol in de ontwikkeling van schildklier autoimmuun reaktiviteit. 
De mogelijke mechanismen via welke jodium de schildklier autoimmuun reaktiviteit 
kan moduleren zijn: 
a. een verhoogde immunogeniciteit van hoog gejodeerd Tg, 
b. direkt stimulerende effecten van jodium op cellen van het immuun systeem en 
c. stimulatie van het immuunsysteem via een verhoogde uitscheiding van afval 
produkten van schildklier cellen tijdens jodium deficientie. 
De data in dit proefschrift benadrukken nog eens dat een dagelijkse optimale 
jodium inname (ongeveer 150 pg) de optimale schildklier funktie in een gegeven 
populatie handhaaft. Echter, individueel verschillende reakties op een bepaalde 
jodium inname (afhankelijk van de genetische achtergrond en gevoeligheid voor 
























































Antibody-Dependent Cell-mediated Cytotoxicity 
Adenosin Triphosphate 
Bio Breeding 






Epidermal Growth Factor 
Enriched Iodine Diet 
Foetal Calf Serum 




Insulin-like Growth Factor 
Immunoglobulin G 
Indirect Immune Fluorecense 
lnterleukin-1 
Inositol 1,4,5-triphosphate 
Moderate Low Iodine Diet 
Extreme Low Iodine Diet 
Macrophage Colony Stimulating Factor 
Major Histocompatibility Complex 
Methimazole 
Myelo Peroxidase 
Normal Iodine Diet ( = COD) 
Obese Strain 







Thyroid-Associated Lymhoid Tissue 
Thyroxin Binding Globulin 
Thyrotropin-Binding Inhibitory Immunoglobulin 
Thyroxin Binding Prealbumin 
T cytotoxic cell 
Thyroglobulin 
Thyroid Growth-stimulating Antibodies 
Thyroid Growth-stimulating Immunoglobulin 
T helper 1 cell 
T helper 2 cell 
Thyroid Peroxidase 
Thyrotropin Releasing Hormone 
Thyroid-stimulating Antibodies 
T suppressor eel! 
Thyroid Stimulating Hormone or Thyrotropin 
213 
DANKWOORD 
Dit boekje is tot stand gekomen door het werk van velen, die ik op deze plaats 
daarvoor wil bedanken. Daar gaat ie dan. 
Hemme, we moesten allebei in het begin aan de nieuwe constructie van AIO's 
OIO's en AGIO's wennen. Het onderzoek verliep dan oak niet geheel vlekkeloos, 
maar is vooral in het laatste jaar in een stroomversnelling geraakt, wat resulteerde 
in dit boekje. Tijdens het schrijven van de artikelen kwamen we er pas achter hoe 
het een en ander in elkaar greep. Je was altijd erg snel met het doorlezen van de 
artikelen en je opmerkingen en discussies over de artikelen heb ik als zeer 
stimulerend ervaren. lk heb er veel van geleerd, bedankt hiervoor. lk vind het leuk 
dat je hoogleraar bent geworden, zodat je mijn promotor kunt zijn. 
Rob, eind 1989 kwamen we met ons groepje vanuit Amsterdam naar 
Rotterdam en we zijn vanaf dat moment eigenlijk ons eigen gangetje gegaan. Je 
hebt je op de achtergrond gehouden, maar wist precies wat er gaande was. 
Tijdens werkbesprekingen was je altijd aanwezig en toonde je belangstelling voor 
ons onderzoek. Het manuscript heb je zeer punctueel doorgenomen en je 
opmerkingen stel ik erg op prijs. 
Andre, als kersverse 010 kwam ik met jou te werken op het schildklierproject 
aan de afdeling lmmunologiejPathologie van de Vrije Universiteit te Amsterdam. Jij 
had als analist al veel ervaring op dit gebied en ik wist nag van niks. Je nam dan 
oak in het begin vaak het initiatief en het onderzoek liep als een trein. De verhuizing 
naar Rotterdam heb je net niet meegemaakt omdat je koos voor een vaste baan. 
Een zeer begrijpelijke keuze, maar ik vond het heel jammer dat je wegging. lk heb 
met veel plezier met je samen gewerkt, het was een leuke tijd. 
Tevens wil ik op deze plaats aile collega's van de afdeling lmmunologie/ 
Pathologie van de VU bedanken voor de fijne werksfeer en de gezellige tijd die ik 
daar heb doorgebracht 
Aan het groepje van Hemmo van de afdeling lmmunologie aan de EUR ben ik 
het meest verschuldigd. 
Harm, in het begin hadden we wat tegenslagen te verwerken maar we hebben 
er ons tach aardig doorheen geslagen, dacht ik. We hebben heel wat uurtjes in de 
stal en achter de microscoop doorgebracht en je was altijd even behulpzaam en 
opgewekt. Zander jouw hulp had ik het nooit gered. Leuk dat je me als paranimf 
tijdens mijn promotie terzijde wilt staan. 
Peter, de korte tijd dat we samen hebben gewerkt verliep vlekkeloos. Je werkte 
zeer zelfstandig en wist veel data op korte termijn te produceren. Je was altijd in 
voor een geinije wat het erg gezellig maakte op het lab. 
Meeny, jij hebt nag even snel voor de laatste resultaten gezorgd, zodat 
hoofdstuk 6 oak afgerond kon worden. Je labervaring is onmisbaar en ik kon altijd 
214 
met vragen bij je terecht. Jammer dat we niet verder samen kunnen werken, want 
er is nog meer dan genoeg uit te zoeken. 
Pieter, toen we in Rotterdam gingen werken was je voor lange tijd mijn 
treinmaatje. Je verhalen over verre Ianden en de Volkskrant maakten het reizen een 
stuk aangenamer (als ik tenminste niet sliep). Sinds je naar Delft bent verhuisd lijkt 
het treinen naar Rotterdam een stuk Ianger te duren. Op het lab hebben we ook 
nog heel even samengewerkt. Je punctualiteit viel me al meteen op. Zo'n netjes 
opgeruimd buro als jij hebt zal ik wei nooit krijgen! 
Maarten, jouw levenstempo houdt volgens mij niemand bij. Naast een drukke 
baan heb je ook nog een intensief sociaal Ieven. Het was altijd heel gezellig met je 
op het lab. Met jou als paranimf aan mijn andere zijde kan het niet meer stuk. lk 
hoop dat je veel geluk in Engeland zult vinden. 
Annemarie, je stond altijd klaar voor een praatje of voor advies. Als jij er niet 
was, was het een stuk stiller op het lab. 
Jan-Maarten en Wilfried ook jullie waren erg behulpzaam. Gelukkig dat er nog 
mensen op het lab waren die iets van SPSS en statistiek af wisten. 
Annemieke, we zijn samen tegelijk begonnen met ons onderzoek op de VU. 
Oat het Ieven van een onderzoeker niet altijd over rozen gaat hebben we allebei wei 
gemerkt, maar de gesprekken in de Eend gaven me weer moed. Je werklust is 
ongeloofiijk en nu met Stijn erbij zal het wei niet gemakkelijk zijn om je proefschrift 
af te ronden. Veel succes ermee! 
Martie, ook jou wil ik op deze plaats bedanken voor de vele TGI bepalingen in 
de rattesera met die rottige FRTL-5 cellijn. De resultaten zien er nu veelbelovend uit. 
Hopelijk rolt er nog een artikel uit. lk vind het leuk dat je in mijn promotiecommissie 
zit. 
Verder bedank ik natuurlijk ook iedereen van de afdeling lmmunologie van de 
Erasmus Universiteit voor de fijne werksfeer en collegialiteit. De regelneven Tom en 
Henk stonden altijd voor je klaar, evenals de lieve secretaresses Geertje, Dany en 
Marjo. Annelies, jou wil ik even apart bedanken. Het was voor ons beiden ons 
eerste proefschrift (een uitdaging!) en volgens mij hebben we er samen iets moois 
van gemaakt. Zender je snelle en accurate hulp had ik het nooit gered. Natuurlijk 
heeft Tar ook in zeer grote mate bijgedragen tot het tot stand komen van dit 
boekje. Ondanks dat je het altijd zo ontzettend druk had wist je toch zeer snel de 
plaatjes af te krijgen. Jouw perfectionisme geeft de inhoud een professioneel 
uiterlijk. Ed, Henk en Corine van het CPS ben ik veel dank verschuldigd voor de 
perfects verzorging van de ratjes. 
Rene en Ronald bedankt voor het maken van de omslag. Bovendien bedank ik 
mijn familie, die mij altijd heeft gesteund. Een heel prettig gevoel. 
En Marcel..., van jou hou ik het allermeest! 
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